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SUMMARY
This thesis is divided into four sections with the 
addition of two appendices. The first section gives a brief 
summary of the theoretical justifications for undertaking the 
research and includes an account of the role of acetylcholine 
at the neuromuscular synapse and an account of the receptor 
theory of neuromuscular blockade. The classification of 
neuromuscular blocking agents is then discussed and a survey 
given of the two point, multi-point and one point attachment 
theories. These considerations are followed by a discussion 
of rigid bisquaternary molecules leading to an outline of the 
factors influencing the choice of the compounds whose syntheses 
were to be attempted and an account of the synthetic routes 
proposed.
The second section of the thesis is a report of the 
preparation and reduction of a number of methanesulphonates 
derived from hydroxy 5P- and 5a-cholanes. These studies were 
deemed necessary in view of the poor yields of p-toluene- 
sulphonates which were encountered in certain instances and 
indeed it was found that utilisation of methanesulphonyl chloride 
rather than the more commonly employed p-toluenesulphonyl 
chloride afforded superior yields of sulphonate esters. In the 
course of this work it was shown that the material previously
reported as 5a,12a-dihydroxy-5P-cholane was in fact a mixture of 
this compound with 12a,24-dihydroxy-5P-cholane. Selectivity of 
sulphonation of the hydroxyl groups at positions 5,7,12 and 24 
of the cholane skeleton is discussed. Lithium aluminium hydride 
reduction of the sulphonate esters was shown to hydrogenolyse 
the sulphonyloxy group when it is in the equatorial configuration 
and to generate the parent alcohol when the sulphonyloxy group 
has the axial configuration. Gas liquid chromatographic analyses 
of certain complex mixtures of steroidal hydrocarbons are reported.
The third section of the thesis reports the results of a 
study of the reductions under a variety of conditions, of 
12-oximino-5P”Cholane and 12-oximino-5a-cholane. In all instances 
only the 12a-amino compound was obtained and the assignments of 
configuration are rigorously proved. All attempts to obtain 
12p-amino compounds by nucleophilic displacement reactions were 
unsuccessful.
The fourth section of the thesis records attempts to 
synthesise various steroidal bisquaternary ammonium compounds.
Appendix I consists of the reprints of a review article 
entitled, ’Biological Activity in Steroids Possessing Nitrogen 
Atoms', published in two parts and prepared as a general background 
with which to place the present work in perspective. An addendum
indicates progress in the field since the review was published 
and points out several errata in the review.
Appendix II describes an attempt to isolate acovenoside A, 
which would have served as a suitable material for the preparation 
of 1-amino steroids, from the trunk wood of Acocanthera longiflora 
Stapf. However although present in the seeds and bark of this 
tree, acovenoside A was not present in the wood. Another hitherto 
unreported cardenolide glycoside was shown to be present but its 
constitution was not established.
INDEX OF CONTENTS
Page
INTRODUCTION   1
Section I. Theoretical Considerations;
The Role of Acetylcholine at the 
Neuromuscular Synapse. 3
The Receptor Theory of Neuromuscular Blockade. 5
Classification of Neuromuscular Blocking ^
Agents.
Two Point Attachment Theory. 9
Multi-point Attachment 1 15
One Point Attachment Theory. 14
Rigid Bisquaternary Compounds. 1*5
Approach to the Selection of New Rigid 
Bis-trimethylammonium Compounds.
Routes to the Bis-trimethylammonium Steroids. 24
Experimental 29
Section II. Methanesulphonates of Hydroxy Cholanes. 52
Experimental 47
Section III Configuration of 12-Amino Cholanes. 73
Experimental 93
Section 17 Syntheses of Bisquaternary Steroidal Salts* 116
Experimental 125
REFERENCES   155
Appendix I 
Appendix I Addendum 
Appendix II
#
,. ., ' ' ■ Ji i', '" ' %  !V''"
^  ' "  V,'
t i L A''j'rr ' ;1. ' I fc. K> -/ I- I, «
C
■}y U4-'
,Tf 13, /:i
\
lau.
: 11.1. ' 7CTU 4-JC
.'IT
,' I ' i vL:cm •v f fj'i i'
j ,i ' 'M' ■ * .7 (■:■, J.
■J,
I 'I I ■
r # b . .rl - ' I ' 4,"1 Ul, Tl J L.f : ^1* V . LJ"■■■■ c.Aji;-Lj. J-
I N T E O D Ü C T I O i r
CHaO 
T /3. E rythro id ine
CH3O
OH O
2X
H C+) T u b o c u ra r in e
—1—
In 1850 Pelouze and Bernard^ demonstrated, for the first time,
that blockade of the normal physiological events at the neuromasculaur
synapse was responsible for the characteristic paralysis of skeletal
muscle induced by curare. About twenty years later Crum Brown and 
2Fraser showed that muscle relaxant activity was associated with many 
chemically diverse quaternary aiitaioidal salts, even thou^ the 
corresponding tertiary bases had pharmacological properties vastly 
different from one another. The association between muscle relaxant 
activity and the quaternary Eunmonium function has thus long been 
recognised and subsequent chemical and ^diarmacological investigations, 
particularly with synthetic compounds, have served to strengthen this 
generalisation, although there are several important exceptions. For 
exajrrple the tertiary base p-erythroidine (l) exhibits greater neuro- 
muscular blocking activity than its corresponding metho-salts .
The successful isolation and chemical characterisation of tubo- 
curarine^ (ll), the active principle of the South American arrow poison 
"tube curare", coupled with the development of methods for its clinical 
use as an adjunct to surgery^ (inhere its muscle relaxant properties 
permit the use of lower doses of anaesthetic with consequent gain in 
safety margin) provided a new impetus to the study of muscle relaxants. 
This work has resulted in the synthesis and pharmacological investigation 
of a large number of structurally diverse quaternary ammonium conpounds, 
although comparatively few of these have seen clinical use. In 
particular, a great deal of attention has been paid to bis, tris and
—2—
tetra-quaternary ammonium compounds. The voluminous literature 
concerning these studies does not permit a detailed coverage to be 
given in this thesis, but a number of extensive reviews^ have recently 
been published on the subject to which reference may be made. The 
following discussion considers only those aspects of the published 
literature pertaining to attempts to coixelate neuromuscular blocking 
activity with chemical structure and in particular with the interonium 
distance in polyonium compounds.
S E C T I O N  I
THEOEETICAL CONSXDEEATIOnS
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The role of Acetylcholine at the Neuromuscular Synapse
In order to place the studies of neuromuscular blocking agents 
in their correct perspective, it is first necessary to consider the 
physiological sequence of events at the neuromuscular synapse and 
especially the role played by the neurohormone involved - acetylcholine.
Peitiaps one of tiriu greatest single aavances in the science of 
pharmacology was provided by the recognition that the conduction and 
translation of nerve impulses in the body involved the intercession 
of "chemical transmitters" or neurohormones. This had, as a result, 
the rational interpretation of the mode of action of many drugs in 
terms of their interference with the normal physiological history of 
these substances which are responsible for the transmission of nerve 
impulses from neuron to neuron, or from neuron to effector cell.
The existence of neurohormones was first suggested by Elliot® who 
postulated a substance "sympathin" (now identified as mixture of nor­
adrenaline and adrenaline) to be responsible for the transmission of nerve 
impulses from the nerve terminals to the effector cells in tissues innervated 
by certain nerves belonging physiologically to the synpathetic nervous system. 
Such nerves are now termed "adrenergic nerves". Recognition of the 
existence of a second neurohormone, now known to be acetylcholine (ill), 
followed as a result of the elegant studies of Hunt and Taveau^, Dixon^^, 
Dale^^, Loewi^^ and Dale, Feldberg and Vogt^^. This second neuro­
hormone is involved in the transmission of nerve impulses from the motor 
nerves to voluntary muscle, from parasympathetic nerve endings to their
-4-
ef fee tor organs, from all autonomic preganglionic fibres to the post­
ganglionic fibres, and from certain nerves belonging anatomically to 
the sympathetic nervous system to their corresponding effector cells.
Such nerves are termed "cholinergic nerves".
Briefly the sequence of events at .the neuromuscular junction 
(i.e. the area embracing the muscle eni plate and the terminations of 
the somatic motor nerves) can be described as follows. A nerve impulse 
after travelling the length of the nerve fibre brings about the release 
of acetylcholine at the nerve terminals and the liberated neurohormone 
diffuses across the synaptic gap between the nerve endings and the muscle 
end plate where it is adsorbed on the latter and induces a brief 
depolarisation. This depolarisation, vhich is associated with rapid
14change in the permeability of the membrane to sodium and potassium ions 
generates a wave of excitation propagating in both directions along the 
membrane of the muscle fibre and leads to the mechanical response, i.e. 
contraction. That there is no direct cytoplasmic continuity between 
nerve and muscle but merely a close association between the muscle 
fibre and the nerve endings^^, vdiich are extensively branched, has been 
firmly established by histological studies^®.
The actual process of liberation of acetylcholine is neither fully
17known nor eanily investigated but it is known that discrete quanta 
of acetylcholine insufficient in themselves to induce a mechanical response 
are continually released even when the muscle is at rest^® and that the 
nerve fibres are not the only source of acetylcholine^^. Moreover,
-5-
the release of acetylcholine in quantities large enou^ to induce a
20response in the muscle fibre appears to be a multistage process .
21Inorganic ions also play a role but again this is not fully understood . 
The acetylcholine within the nerve fibre is synthesised through the
noacétylation of choline by acetylcoenzyme A in the presence of choline
23acstylase and it is then stored in an inactive protein-bound form
in the fibre pending release^. Actually the existence of vesicles,
idiich are believed to store the bound acetylcholine, has been established
in the terminal portions of the motor nerves by means of electron
25microscope studies . Once the liberated acetylcholine has depolarised 
the muscle end-plate lAiich shows a high sensitivity towards this agent , 
it is then rapidly destroyed through hydrolysis to choline and acetate 
by the enzyme acetylcholinestrase^^, which is present in very high 
concentrations at the neuromuscular synapse^; this permits repolarisa­
tion of the end plate. It is of considerable interest, that it is only 
the external surface of the muscle end plate idiich is sensitive to
acetylcholine. Microinjection of acetylcholine into the muscle itself
20fails to induce contraction .
The Receptor Theory of Neuromuscular Blockade 
The fact that the external surface of the muscle end plate is so 
extremely sensitive to acetylcholine has given rise to the concept that 
incorporated in it are certain receptors for this neurohormone. These 
are considered also capable of occupation by the molecules of neuro­
muscular blocking agents which thus exert their action by competing with
—6—
the acetylcholine for access to the receptors.
30 . _Ehrlich was the first to formally postulate the existence of
receptors as a general concept applicable to the explanation of drug 
action. He defined a receptor as "that combining group of the 
protoplasmic molecule to which a foreign group, when introduced, 
attaches itself". The lock and key analogy of Fischer''^  and the 
concept of a "receptive substance" proposed by Langley^^ and Lucas^^ 
are further examples of early receptor theories. In the course of 
time these original ideeus have undergone considerable modification but 
the receptor theory of drug action is still in vogue to-day although 
little is known of the intimate nature of the majority of receptors 
lihose very existence is still inferential.
Despite attempts to present detailed pictorial representations
of various receptors^ there would appear to be several advantages in
accepting a rather generalised concept of the receptor such as that
35presented by Van Rossum and Ariêns . These workers visualise drug- 
receptor interaction as being essentially an interaction of fields of 
force originating in the drug molecule and in the receptor itself.
The ability of a drug to evoke a physiological response is then considered 
to depend upon two basic factors - the "affinity" and the"intrinsic 
activity" which by mathematical treatment can be shown to be represented 
by rational constants^^. The affinity of a drug may be defined as its 
ability to enter into complex formation with a given receptor and is 
inversely proportional to the dissociation constant of the drug-receptor
-7-
complex . The intrinsic activity, on the other hand, is a measure
of the power of the drug-receptor conç)lex to evoke a positive biological 
35response and arises as a proportionality constant relating the biological 
effect to the number of occupied receptors. Electrostatic and Van der 
Waals forces are assumed to play the dominant role in the formation 
of the -drug-receptor complex and the general interaction is considered 
to determine the affinity of the drug for the receptor^^. At the same 
time, certain specific interactions within the general field of force 
determine the "intrinsic activity" of the drug. Thus, for drugs showing 
an affinity for the acetylcholine receptors at the muscle end plate, 
those with a high intrinsic activity will mimic the action of acetyl­
choline whilst those with a low or zero intrinsic activity will antagonise 
the action of acetylcholine, i.e. function as antimetabolites. The 
concept thus accommodates two extreme types of blockade of the acetyl­
choline receptors at the muscle end plate. In one, drugs with high 
affinity and very low intrinsic activity will block the action of 
acetylcholine without any depolarisation, whilst in the other drugs 
possessing high affinity and hig^ intrinsic activity will block the 
action of acetylcholine but themselves produce a depolarisation. 
Representatives of both types are indeed known, as well as a number of 
drugs showing intemediate properties.
Occupation of the receptors normally occupied by acetylcholine 
molecules is, however, by no means the only way in which interference 
with the normal function of acetylcholine at the neuromuscular junction
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Pictorial representation of the acetylcholine receptor at the muscle end-plate as given by Waser in "Curare and Curare-like Agents" ed., Bovet, Bovet-Nitti and Marini-Betollo, Amsterdam, Elsevier, 1 9 5 9, p.2 2 7. A further description of the receptor has been given by Waser, Arch. Ces. Physiol., 1 9 6 2, 2 7 4, 4 3 1.
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may be brought about. Thus drugs such as the hemicholiniums are 
believed to act by blocking the synthesis of acetylcholine^*^,
compounds such as botulinum toxin are believed to act by blocking the
S8release of acetylcholine from its bound form and drugs such as 
neostigmine prevent the destruction of acetylcholine "by cholinesterase^^ 
idîilât pi*odeconium is believed to act at receptors other than those
40conç)etitively occupied by drugs such as décaméthonium and tubocurarine •
A detailed pictorial representation of the intimate nature of the
acetylcholine receptor at the muscle end plate has, however, been given
by Waser^^ and this is shown in Pig. 1. Experimental evidence, to
support the view that the receptor is a protein, has been provided by
42Nachmansohnaund his associates , and atten^ts have been made to achieve 
isolation of this protein by means of conqplex formation with radioactive 
muscle relaxants. Indeed after the earlier isolation of a strong but 
unspecified complex formed between the muscle relaxant gallamine and a 
mucopolysaccharide^^ more refined techniques have recently led to claims 
for the successful isolation and purification of a protein material^ 
vhich showed many of the characteristics of the in vivo receptor substance
Classification of Neuromuscular Blocking Agents 
It has now been established that the various muscle relaxant drugs 
do not act by identical mechanisms^^, eOLthough at one time all such drugs 
were grouped together regardless of their site or mechanism of action.
In recent years classification of muscle relaxants has been attempted 
both in terms of their mode of action and in terms of their chemical
-h
N CK 'n N
IV-
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structure. Thus Baton and Zaimis^ classified neuromuscular blocking 
agents as con^etitors (e.g. tubocurarine) and depolarisers (e.g. déca­
méthonium), but the recognition of compounds showing a "two phase" 
block^^ and the recognition of species variation in the mechanism of 
action of certain compounds^® have rendered this classification somevtiat 
unsatisfactory. Bovet^^ attempted to base his classification on the 
dimensions of the relaxant molecules and termed those muscle relfiLxants 
having long thin molecules, "leptocurares" and those with thick molecules, 
"pachycurares". Broadly the leptocurares corresponded to the depolarisers
and the pachycurares to the conqpetitors but there were several striking 
50anomalies . The basis of classification of muscle relaxant drugs 
suggested by Ariëns et al^^ which utilises the nature of the dose response 
curve obtfidned from experiments using the frog rectus abdominis prepara­
tion appears to be more satisfactory in so far as it is not rigid and 
allows for the variabilities in the biological response towards the 
muscle relaxants under different conditions'^.
Two Point Attachment Theory 
Since bisquaternary ammonium compounds are in general, much more 
potent neuromuscular blocking agents than mono quaternary compounds, 
greater attention has been focussed upon the synthesis and pharmacological 
studies of the former^^. Baton and Zaimis^^ have advanced a "two point 
attachment" theory to explain the high activity of such compounds as 
décaméthonium. In this, it is postulated that bis quaternary compounds 
interact simultaneously with two anionic sites in the receptor (IV)
••10—
giving rise to the concept of a **pharmacologically "bivalent receptor”^^ . 
Many experimental attenpts to define more closely the exact nature of 
these "bivalent" receptors have been made, and it has been possible 
to show that not only does the potency vary with change in interonium 
distance in the bis quaternary compounds, but also that the mode of action 
can change. Tills is well illustrated by reference to tiie phai-macological 
properties of the polymethylene bisammonium c o m p o u n d s T h u s  
décaméthonium is a powerful neuromuscular blocking agent, but lower 
homologues possess mixed ganglion blocking and neuromuscular blocking 
properties until the chain length is reduced to six carbon atoms when 
hexaméthonium, a potent ganglion blocking agent with weak non-depolarising 
muscle relaxant properties is obtained. Reduction in the chain length 
to below six carbon atoms or an increase to above ten carbon atoms 
results in a gradual loss of both muscle relaxant and ganglion blocking 
properties. Factors such as the bulk of the substituents on the 
nitrogen atoms and the presence of ether oxygen or other functional 
groups in the molecule are known to exert considerable influence on the 
pharmacological properties of muscle relaxants but the greatest attention 
has been paid to attenpts to correlate the type and degree of activity 
with interonium distance. Unfortunately nearly all such studies have 
been conducted with non-rigid molecules capable of existing in an infinite 
number of conformations, thus denying unequivocGil determination of the 
exact distance between the anionic sites of the receptor.
Consideration of the homologous series of polymethylene bisquaternary
CH CH.'3CHg—  N —  (CHg^^—  N — CH; 2 X
CH3 CH3
V  Polymethylene bism ethonium  
com pound Ç S e m r ^ J  -formu/s')
Staggered E clipsed
VI
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ammonium compouxids (V) led to the observation that^^ for optimum activity 
the interonium distance should be about 14^. This figure was based 
on the fact that the maximum neuromuscular blocking activity displayed 
within the series was shown by décaméthonium (V, n = 10) and on the 
assumption that the interonium methylene chain of this confound would 
remain fully extended during complex formation with no eclipsed inter­
actions (Vl) within the chain. tloreover, it was claimed that the 
ovalue of 14A. would also accommodate tubocurarine despite the difference 
in the mode of action of the two compounds. It is to be noted, however, 
that examination of Dreiding models shows that tubocureirine also possesses 
a flexible molecule #iich allows considerable folding and gives interonium 
distances ranging from about to a maximum of 12& (VIl). There is 
no a priori reason #iy either décaméthonium or tubocurarine should react 
with the receptor in its thermodynamically most stable conformation.
57The fact that tubocurarine does show weak ganglion blocking activity 
in addition to its muscle relaxant properties could be taken as supporting 
evidence for the existence of conformational changes within biological 
systems. Indeed Burger^^ considered the possibility that the poly­
methylene chain of décaméthonium might not necessarily be in its most 
extended conformation but nevertheless concluded that it probably was, 
due to mutual repulsion between the two positively charged nitrogen atoms. 
He thus neglected the opposing influence of entropy irtiich would tend 
to create the coexistence of numerous conformations within a given 
population of bis quaternary molecules. Burger further considered the
b c
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molecules of the bis quaternary compound to be spread in a monomolecular 
layer over the end plate (a contention supported by the experimental 
work of Waser^^ using labelled calabashcurarine) with the positive 
onium groups assuming as close a juxtaposition as possible to the anionic 
groups of the receptor. This would lead to the most extended conforma­
tion only if the anionic heads of the receptors are separated by a distance 
of 14& or more (Fig. 2a). Should the distance be less than 14%, buckling 
of the polymethylene chain from its most thermodynamically stable extended 
conformation would be expected to follow as a result of the diminished 
repulsion between the onium centres consequent upon the attraction of 
each for the anionic sites in the receptors (Fig. 2b). Alternatively, 
idien one cationic charge is idiolly or partially neutralised by one 
receptor anion, intramolecular repulsion between the onium groups in 
the polymethylene compound disappears (or at least is greatly reduced) 
allowing the other onium centre to move closer to the first (Fig. 2c). 
Again although little is known concerning the exact nature of the forces 
involved in drug-receptor interaction, it would seem safe to assume 
(by Einalogy with known physical and chemical processes) that energy must 
be supplied in order to give rise to drug receptor complex formation.
Thus an increase in energy can be considered necessary in order to pass 
from the system, "drug molecule and receptor" (A - Pig. 3), to the system, 
"drug-receptor complex" (B - Pig. 3) via point C on the energy diagram, 
and one way in #iich this energy could be supplied would be for the drug 
molecule to leave its thermodynamically stable conformation. Hence
VÏÏT a
+ X H
C H 3 
V lli Tbxiferine  I
2 x=
CgHg—  N . CHg.CHp-O 
C2H 5-
CHg.CHg.Nç C2H5
C2H5 ,CoK+ /-2' '5O CH5.CH5. N — CoH\ ’2‘ 'S 31CgH2‘ «5
IX  G a lla m in e  T r ie th io d id e
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arguments based on the thermodynamically most stable conformation of 
the isolated drug molecule have no necessary validity vAien applied to 
deductions concerning the nature of the receptor.
There are actually a number of experimental observations -which 
slIso controvert the postulated interonium distance of 14%. Thus cyclo- 
octadecaiie-l,lC-bis (trimethyl aininoxiium) iodidef'gailamine^^ and 
hexaméthonium^^ as -well as several polyme “thylene bis (tropinium halides)^^ 
with a maximal interonium dis“bance of approximately display high 
muscle relaxant activity. Furthermore, Lewis et al^  ^have recently 
shown that potent neuromusculai' blocking properties are present in a 
series of polyonium compounds having interonium distances lower than 
the I4S value and “they have also suggested as “the optimum distance 
between recurring anionic receptor sites. This value is in close
64agreement with the interonium distance in the fully rigid toxiferine I 
(VIIl) n^ich has been calculated to be
Multi-point Attachment 
The hi^ muscle relaxamt activity displayed by certain bis quaternary 
compounds inspired the preparation of a number of tris, tetra, penta 
and hexa ammonium compounds in the belief “that vdiereas “the bis quaternaries 
would span “two anionic sites, suitable polyonium derivatives would be 
capable of interacting with several anionic sites, thus producing more 
potent compounds. Of the compounds so prepared, none has shown any 
truly significant increase in potency over the bis quaternaries, however. 
Gallamine, a tris onium compound (IX), has been employed clinically
Ach
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A
CH
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C H CH
C
Fi g-5.
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because of its freedom from side effects®^, but in fact it is only 
one-fifth (weight basis) as potent as tubocurarine®^. It has been 
suggested that the centreil ammonium chain in gallamine acts 8ts a 
stabiliser to keep the other two amiaonium groups at a certain optimum 
distance apart (S&)®^.
One Point Attachment Theory 
Although the two point attachment theory has never been totally 
refuted, some pharmacologists believe that it has been overs tressed. 
Loewe and Harvey^® have postulated a one-point attachment theory, 
according to which only one cationic head of the drug molecule interacts 
with the receptor whilst the bulk of the molecule shields the receptor 
with the second cationic group exerting a repulsion against incoming 
acetylcholine molecules (Pig. 4). This theory, idiich is called the 
"adumbration theory" has been extended to ganglion blocking agents by
goFakstozp and others . Again, conduc time trie experiments have shown 
the extreme stability of the ion pair involving a single anion and a 
bis quaternary ammonium cation in aqueous solutionswhich raises the 
possibility that the receptor complex could be of type A rather than 
type B (Pig. 5). It is also possible that the receptor conplex could 
be of type C.
—15“
Rigid Bisquaternary Molecules 
In view of the ambiguities inherent in all attempts to deduce
theinformation concerning the anionic centres of^receptor site from 
conformationally non-rigid molecules aa just outlined, it appeared 
an attractive proposition to prepare a number of conformationally 
rigid bis quaternary ammoiiiuja salts each having a different interonium 
distance. Although the receptor could conceivably be non-rigid and 
adjust itself to suit the demand of a given rigid molecule (the so 
called "induced fit" theory^) demonstration of activity in one rigid 
bis quaternary salt and absence of activity in another with a different 
inter-group distance would represent a great advance. Very few such 
compounds^^* have so far been investigated for muscle relaxant 
activity and there is no report of a systematic approach towards this 
problem. Toxiferine I and the related calabash curare alkaloids 
would appear to be the only such naturally occurring rigid molecules 
studied.
Moreover, it was considered that the preparation of a series of
rigid bis quaternary salts would be of interest from another point of 
72view as Gill has proposed that completely rigid molecules might prove 
inactive due to variability in the receptors and the need for a certain 
degree of flexibility in the drug molecule to ensure that an appreciable 
percentage of the available receptors can be occupied. This generalisa­
tion vAiich rests on the absence of ganglion blocking activity in such 
compounds as the completely rigid NNRN tetramethyl p-phenylenediamine
C H . .  + / C H ,vS—  M — éy - N - C H g  21 
\ = /  ^  C H 3
X  NNNN" letramethyl-p-phcnylene- 
diam ine d im e th io d id e
A
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dimethiodide (X)^^ and some furan derivatives still retaining a limited 
degree of rotational flexibility*^^ certainly requires further substantia^ 
tion. There would appear to be no a priori reason why some receptors 
(such as those involved in ganglion blockade) should not accept rigid 
molecules v^ilst others (such as those concerned in the action of the 
steroid hormones) obviousxy can accept the rigid oestrone or testosterone 
molecules, and so the possibility that the rigid molecules selected by 
Gill have the wrong interonium distance cannot be overlooked.
The present project to synthesise rigid bis-trimethylammonium 
compounds with varying interonium distances was therefore undertaken 
in the hope that ^jiarmacological evaluation of such compounds might 
more closely define the nature of the distance between recurring anionic 
receptors. The studies were confined to the t rime thy launmonium conpounds 
so as to maintain uniformity of the cationic heads and on account of 
steric considerations in the molecules concerned (vide infra).
Approach to the Selection of New Rigid Bis -Trimethylamnonium Compounds
The first problem in such a project was the selection of a suitable 
molecular framework on #iich to base the rigidly held onium groups.
Such a framework had to provide severatl sites at which to place the 
quaternary nitrogen functions in order to afford a series of confounds 
with different fixed interonium distances, end at the same time it had 
to be readily available. The choice therefore logicadly fell on larger 
polycyclic systems as these not only fulfilled the requirements but also 
provided for larger inter-group distances than were possible in mono
(a) Phcnanthnene
IIII
(b) Perhydrophenanthnene. 
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i9
18
II 13c 14
B 76^ /
R= C-17 S id e  C h a in
x n
Genera/ Steroid S/ce/eton 
Cyclopentanoperhydrophenanthnrne
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or bicyclic systems. Aromatic systems were rejected, on the grounds 
that the substituents would be held in the plane of the flat molecule 
(XIa) and it was felt that if the receptor was not itself planar, 
suitable steric fit might not be achieved. On the other hand, were 
the ammonium groups to radiate away from the plane of the molecule, 
as is possible in alicyciic sys terns(XId) , xhe probability of tneir 
being able to interact with the receptor would be enhanced. Apart 
from steric considerations, incorporation of aromatic characteristics 
was felt to be undesirable, because of modification of the chemical 
properties of the substituents. For example aromatic amines are 
wesLk bases and phenols are acidic. Pharmacological evsiluation of 
aromatic quaternary ammonium compounds also indicates that such compounds 
show weak muscle relaxant activity^^.
The ultimate choice fell on the steroid nucleus (XII) which was 
considered a suitable structure for the following reasons:
a) Being con^ josed of four rigidly interlocked rings, it provided 
a uniform skeleton for the synthesis of several bis-trimethylammonium 
compounds of varying interonium distances.
b) The chemistry of the steroids has been thoroughly studied 
providing a large body of background knowledge #iich would be expected 
to reduce greatly the amount of preliminary investigations necessary.
c) Several steroidal derivatives are readily available as starting 
materials.
d) Conformational analysis has been well applied to this group 
of compounds.
—18—
e) The utilisation of the steroid skeleton was regarded as favourable 
from the biological point of viev/ since the coupling to this predominantly 
lipid soluble nucleus would be expected to confer upon the trimethyl- 
ammonium groups, a certain degree of lipid solubility and perhaps also 
more favourable adsorption properties. Since the plasma proteins are 
or such a nature as to readily bind cholesterol, it was further conceivable 
that such steroidal compounds could use an existing transport mechanism 
although it must be admitted that binding to the blood proteins might 
produce sensitisation effects. These considerations are inherent in 
the "supporting moiety theory"^^ which contends that the molecules of 
pharmacologically active substances consist of a radical moiety, determining 
the type of aotivity displayed, and a supporting moiety conferring affinity 
for the site of action. Cavallini and his colleagues'^ *^  vho formally 
stated this theory, employed several nitrogenous steroids in their 
early experiments. The actual compounds included the p-diethylaminoethyl 
ethers of oestrone, testosterone and 3o-hydroxy-17-oxoandrost-5-ene and
the bis-p-diethylaminoethyl ethers of oestradiol and 3,17-dihydroxyandrost-
78 795-ene . The combination of a "stripped down" drug molecule or radioed.
moiety (diethylaminoethanol) and the steroidal supporting moiety produced 
drugs with potent coronary vasodilator properties®^* whilst the 
bis quaternary derivatives from the two diether compounds showed curare­
like properties®^* The quaternary salts also showed vitro
opeuiticholinestrase activity . Quatemeury salts derived from the mono­
die thylaminoe thyl ethers exhibited ganglion blocking activity^^.
CH,-N
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The present project received further encouragement from the reports 
of the potent neuromuscular blocking properties displayed by the recently 
characterised practically rigid bisquaternary steroidal alkaloid 
malouetine (XIIl), n^ich occurs in Malouetia be quaertiana^^. This
compound has been shown, in preliminary experiments, to possess 
competitive neuromuscular blocking potency quanîitativeiy similar to 
that of (+)“tubocurarine #iilst being only one third as toxic®^, and 
so malouetine or structurally related drugs could conceivably offer 
alternatives to tubocurarine as adjuncts to surgery. The remaining 
three possible isomers of malouetine involving the configuration of 
the nitrogen atoms, namely the bisquatemary bases in which the nitrogen 
atoms are in the 5P“20p“, 3a^ 20or- and 3a-20p“Configuration have been 
prepared synthetically®^ though the potency of these compounds as muscle 
relaxants has not been reported. Although the molecule of malouetine 
is not completely rigid, due to rotation about the C“17, C“20 bond, 
measurements using Dreiding models (Xllla and b) show that the range 
of variation does not exceed ca 1.5& frcan the maximum possible interonium 
distance of ca 11.bX.
Apart from interest in the bis quaternary steroidal compounds, it 
was also conceivable that the primary and tertiary steroidal amines,
"#iich would be intermediates in the syntheses of the bis quaternary 
compounds, themselves mi^t well be of pharmacological interest. . 
Pronounced pharmacological activity is characteristic of many nitrogenous 
steroids but there had been no comprehensive treatment of the subject
3R
2 b =3
c = tra n s  A /B
xn:
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R = Acovenos<2 CCiHjjOs)
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at the time the work described in this thesis was undertaken.
Accordingly the biological activity found in nitrogenous steroids was 
reviewed in connection with the present work®^. Reprints are included 
as appendix I.
The conformational formulae of three steroidal systems (XIV) illus­
trate those positions in the zuolecule #mere substicuents project below 
the plane of the molecule on the a face, and it was decided to utilise 
certain of these positions in order to avoid steric interference from 
the p-oriented angular methyl groups at C-10 and C-15 Euid the side chain 
at C-17. As it is difficult to introduce substituents at the tertiary 
carbon atoms 0-5, C-9 and 0-14 attention was directed in the first 
instance towards securing substitution at 0-1, 0-3, 0-7 and 0-12.
Steroids bearing suitable substituents at 0-1 which would permit 
the introduction of a nitrogen function at this position are not readily
available but Acovenoside A (XV)®®, a cardiac glycoside occurring in
87Acocanthera longiflora Stapf. , appeared to be a convenient starting
materiSLl for the preparation of 0-1 amino steroidsi ' An attempt'was ' 
therefore made to secure this conqpound from the trunk wood of this plant 
which was available in large quantities. However, examination revealed 
that this material, unlike the seeds, wood bark and root bark^^, did not 
contain detectable quantities of Acovenoside A although other known 
"chloroform insoluble" glycosides®^ were present in hi^ percentage.
In addition the extract also yielded a steroidal glycoside in about 
0.0^ yield, which appeared to be a new compound belonging to the
a
C O O H
C h o l ic  A c id  : ^ 2 = ^ 3  = O H
D e o x y c h o l ic  A c id  : R,= ^ 3 = OH, R ^ - H
Chenodeoxycholic Acid:  R, = R2=OH^  R3=H.
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" chloroform soluble" fraction. As Ac ovens ide A ims not readily 
available, this work was not pursued further. A brief account of 
it appears in appendix II.
The readily available bile acids (XVI) offered eui obvious dioice 
of starting material as they provided a means for facile attack at 
Ü-5, 0-7 ana 0-12. These compounds possess a cis A/B ring junction 
but conversion into the trans A/B series via A compounds is a well 
established procedure. Measurements on Dreiding models of the distances 
between the centres of the substituents in the a positions at C-5,
C-7 and C-12 show that the values are approximately as follows : -
g-Substituents on; Intergroup Distance
A/B cis steroids C-3, C-7 4.5&
4.2S
5.aS
A/B trans steroids C-5, C-7 5.lS
4.2X
6.eS 3
4- ■ !steroids C-5, C-7 5 #Ck^
4.1&
6.8&
— C-7
0—7, 0-12
0—3, 0-12
0—3 0-7
0—7, 0-12
0—3, 0-12
0—3, 0-7
0—7, 0-12
0—3, 0-12
T r im e th y la m m o n iu m  group  
F ig .6
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Since the long diameter of the ovoid envelope bounding the 
trimethylamino group as measured from catalin models is ca (Fig. 6) 
it is clear that in addition to the charge repulsions between pairs 
of trimethylammonium substituents in the 3o^, 7o- and 12o- positions, 
severe steric interactions between such pairs of substituents will 
cocur in all the abuve compounds except the 3,12 bis quaternaries.
It is to be emphsLsised, however, that these steric interactions can 
be lessened through suitable geometrical adaptations of the trimethyl- 
ammonium groups themselves and through certain changes in the geometry 
of the steroid nucleus^ via bond angle distortions and so consideration 
of models alone is no sure guide to the possible existence of a molecule. 
For example in the present work construction of a catalin model of 
12o- trimethylammonium-5p-cholane was difficult due to non-bonded 
interactions with the axial hydrogen atoms on C-9 and C-14, yet the 
compound was successfully prepared.
Nevertheless, consideration of models led to the conclusion that 
steric hindrance was particularly unfavourable in all compounds showing 
an interonium distance of 5% units or less and so compounds of this 
type were not considered further. It was also noted that in the cis 
A/B series it was not possible to construct a model incorporating 
a trimethylammonium group in the axial configuration at G-7. In 
addition to the normal 1, 5 non-bonded interactions with the axial
 ^ ÛÛ^ Of the work of Ourisson and his colleagues in the dipterocarpol series .
• NH;
3a, I7a-diam inoandrostane
zvn
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hydrogen atoms on C-9 and 0-14, the 7a position in cis A/B steroids 
suffers âttong steric interaction from 0-4. Preparation of ammonium 
salts possessing N-alkyl substituents higher than methyl would be 
expected to be extremely difficult.
Attention was therefore directed in the first instance towards 
the syntheses of the 3a, 1 tiimeth^lamiuonium derivatives of tiie 
5o and 5p series utilising desoxycholic acid as starting material, 
although attempts were also made to prepare 3a, 7o-bistrimethylammonium- 
cholestane from 7-ketocholesteryl acetate in order to ascertain if a 
rigid bisquaternary salt of interonium distance as low as 5.1& was 
indeed capable of synthesis.
Attention was also directed towards the synthesis of 3a, 17a- 
diauidnoandrostane (XVII) as the interonium distance of 9.s8 in this 
compound falls very close to that of toxiferine I and so it would be 
expected to yield extremely valuable information, after pharmacological 
study, concerning the importance of interonium distance.
In the course of the above synthetic work detailed investigations 
on methanesulphonate formation and on the configuration of the amino 
group at C-12 in the cholane series became necessary and the undertaking 
of this work precluded the extension of studies to other confounds with 
interonium distances greater than 9.52. Suitable compounds possessing 
such large interonium distances could be prepared by the addition of 
a pre ring A through application of the Robinson-Mannich reaction®^ 
to suitably substituted steroidal 3-ketones by analogy with the 
work of Ourisson*s school^.
L a c to n e
Y v m
■
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Routes to the Biatrimethylammonium Steroids
As mentioned in the earlier part of this thesis, the readily
available bile acids appeared to be promising starting materials for
the proposed syntheses of the rigid bis quaternary compounds. In
the first instance it was considered highly desirable to achieve total
elimination of any functional group in the side diain. Apart from
the likelihood of interference with certain of the necessary chemical
conversions at the substituted nuclear centres, there was the strong
possibility that a side chain substituent might itself show an affinity
for groups in the receptor and so prevent the acquisition of unambiguous
information concerning interonium distances alone on biological evaluation.
Intramolecular hydrogen bond formation would also be expected to occur
between certain substituents at C-12 and C-24, again introducing
intangible factors into the interpretation of the biological results.
The presence of a side chain in the 17p position per se was not
considered disadvantageous for like the angular methyl groups in the
P-positions at C-10 and C-13, it would be so oriented as to leave the
o-face of the molecule with its appended axial nitrogen functions free
frcxn steric interference to drug-receptor interaction.
Direct decarboxylation in the bile acid series would be expected
to be difficult owing to the already established facile nuclear dehydration^^
at the high temperatures employed, or to intramolecular reaction between
the side chain arid C-12, leading to lactone formation (3CVIII) '^ere there
92IS a hydroxyl group present at C-12 or to condensation to form
HX U .
C O O H
D e h y d ro c h o lic  a c id
XX
O OH
O
L a c to lXXI
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derivatives of the cholaLnthrene ring system^XIX), -where the 12- 
substituent is a keto g r o u p A c t u a l l y  there would appear to be no 
reports in the literature of successful single decarboxylations of 
substituted cholanic acids by the standard procedures employing metal 
salts and soda lime, or copper powder and quinoline.
preliminary studies undertaken in connection with this thesis 
showed that decarboxylation did not take place vhen dehydrocholic acid 
(XX) was heated with copper powder in quinoline. In addition to the 
recovery of starting material, a neutral compound was also obtained 
in good yield. This compound analysed for ^ 24^54^5 showed a 
characteristic large ring lactone absorption in the infra red at 
1735 cmT^ in addition to six membered ring ketone absorption at 
1700 cm*"^  and broad OH stretching from ca 3400-2650 cm~^. It was 
readily converted into the parent acid on treatment with hot alcoholic 
alkali and also formed the trioxime of dehydrocholic acid on treatment 
with excess of hydroxylamine under basic conditions. These observations 
indicate that the neutral product was the lactol (XXI) resulting from 
cyclisation between the carboxylic group of the side chain and the C-12 
0X0 group. Presumably the reaction conditions were not sufficiently 
vigorous to give a cholanthrene derivative by loss of carbon dioxide 
and water.
A number of indirect methods for the removal of the carboxylic 
function in the bile acid series have, however, been reported in the 
literature. These include application^ of -the mixed Kolbe synthesis^^
HO
HO
C00H(CH3)
UAIH4
HO
ÜAIH.
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CH2OH
CH2O. pTs
HON
Li AI H4
KzCOg
CH3\
CH
N
HiNO H
HON
CHs CH3
HCHO + HCOOH
CHi CH.I^CHs 
N ©
Fig. 7.
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96uriaich affords an extension of the side chain, application of the 
Hunsdiecker reaction®'^ , application^® of the Curtins reaction^^ to 
the derived acid aside followed by reductive deamination, and reduction 
of the carboxylic function to the corresponding primary alcohol^^^ 
followed by reductive elimination of the derived p-toluenesulphonate^^^.
The uientioned procedure appeared the most attractive as it
could be utilised in conjunction with selective attack at the nuclear 
centres thus reducing the number of stages, in the chemical trans­
formations, to a minimum.
After removal of the side chain function via the sulphonate ester, 
it was planned to employ various combinations of selective esterifications^^^, 
oxidations^^^ and reductions^^^ already established in the steroid series, 
to yield diols with different combinations of the hydroxyl groups on two 
of the possible C-5, C-7 and C-12 positions. These in turn were to 
be converted into the corresponding diketones and thence into the dioximes, 
on which stereoselective reduction techniques were to be used in order to 
give the required aixisl primary diamines. Finally, méthylation and 
quaternisation were to be employed to give the bis quaternary salts.
An outline of the application of these procedures to the preparation 
of 5a, 12a-bis-dimethylaunino-5p-cholane bis-methiodide is illustrated 
in Pig. 7 to indicate the general approach.
Preparation of the bis quaternaries of the 5o-series was to be 
achieved by utilising the well established 4-bromination of 3-oxo- 
6p-steroidsfollowed by dehydrobromination to the corresponding
o H
Br,
O
HO H
Fiq. 8.
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compound by means of collidine^^^ or other methods^^^. Reduction of
the 3-0X0-4 -ene by means of an exact equivalent of lithium in liquid
ammonia would then afford the 3-oxo-5a-steroid^^® and with an excess
109of lithium in liquid ammonia would afford the 3p-hydroxy-5o-steroid 
(Fig. 8).
rreiinunar'y investigation of oxime formation with dehydrocholic 
acid followed by the application of severail different reduction
procedures served only to confirm the difficulties, already reported
111 & in^literature , in obtaining the triamine in^pure state. The
previously reported procedure for the preparation of the trioxime using
methanol as solvent^^^ was found to be unsatisfactory, probably on
account of precipitation of the highly insoluble dioximes during the
reaction. However, use of a higher boiling alcohol or tetra hydrofuran
as solvent gave a satisfactory yield of the trioxime. Lithium
aluminium hydride in ether/tetrahydrofuran, even on prolonged refluxing,
failed to reduce any of the oximino groups of trioximino-methyl
dehydrocholate. The only group attacked was the ester group yielding
ttxea C-24-hydroxy compound. In view of the reports in^li te rature that
oximino groups at C-3 and C-7 in the steroid series are readily reduced
112by lithium aluminium hydride , it appeaired that the hydroxyl group 
at C-24 was complexing with the reagent, preventing further attaick on 
the oximino groups through unfavourable solubility. Catalytic 
hydrogenation, on the other hand, proceeded extremely slowly and 
incompletely. The partiadly hydrogenated "mixture" after chromatography
12-0X0- 5^ - c h o l a n ezxn
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gave no pure crystalline material nor would it yield crystalline salts 
with acids.
In view of the difficulties encountered in these preliminary 
experiments, it was deemed necessary to undertake a separate investiga­
tion of the 12-oximino function since it appeared to be this group 
Wiiich wati responslDle for the incomplete catalytic reductions. The
formation and reductions of oximes at C-3 and C-7 had already been
113studied in detail and considerable information concerning these 
compounds and their derivatives was available. On the other hand 
very little attention had been paid to the 12-oximino function^^^.
In order to study the 12-position without interference from other 
substituents, a procedure affording 12-oxo-5p-cholane (XXII) in good 
yield via 12o^hydroxy-6p-cholane was evolved and in the course of this 
work it was found that methanesulphonate esters afforded a more acceptable 
route than the more commonly employed p-toluenesulphonate esters. 
Accordingly a survey of selectivity of methanesulphonate formation and 
the behaviour of the esters on lithium aluminium hydride reduction was 
undertaken. The results of these studies are reported in Section II 
of the thesis.
The information obtained on reduction of 12-oximino-5p-cholane 
was of sufficient interest to warrant study of 12-oximino-5o-cholane.
The studies on both of these compounds are reported in Section III of 
the thesis.
The studies directed towards bistrimethylammonium salt formation 
form the substance of Section IV.
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EXHSRIMEMTAL
Lactol of Dehydrocholic Acid (XXI) ; CommercifiLl dehydrocholic acid
(XX) (4.0 g.) in freshly distilled quinoline (40 ml.) was heated under
nitrogen with copper bronze powder (l.O g.) for 3 hr. at 190® to 230® C.
The reaction mixture was cooled under nitrogen overnight and filtered.
àüdition of excess of hydrochloric acid (6h) to the filterate gave a
precipitate which was taken into chloroform, waahed with water and
the organic solvent removed under reduced pressure. Digestion with
ether left a noncrystalline solid, idiich was fractionally recrystallised
from methanol, yielding unchanged dehydrocholic acid as the least
soluble fraction. The more soluble fraction on further crystallisation
from methanol gave needles of the lactol (l.Og, 25^), m.p. 136-142®,
[a]^ + 21 ♦ 2 (2.1^ CHCl,). (Pound: C, 71.22; H, 8.53.DC24H34O5 requires; C, 71.64; H, 8.4^). Infrared in nujol mull 
showed hydroxyl absorption (3400 - 2650 cm*^) ketonic absorption (1700 cm 
and lactol carbonyl (1735 cm“^).
Refluxing the lactol (0.24 g.) in methanol (lO mis.) with hydroxy­
lamine hydrochloride (0.14 g.) and sodium acetate (0.3 g.) in the 
presence of water (l ml.) for 6 hr., converted the lactol into the 
trioxime of dehydrocholic acid, m.p. 265-272 (deconç).) (reported 
273-274 ( d e c o m p . ( P o u n d ;  C, 63.95; H, 8.66; N, 8.88. 
Calculated for Cg^gyO^Ng. C, 64.14; H, 8.90; N, 9.35^ o).
Hydrolysis of the lactol with hot alcoholic sodium hydroxide gave 
dehydrocholic acid m.p. 234-236, and mixed m.p. 234-237.
—30-
Reduction with lithium a.1 nm-i ni iim hydride in tetrahydrofuran gave
5,7,12-trioximino-24-hydroxy-Sg-cholfiine, crystallised from methanol, 
plates m.p. 260-270 (deconç).),. [a] 4^ 40 ♦ 2 (2.0% CHCl^ 4 EtCH 4:1).
(Pound: C, 65.87; H, 9.38; N, 8.96. C24H59O4N3 requires C, 66.35;
H, 9.20; N, 9#6*^ ). The same confound resulted from the action of 
lithium aluminium nydrioe (o-7 equivalents^ in tetrainydLroiui'an on the 
methyl ester of the trioxime of dehydrocholic acid m.p. 265-275 (deconp.) 
mixed m.p. 265-275 (decomp.).
Attempts to further reduce purified 3,7,12- trioximino- 24-hydroxy- 
5p-cholane with lithium aluminium hydride proved unsuccessful and the 
unchanged trioxime was recovered in virtually quantitative yield.
Trioxime of Dehydrocholic acid Methyl ester: Dehydrocholic acid was
converted into its methyl ester by the method of Borsche^^^ m.p. 244-47
110(reported 241-242). Alternatively the action of diazo-methane in 
methanol/ether afforded the same con^ounoL. It was found convenient
to modify the previously reported^^^ procedure for conversion of the 
ester into the trioxime.
Me thyldehydrocholate (0.5 g.) in ethanol (35 mis.) was re fluxed 
with hydroxylamine hydrochloride (0.31 g.) and sodium acetate (0.65 g.) 
in the presence of water (3.5 mis.) for 6 hr. After steuiding overnight 
the product had separated as plates. Recrystallisation from ethanol 
gave 0.5 g. (9C^ o) m.p. 258-260 (decomp.), reported^^^ 265-266 (Pound:
C, 64.94; H, 8.69; N, 9.27. Calculated for CgghggO^N^: C, 65.03;
H, 8.51; N, 9.12^ 6).
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Repeated attenpts at catalytic hydrogenation employing a platinum 
oxide catalyst in acetic acid failed to yield a homogenous product.
The maximum uptake of hydrogen observed in these experiments was ca 
5 moles in 80 hr. (theory requires 6 moles for reduction of the three 
oximino groups).
S E C T I O N  II
METHANESaLEBOKâTES OF HIDHCQCZCQOLANES
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As outlined in Section I of this thesis, it was necessary to achieve 
selective removal of the functional groups in order to utilise the 
commonly available bile acids as starting materials for the syntheses 
of the desired bi s trime thylammonium steroidal bases. Initially, this 
was attempted by selective ^ toluenesulphonic ester formation followed 
Dy lithium aluminium hydride reduction, but the poor yield of the 
2-toluenesulphonates obtained in certain instances made it higjily desirable 
to evolve a more satisfactory procedure. The reason for the low yield 
of the j^toluenesulphonates was not immediately apparent, but in view
1 1 C  1 T 17of the work of Leanza £t al and Madaev and Babanova who showed 
that pyridinium salt formation occurred on treatment of certain hydroxy- 
steroids with ^ -toluenesulphonyl chloride in pyridine, it would seem 
likely that a similar reaction was occurring in the cholane series.
Such pyridinium salts would be expected to be water soluble and so be 
readily lost in the aqueous layer during the working up of the reaction 
mixture.
It was decided to substitute methanesulphonate formation for
2-toluenesulphonate formation, the decision being based on two main
considerations. Firstly, the rate of reaction of hydroxy compounds
in pyridine with methanesulphonyl chloride is well known to be much
faster than that with p-toluene sulphonyl chloride - the former proceeding
readily at 0 %  whilst the latter often requires prolonged treatment
118at elevated temperatures . Secondly, the results of solvolysis rate 
studies have indicated that the p-toluenesulphonate anion is a better
—33—
n oleaving group than the methanesulphonate anion in Sjj displacements 
Although rates of solvolysis depend upon the dielectric constant and 
the molar volume of the solvent^^ and idiile the rate studies were 
for water not pyridine, it was reasoned that the steroidal methane- 
sulphonates would be less likely to suffer nucleophilic attack by 
pyridiiie to give pyridinium salts than their p-toluenesulphonate analogues.
Accordingly a thorough investigation of methanesulphonate formation 
in the hydroxycholane series was undertaken and the results of these 
studies as well as comparisons with p-toluenesulphonate formation are 
described in this section of the thesis.
Previous studies of methanesulphonate formation at the 3- and 6- 
positions of the steroid nucleus^^ had given rise to the généralisation^^^ 
that methanesulphonate formation was less selective than p-toluenesulphonate 
formation, but for the compounds studied in the present work it was found 
that not only were the me thane sulphonate s formed in better yield than the 
corresponding p-toluenesulphonates but also that a conç>arable selectivity 
of attack existed for both reagents. In neaurly all cases, the sulphonate 
esters did not crystallise readily and so they were characterised by 
means of infrared analysis and by the crystalline products obtained sifter 
reduction with lithium aluminium hydride. Similar difficulties in
obtaining ciystsilline p-toluenesulphonates and acetates of certain hydroxy-
123cholane derivatives have been reported by Blickenstaff and Chang 
These authors silso quote other examples of such difficulties reported 
elsewhere in the literature.
H O ­
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As expected, all the compounds studied idiich possessed a primary 
alcoholic group in the C-24 position (formed by the reduction of the 
bile acid carboxylic group by lithium aluminium hydride^125j reacted 
readily with one equivalent of methanesulphonyl chloride in pyridine 
at 0 %  but only in those compounds lacking an equatorial hydroxyl group 
in Uie Ü-3 position, was attack confined to the C-24 position. In 
both the 5a- and 5p-cholajie series the equatorial secondary hydroxyl 
group at C-3 was virtually as reactive as the primary hydroxyl group 
at C-24. Thus 3a,12a,24-trihydroxy-5p-cholane (XXIIl), prepared in 
conç>arable yield by the action of lithium aluminium hydride on either 
desoxycholic acid or methyl desoxycholate, on treatment with up to 1.5 
equivalents of methanesulphonyl chloride in pyridine at 0%, failed 
to give conqplete estérification at C-24. Proof of this was afforded 
as follows.
Treatment of the crude mixture of methanesulphonates with lithium 
alumi ni urn hydride gave an ether-soluble mixture which, after chromato- 
gi^phy over alumina, was resolved into three fractions. The two smaller 
fractions were identified as 12o-hydroxy-5p-cholane (ca 8^ of total 
product) and 3a, 12a, 24-trihydroxy-5p-cholane (ca 4Q/o of total product) , 
whilst the main fraction (ca 5^t) had the properties of a diol. However, 
oxidation of this diol fraction with chromic oxide furnished a mixture 
12-oxo-5p-cholanic acid and 3,12-dioxo-5p-cholane in the ratio of 2:3, 
thus proving it to be a mixture of 2 parts 12a,24-dihydroxy-5p-cholane 
to 3 parts 3a,12o-dihydroxy-5p-cholane, vAiich was not separable by
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chromatography over alumina. The formation of the three compounds
12o-hydroxy-, 3a,12a-dihydroxy- and 12a^ 24-dihydroxy-5p-cholane thus
shows that selective attack at the primary hydroxyl group on C-24 over
the secondary hydroxyl group in the equatorial position on C-3 does
not occur with methanesulphonyl chloride. The recovery of 3a, 12a,
24-trihydroxy-5p-cholane does not necessarily support the same argument,
as this compound could have been regenerated by 0-8 cleavage rather
than C-0 cleavage of 3a,12a-dihydroxy-24-methanesulphonyloxy-5p-cholane
by the lithium aluminium hydride. However, such preferential 0-8
cleavage would not be expected for a sulphonate of a primary alcohol
although it is well known to occur with sulphonates of phenols and
126certain secondary alcohols . Indeed, the present work demonstrated 
that 0-S cleavage was typical of sulphonates of steroidal secondary 
alcohols vhere the hydroxyl group was in the axial configuration - vide 
infra.
Actually the properties of the 5p-cholane 3a,12o-diol and 12a, 24-
diol mixture corresponded closely to those assigned to 3a,12o-dihydroxy-
1235p-cholane by Blickenstaff and Chang vAio prepatred their sangle by 
the action of £-toluene sulphonyl chloride on 3a, 12a, 24-trihydroxy-5ar- 
cholane followed by treatment with lithium aluminium hydride. The 
extreme similarity between their method and that utilising methane­
sulphonate formation made it seem highly probable that their so called 
"3a, 12o-dihydroxy-5§-cholane" was also in fact a mixture of 3a,12om 
dihydroxy-5p-cholane and 12a, 24-dihydroxy-5p-cholane in the proportion
HO
HO
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of 3:2. Indeed, repetition of the Blickenstaff and Chang procedure 
gave identical results to that employing methanesulphonyl chloride.
Once again 12o-hydroxy-5p-cholane, 3a,12a,24-trihydroxy-5p-cholane 
and the mixture of 3a,12o- and 12a, 24-dihydroxy-5p-cholane were obtained 
i^en the crude ^ toluenesulphonate mixture was treated with lithium 
aluminium hydride and cnromatographed over alumina - the diol fraction, 
as before, yielded 3,12-dioxo-5p-cholane and 12-oxo-5p-cholanic acid 
in the ratio of 3:2, after oxidation with chromic oxide. It is therefore 
apparent that both methanesulphonyl chloride and ^ -toluenesulphonyl 
chloride show an identiceil lack of selectivity and that both the 3a^
hydroxyl gro^ ap and the 24-hydroxyl group show high reactivity.
(3SH)3a,12a-Dihydroxy-5p-cholane^was obtained by catalytic hydrogenation 
of 3,12-dioxo-cholane obtained from the above oxidations (ccxnpare the 
catalytic reduction of dehydrocholic acid to cholic acid^^^).
Authentic 12a,24-dihydroxy-5p-cholane was prepared by lithium 
aluminium hydride reduction of 3o-me thane sulphonyl oxy-12o-hydr oxy-5p- 
methylcholanate. The same compound was also obtainable from 3a-p- 
toluenesulphonyloxy-12o-hydroxy-5p-methylcholanate (prepared as described 
previously^by reduction with lithium aluminium hydride.
A similar lack of preferential me thane sulphonat ion at the hydroxyl 
group on C-24 over the hydroxyl group on C-3 was observed in the case 
of 3a, 7a^  ,24-trihydroxy-5p-cholane, which was obtained by lithium aluminium 
hydride reduction of chenodeoxycholic acid. Once again the diol fraction 
of the crude product resulting from lithium aluminium hydride reduction
HO
OH
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of the unpurified me thane sulphona tes, after oxidation gave acid and 
neutral components although in this csise the 7-keto acid and 3,7-diketone 
were not characterised further.
On the other hand, selective attack at both C-3 and G-24 over attack 
at either C-7 or C-12 by me thane sulphonyl chloride was observed. Thus, 
treatment of 3a,7a,12a,24-tetrahydroxy, 3a,12a,24-trihydroxy-and 
3a, 7a, 24-trihydroxy-5p-cholanes with exactly 2 moles of me thane sulphonyl 
chloride in pyridine at 0 %  followed by lithium aluminium hydride 
reduction of the noncrystalline dime thane sulpho nates gave rise to 
7a,12a-dihydroxy-5p-cholane (XXIV), 12a-hydroxy-5p-cholane (XXV) and 
7a-hydroxy-5p-cholane (XXVI) in virtually quantitative yield in each case.
Attempted partial hydrolysis of 3a,24-di^toluenesuli)honyloxy- 
12o-hydroxy-5p-cholane by the procedure used successfully in the partial 
hydrolysis of 5-androstene-3p,17p-di-£-toluenesul][^onyloxy-16-one to
T 905-andros te ne-3p-hydroxy-17p-£- toluene sulphonyl oxy-16- one  ^failed to 
give selective hydrolysis as evidenced by the product obtained after 
reduction with lithium aduminium hydride. The hoped-for dihydroxy 
compound on oxidation with chromic oxide gave a mixture of neutral keto 
compound and keto-acid showing the compound to be in reality a mixture .
Due to the failure of selective hydrolysis, these compounds were not 
considered further.
In order to investigate methanesulphonate formation in the hydroxy- 
So^cholane series, methyl 5,12-dioxochol-4-ene-24-carboxylate (XXVIl), 
prepared by elimination of the elements of hydrobromic acid from methyl
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4-‘bromo-3,12-dioxocholanate, was treated with an excess of lithium in 
liquid ammonia in the presence of ethanol. The action of an exact 
equivalent of lithium in liquid ammonia on A^-3-oxo-steroids is well 
known to yield the corresponding 3-ketone of the trans A/B series^^ 
whilst an excess of the metal in the presence of a proton donor gives
0 nthe 3p-Lyuxoxj-iiaiii> A/'B steroios*^'^^.
Considerable difficulty was encountered in preparing pure methyl,
3.12-dioxochol-4-ene-24-carboxylate which must be attributable to side
reactions during the formation of methyl-4-bromo-3,12-dioxocholanate.
Although cis A/B steroids are well known to brominate predominantly
in the 4 position^^^ (unlike trans A/B steroids where bromination occurs
133\at the 2 position ), it has been observed that a certain percentage 
of 2-bromination can occur in steroids of the cis A/B series^^ and
such bromination in the 2 position may have occurred in the present
135case. Moreover, it has been observed that treatment of 3-ketocholane 
derivatives with exactly one mole of bromine leads to the formation of 
a certain proportion of 2,4-dibrominated material with unreacted starting 
material left in the reaction mixture. Thus methyl 4-bromo-3,12- 
dioxocholanate contaminated with the 2-bromo isomer or with unreacted 
methyl 3,12-dioxocholanate would give rise to 5p-cholane derivatives 
as contaminants of the methyl 3,12-dioxochol-4-ene-24-C£Lrboxylate.
Gas liquid chromatography under standardised conditions failed to 
separate a synthetic mixture of methyl 3,12-dioxocholanate and methyl
3.12-dioxochol-4-en-24- carboxylate nor could separation be achieved on
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alumina chromatography.
The lithium ajid liquid ammonia reduction product of the crude 
methyl 3,12-dioxochol-4-en-24-carboxylate certainly contained a percentage 
of 5p-cholane derivatives and these are ascribed to the initial presence 
of small amounts of 5p compounds contaminating the enone and not to 
ciü A/b ring formation during the reduction itself.
Actually the mixture resulting from the lithium and liquid ammonia 
reduction of the crude methyl 3,12-dioxochol-4-en-24-carboxylate was 
not itself resolved into its components but treated with methanesulphonyl 
chloride (2 moles) followed by reduction of the total product with 
lithium aluminium hydride. Chromatography of the reduction product 
over alumina yielded three main fractions in the proportion of 3:5:2.
The first of these fractions proved to be a mixture of hydrocarbons 
(infrared spectrum) which was resolved into six components on gas liquid 
chromatography. The two major conponents, which together constituted 
ca 8CÇb of the total hydrocarbon fraction, were identified as 5p-cholane 
(comparison with the retention time of an authentic specimen) and 
5or-cholane (same difference in retention time as was found for the pairs 
of 5a and 5p 12-oxo-cholanes and 12of-hydroxy-cholanes in separate experiments). 
The four minor constituents of the hydrocarbon fraction were not identified 
but were concluded to be cholenes or jervicholenes arising from elimination 
reactions of the methanesulphonates. Jervicholenes would be expected 
to arise from eliminations involving the 12p-methanesulphonyloxy group^^®.
The formation of the 5a^cholane could only have arisen from the formation
HO
XXVIII
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of 3p,12p,24-trihydroxy-5a-cholane during the lithium and liquid ammonia 
reduction since it was shown in a separate experiment (vide infra) that 
lithium aluminium hydride reduction of 12o-methanesulphonyloxy-5a-cholane 
led to an 0-8 cleavage regenerating 12o-hydro3cy-5a^cholane.
That 3p,12a,24-trihydroxy-5o^cholane was also formed in the lithium 
and liquid euumcniu reduction of methyl 3,12-dioxochol-4-en-24-carboxylate 
was demonstrated idien the second fraction from the alumina chromatography 
of the methanesulphonate reduction product was shown to be 12o-hydroxy- 
6a-cholane (XXVIIl) contaminated with a very small trace of 12o-hydroxy- 
5p-cholane. Identification was achieved by means of quantitative gas 
liquid chromatography and conç>arison with a specimen of authentic 12om 
hydroxy-5o^cholane prepared from methyl 12o—acetoxy-3-oxochol-4-en-24- 
carboxylate as described below.
The third fraction from the alumina column was a mixture of diols 
which on oxidation with chromic oxide gave rise to equal quantities of
3,12-di0X0-5o-cholane and 12-oxo-5o-cholanic acid.
Treatment of the lithium and liquid ammonia reduction product of 
methyl 3,12-dioxoch^r4-en-24-carboxylate with ^ -toluenesulfhonyl chloride 
(2 moles) followed by lithium aluminium hydride reduction gave an identical 
mixture to that obtained by the methanesulphonate method.
Reduction of methyl 12c^acetoxy-3-oxo-chol-4—en-24-carboxylate 
(prepared by elimination of elements of hydrobromic acid from the 4-bromo 
derivative of methyl-3-oxo-12a-acetoxy-5p-cholanate^^'^) with excess of 
lithium in liquid ammonia, in the presence of etheuiol, followed by treatment
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with two moles of methanesulphonyl chloride in pyridine at 0%, and 
subsequent reduction of noncrystalline dimethanesulphonate with lithium 
aluminium hydride, gave 12a-hydroxy-5o-cholane in virtually quantitative 
yield. The same compound resulted in overall lower yield vdien 
2"toluene sulphonyl chloride was employed at room temperature in place 
oi the me thane sulptionyi ciiloride in the above procedure.
In view of the complexity of the above experiments, all of which 
clearly show the non-selectivity of attack by both methanesulphonyl 
chloride and ^ -toluenesulphonyl chloride, sulphonation studies were 
conducted separately at positions 7 and 12 of the cholane nucleus.
7o-hydroxy-5p-cholane, prepared by lithium aluminium hydride 
reduction of 3a# 24-dimethanesulphonyloxy-7a-hydroxy-5p-cholane, failed 
to react with ^ -toluenesulphonyl chloride in pyridine even on prolonged 
treatment at 37-40°C. It was however readily converted into 7o- 
me thane sulphonyloxy-Sp-choleine, in quantitative yield, on treatment 
with methanesulphonyl chloride in pyridine at 0%. The noncrystalline 
'sulphonic ester readily underwent elimination on treatment with cold 
methanol, affording a crystalline mixture of unsaturated hydrocarbons 
(tetranitromethane test) which showed the presence of two components 
in equal quantities on application of gas liquid chromatography. This 
material would appear to be a mixture of A'^-Sp-cholene and its rearremged 
isomer. Such a rearrangement of a double bond from the 7-8 
to the 8-14 position, in the steroid nucleus, is known to be particularly 
facile^^. The freshly prepared noncrystalline 7a-me thane sulphonyl oxy-
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5p-cholaiie, on reduction with lithium aluminium hydride, regenerated 
7a-hydroxy-5p-cholane in virtually quantitative yield proving 0-S 
cleavage. 7(3-Hydroxy-5p-cholane (XXIX), obtainable in 85^ yield on 
reduction of 7-oxo-5p-cholane by sodium and ethanol, required fairly 
vigorous conditions before complete estérification occurred with
toluènesulphoijyl chloride (io hours at 57-40'^). On the other hand 
methanesulphonate formation took place readily at 0%. Althou^ neither 
7p-sulphonate ester could be obtained in crystalline form, both were 
stable in alcoholic solutions and both, on reduction with lithium 
aluminium hydride, gave pure 5p-cholane showing C-0 cleavage.
12o-hydroxy-5p-cholane was found not to react with ^ -toluenesulphonyl 
chloride, when the reaction was carried out at 37-40% for 36 hours.
118This observation is in agreement with the work of Von Euw and Reichstein 
#io showed that jp-toluenesulphonate formation at the 12a position in the 
cholsuie series required incubation at 30% for 4-6 days. ^-Toluene- 
sulphonation of 12o-hydroxy-5p-cholane occurred v*ien the reaction was 
carried out at 60-65® for 2-3 hours, but the low melting, semicrystalline 
product still indicated the presence of free 12o-hydroxy-5p-cholane 
(infrared). On the other hand 12a-methanesulphonyloxy-5p-cholane was 
readily formed at 0 %  in pyridine. The crystalline methanesulphonate 
was stable at room temperature but decomposed on heating to 60% vacuo 
yielding a mixture of noncrystalline unsaturated hydrocarbons (tetra­
nitrome thane test). Gas liquid chromatography showed very little material 
corresponding in retention time to A-5p^cholene. The major components
OH
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Xi -had. lower retention times than A*5^-cholene. Presumably A-5^-cholene 
was formed initially and in the presence of the eliminated me thane sulphonic 
acid underwent rearrangement. Indeed treatment of authentic A-5p-cholene 
with 2" toluene sulphonic acid in benzene under re fluxing conditions gave 
a mixture of five components as shown by gas liquid chromatography. 
Application of the same conditions for Uie formation of 7p-2-toluene- 
sulphonyloxy-5p-cholane to 12p-hydroxy-5|3-cholane (XXX) (prepared by 
the reduction of 12-oxo-5p-cholane by lithium aluminium hydride (60-80^) 
or sodiuny^ e thanol (50^ )) gave inconçdete sulphona te formation (infrared), 
indicating the greater reactivity of the hydroxyl ftinction in the 7p- 
position than in the 12^-position. Lithium aluminium hydride reduction 
of this partially esterified product yielded a mixture of Sp-cholane auid 
12p-hydroxy-5p-cholauie in the ratio of 2:1. Methanesulphonyl chloride 
in pyridine at 0 %  readily converted 12p-hydroxy-5p-cholane into the 
crystalline 128-methanesulphonyloxy-5p-cholane. This compound proved 
to be very unstable although it could be stored as a solution in nonpolar 
solvents for comparatively long periods without any signs of deconçosition. 
A solvent-free sample decomposed on keeping at room temperature for 
48-72 hours or on simple evacuation on the water punp for 50-40 minutes, 
yielding a colourless unsaturated noncrystalline hydrocarbon mixture
(infrared and tetranitromethane test). Gas liquid chromatography showed
.uvery little material corresponding in retention time to A5^-cholene.
The main conponent had a lower retention time than Z&p-cholene. Boiling 
the 12p-methane sulphona te in ethanol afforded a mixture of products
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^ich could be divided into petroleum ether-soluble and petroleum ether- 
insoluble (water soluble) fractions. The petroleum ether-soluble 
material was a colourless gum which showed a complex pattern in the 
infrared spectrum with absorption peaks indicating a hydroxyl group 
(3500 cm”^), a carbonyl peak (1700 cm"^) and a double bond (1650 cmT^). 
Chroma.tography over alumina yielded an oily unsaturated hydrocarbon 
(infrared and tetranitromethane test). Gas liquid chromatography showed 
the presence of three conponents one of which was identified as 
Zi-5^ -cholene.
The presence of both hydroxyl euid ceurbonyl absorption was not due 
to the presence of 12p-hydroxy-5p-cholane in admixture with 12-oxo- 
5p-cholane, as these two conpounds would be separable on chromatography 
since for 5p-cholanes the order of elution is hydrocarbon, 12-oxo compound, 
12o-hydroxy compound and finally 12p-hydroxy compound (See pages 6 8,99 ).
Lithium aluminium hydride reduction of 12a,-me thane sulphonyl oxy- 5p- 
cholane and 12a-2-toluene sulphonyloxy-5p-cholane (partially esterified) 
regenerated 12o-hydroxy-5p-cholane in virtually quantitative yield 
showing 0-S cleavage, vhilst the reduction of freshly prepared 12(3- 
methanesulphonyloxy-5p-cholane and 12p-2-toluenesulphonyloxy-5p-cholane 
(discussed earlier), like the equatorial sulphonate esters at C-3 and 
C-7, gave 5p-cholane, showing exclusive C-0 cleavage.
■ ?h,12a-Dihydroxy-5p-cholane (prepared by lithium aluminium hydride 
reduction of 3a,24-dimethanesulphonyloxy-7a,12o-dihydroxy-5p-cholane), 
on treatment with one mole of methanesulphonyl chloride in pyridine at
XXXI
if 
....
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0%, gave a noncrystalline solid #iose infrared spectrum showed the 
characteristic absorption of a me thane sulphonate group (875-930 cmT^,
1160 cm"^ and 1320 cm"^) and also a sharp peak at 3570 cmT^ similar 
to that observed in the spectrum of 12a-hydroxy-5p-cholane. However, 
reduction with lithium hydride quentitatively regenerated 7a,12a- 
dinydLroxy-5p-oholane, again showing Ü-8 cleavage.
12a-Hydroxy-5a-cholane also failed to yield any ^ toluenesulphonate 
ester on treatment with j^-toluenesulphonyl chloride in pyridine at 
37-40% for 36 hours. However, it readily formed the crystalline 
12o-methanesulphonyloxy- 5o-cholane in pyridine at 0%. Like the axial 
sulphonate esters at C-7 and G-12 in the 5p-series, this ester regenerated 
the alcohol on reduction with lithium aluminium hydride in quantitative 
yield.
In order to study the lithium aluminium hydride reduction of the axial 
sulphonate group at C-3 of steroids, 3a-methanesulphonyloxy-cholestfiLne 
was prepared by treatment of epicholestanol (XXXI) with methanesulphonyl 
chloride in pyridine at 0%. The crystalline methanesulphonate showed 
Conniete estérification (infrared). Lithium aluminium hydride reduction 
afforded a mixture of epicholestanol (6^ ) and choiestane (3^) easily 
separable on grade I neutral alumina. Epicholestanol and choiestane 
were characterised melting point and by con^arison of their infraured 
spectra with those reported in the literature . This dual 0-S auid 
C-0 cleavage has an analogy in the report that steroidal 6p(axial)-^- 
tolue ne sulfonate 8 on lithium aluminium hydride reduction afford a
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mixture of the 6p-hydroxy compound and the 6-methylene compound, with 
the former predominating^^.
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EXPERIMENTAL
All m.p.*s were recorded on a Kofler block and are uncorrected.
All [ft] are in CHClg unless otherwise stated.
Light petroleum refers to petroleum ether of b.p. 40-60%.
Pyridine was dried over NaOH and distilled before use. Commercial 
àiüïjdzoua ether was dried over sodium before use. Tetrahydrofuran 
was distilled and left over NaOH being redistilled just prior to use. 
Acetic acid refers to glacial AnalaR acetic acid. Para-toluenesulphonyl
chloride was recrystallised from light petroleum, taken up twice in 
benzene and the benzene evaporated under reduced pressure. Alumina 
is Brockmann unless otherwise stated.
Gas liquid chromatography was performed using O.S^ o apiezon ApL on 
celite at ca 200% on a Pye Argon instrument unless otherwise stated.
The following describe typical reaction conditions for given 
preparations although in many cases several runs were performed.
5g,12ft,24**Trihydroxy-5B-Cholane (XXIIl) , was prepared in 92^ yield by 
lithium aluminium hydride reduction in re fluxing tetrahydrofuran of 
deoxycholic acid^^^ or its methyl ester m.p. 120-127° (reported 107- 
II40IOI, i06-118Ol24b, 1230124a^  165°, 185°^^^), [a] d + 43° (o = 2.0) 
(reportedl^l . 59° (ethanol)).
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Formation of the Mixture of 12a-Hydroxy-5g-Cholane, 5g, 12a-Dihydroxy- 
53-Cholane and 12g,24-Dihydroxy-5(3-Cholane from 3a, 12a,24-Trihydroxy- 
53-Cholane.
(a) To an ice cold solution of 3a,12a,24-trihydroxy-53-cholane (2.0 g.) 
in pyridine (5 ml.) was added, dropwise, methanesulphonyl chloride 
(O.S2 iiii. 1.5 eyuiv.), and tlie reaction mixture left at O^ 'C for 50 min.
At the end of this time ice was added, the mixture acidified with ice- 
cold 6N HCl and extracted with ether. The ether layer was washed (water) 
and dried (anhydrous sodium sulphate). The crude gum resulting on 
removal of the solvent wais taken up in ether (lOO ml.) and re fluxed 
with a slurry of lithium aluminium hydride (4 g.) in ether (lOO ml.) 
for 15 hr. After destroying the excess of reagent with moist ether 
and acidifying with HCl, the ether layer was taken to dryness under 
reduced pressure to yield a crude mixture of hydroxy-5p-cholanes (ca 1.6 g.) 
This material was incorporated in alumina (5 g.) by permitting a con­
centrated ethereal solution to evaporate over alumina powder, and the 
resulting dry mixture placed over a column of alumina (grade V 30 g.).
Light petroleum eluted 12a-hydroxy-53-cholane (115 iqg. 8^o) m.p. 104-106% 
(reported^Ol 100.9-103.3), [a 4 40° (c = 2.0) (reported^^^ + 41.0° 
(Pound; C, 83.54; H, 12.33, calculated for C24H42O: C, 83.21;
H, 12.24^ 6). Ether/light petroleum (2:3) eluted material which on further 
investigation, proved to be a mixture of the 3a,12a-diol and the 
12a,24-diol (0.8 g. 5^), the mixture showed a double m.p. 110: 170-172°
(reported^^^ 171.2-172.2°and 109-120% 168-169.^. Pound: C, 79.59;
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H, 11.57, calculated for C2^H^2^2* 79.50; H, 11.68^). Finally,
elution with S^o ethanol in ether afforded unchanged 3a,12a,24-trihydroxy- 
5p-cholane (0.62 g. 40^) m.p. and mixed m.p. 120-128%.
Oxidation of the mixture of 3a, 12o-dihy dr oxy- 5p-cholane and 
12a,24-dihydroxy-5p-cholane: The diol mixture (0.75 g.) was dissolved
in acetic acid (2ü ml.) ana, with efficient cooling, treated with a 
solution of chromic oxide (0.6 g.) in acetic acid (l5 ml.) contsdning 
water (2 ml.). After 16 hr. at room ten4)erature, the mixture was 
treated with methanol to decompose the excess of chromic oxide. The 
oxidation product was precipitated by diluting the reaction mixture 
with water, extracted with ether and the ether layer washed (water).
The ethereal layer 7ra.s then extracted with 1.5N sodium hydroxide solution, 
washed (water) and dried (anhydrous sodium sulphate). On removing the 
solvent #iite plates of 3,12-dioxo-53-cholane (0.44 g. 6C^) resulted. 
Recrystallisation from ether gave m.p. 145-47%, [a] + 103.6°(c = 1.9),
(Pound: C, 80.27; H, 10.50, C24H33O2 requires C, 80.44; H, 10.61ÿb).
The aqueous alkaline washings on acidification with dilute hydrochloric 
acid, afforded a white semicrystalline precipitate of 12-oxo-53-cholanic 
acid (0.30 g. 40^ o), m.p. 185-189% (reported^^^ 187°) [a] d 4 100 (c = 1.9).
(b) In a separate experiment j^-toluene sulphonyl diloride was used 
in place of methanesulphonyl chloride following the conditions of 
Blickenstaff and C h a n g é Results identical to the experiment using 
methanesulphonyl chloride were obtained. That the 3a, 12omdihydroxy-53- 
cholane and the 12a, 24-dihydroxy-53-cholane were formed in the same
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proportion as before was shown by chromic oxide oxidation of the diol 
fraction resulting after chromatography over alumina (gr. V), i^en 
5,12-dioxo-53-cholane and 12-oxo-cholanic acid were obtained in the 
ratio 5:2.
5a,12q-Dihydroxy-53-Cholane (XXXIl). 3,12-Di0x0-53-cholane (50 mg.) 
was added to prereduced platinum oxide (25 mg.) in acetic acid ( 7 ml.) 
and the mixture was shaken for 6 hr. under hydrogen at atmospheric 
pressure. The catalyst was removed by filtration and the solid 
residue remaining after removal of the solvent (the infrared spectrum 
showed strong hydroxyl absorption at £a 3500 cnT"^  and no carbonyl 
absorption), was chromatographed over alumina (gr. I Woelm, neutral,
7 g.) . Ethanol/ether (1:99) eluted 3a, 12g-dihydroxy-53-cholane
(40 mg.), Ti^ ich was crystallised with a minimal quantity of ethyl acetate. 
m.p. 174-175%, [a] ^  4 34.2°(c = 0.85). Oas liquid chromatography 
employing l^ o SE-30 column at 225% indicated only one component with 
the expected retention time of a G24 diol to be present.
12g , 24-Dihydroxy-53-Cholane : (a) Methyl-deoxycholate^^^ (l g.) on
treatment with methanesulphonyl chloride (l.05 mole) in pyridine (3 ml.) 
at 0°C for 16 hr., yielded methyl 3a-methanesulphonyloxy-12a-hydroxy- 
cholanate (l.05 g.) after the normal isolation procedure. The product 
did not crystallise and was subjected to reduction with excess of lithium 
aluminium hydride in re fluxing ether for 16 hr. The crude reduction 
product (m.p. 117-120%) was chromatographed over alumina (gr. I, 25g.).
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Benzene (250 ml.) eluted 12a,24-dihydroxy-53-cholane vdiich was recrystallised 
from light petroleum (850 mg.), m.p. 118-120%, [a] 4 39.5 (c = 2.1).
(Found, G, 79.93; H, 11.48, quires G, 79.56; H, 11.6Cÿo).
(b) Methyl-3a-£-toluenesulphonyloxy-12o-hydroxy-cholanate (5 g.)
(prepared according to the reported^^^ method in ca 60^ yield) was 
reduced with an excess or iithJLum aluminium hydride in re fluxing ether 
for 16 hr. to yield crude 12a,24-dihydroxy-5p-cholane (3.2 g.) which 
on purification by chromatography over alumina (gr. l) gave 3 g. of 
pure product m.p. 118-120%.
5q, 7g, 24-Trlhydroxy- 56^holane'^ : Chenodeoxycholic acid was prepared
by Wolff Kishner reduction of methyl 3a,7o?-diacetoxy-12-oxo-cholanate^'^
144-in 6(ÿu yield, m.p. 140-144% (reported 140-142°). This oompound (4.7 g.) 
was then re fluxed with lithium aluminium hydride (3 g.) in ether (150 ml.) 
for 12 hr. Working up of the reaction mixture in the normal way gave 
a nonciystalline solid (4.6 g.) which was chromatographed over alumina 
(gr. V 60 g.). Ghloroform (1,000 ml.) eluted 3a,7a,24-trihydroxy-53- 
cholane as a gum which on seeding became crystalline (4.4 g.) double 
m.p. 82-84°: 150%, [a] ^  + 14.5°(c = 2.1). ( Pound: C, 76.10;
H,10.36, Cg^^gOg requires G, 76.19; H, 11.11^).
This compound has been re porte d^^^ as a noncrystalline solid obtadLned by the reduction of chenode oxy cholic acid with sodium in ethanol.
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Formation of the Mixture of 7a-Hydroxy-53-ChoIane, 5a,7a-Dihydroxy-53- 
Cholane and 7a,24-Dihydroxy-53-Cholane from 5a,7a,24-Trihydroxy-53-Cholane;
(a) 3a,7a,24-Trihydroxy-53-cholane (300 mg.) dissolved in pyridine (2 ml.)
was treated with methanesulphonyl chloride (l.5 mole) at 0°C for 20 min. 
Working up the reaction mixture in the usual way gave an ether soluble 
colourless gum (315 mg.) . Tne crude metnanesul]^)hon&ueswerereduced 
with an excess of lithium aluminium hydride in refluxing ether for. 10 hr. 
and the mixture of hydroxycholanes obtained by the normal isolation 
procedure was chromatographed over alumina (gr. V 30 g.) to yield three 
fractions; light petroleum eluted 7a^hydroxy-53-cholane (30 mg. 10^). 
After recrystallisation from methanol had m.p. 86-88%  [ a] ^  4 19^
(c = 2.1). (Found ; C, 83.56; H, 12.36, G24H42O requires C, 83.21;
H, 12.24^ ü). Ethanol/ether(l; 20) eluted ^at proved to be a mixture 
of 3a,7a-dihydroxy-53-cholane and 7a,24-dihydroxy-53-cholane (l63 mg.
5^), recrystallised from ethylacetate, needles m.p. 89-94%. Ethanol/ 
ether (l:4) eluted unchanged 3a,7a,24-trihydroxy-53-cholane (90 mg. 30/o) 
double m.p. 80-82°: 148-150%.
Oxidation of the diol mixture with chromic oxide in acetic acid 
gave, after washing the ethereal solution of the product with 2N sodium 
hydroxide (aqueous), a ketone (carbonyl absorption in the infrared 
spectrum at 1700 cm"^) (92 mg. 61^) m.p. 92-94°. The alkaline washings 
on treatment with 2N HCl gave 7-oxo-cholanic acid (absorption at 
1700 cm"^ for carbonyl group, at 1730 cm"^ for carbo^ qrlic 0 = 0  and 
between 2900-3300 cm"^ for csLrboxylic OH stretching) : (55 i^ g. 36^ o),
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m.p. 146-150% (reported^^^ 149-150°).
(b) An identical mixture of products resulted from 3a,7a,24- 
trihydroxy- 53-cholane when p-toluenesulphonyl chloride was substituted 
for methanesulphonyl chloride in the above experiment and the reaction 
carried out at room teii5)erature for 30 min.
3g, 7a, 12a, 24-Tetrahydroxy-53-Cholane, was prepared by lithium aluminium 
hydride reduction of cholic acid (in tetrahydrofuran) or its methyl 
ester (in ether) in 80-85^ yield, m.p. 234-235%, (reported^^^*^^^
231-233) [ a j 4 39° (c = 2,ethanol) (reported^ *^^  4 37.^.
7g, 12a-Dihydroxy-53-Cholane (X3CIV); (a) A solution of 3a,7a,12a^4- 
tetrahydroxy-53-cholane (1.5 g.) in pyridine (7 ml.) was treated with 
methanesulphonyl chloride (2.1 mole) at 0% for 16 hr. On working 
up the reaction mixture a noncrystalline solid (1.7 g.) was obtained, 
vdiich on reduction with an excess of lithium aluminium hydride in 
refluxing ether ( 12 hr.) auid concentrating the ethereal filtrate, 
obtained after destruction of the unreacted hydride, gave 7a,12g-dihydroxy- 
53-cholane, needles (1.3 g.) m.p. 203-204%, [ a ] 4 25°(c^ = 2.0).
(Pound: C, 79.56; H, 11.36. C24H42O2 requires C, 79.50; H, 11.6^0).
(b) The tetra-ol on treatment with £-toluene sulphonyl chloride 
(2.2 mole) in pyridine at room temperature ( 16 hr.) gave the gummy 
3a,24-di^-toluenesulphonyloxy-53-cholane in 50/ yield. Lithium 
aluminium hydride reduction of the crude di^toluenesul].ihonate (3 g.), 
under the usual conditions, gave pure 7a,12a^dihydroxy-53-cholane (1.35 g.).
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(c) Methyl-3a-£-toluenesulphonyloxy-7a, 12a-dihydroxy-cholanate^^^
(5 g.) on réduction with excess of lithium aluminium hydride in refluxing 
ether (200 ml. ) gave crude triol (3.1 g.). Chromatography over 
alumina (gr. I, 60 g.) using ethyl acetate/benzene (7:3) as eluant gave 
pure 7g, 12g,24-trihydroxy-53-cholane (2.9 g.) m.p. 198-200°C,
[ a ] + 2b.7° (c = 2.0;. (Found: C, 76.54; H, 10.86, Gg^^gOg requires
0, 76.2; H, H.ll^«).
7a, 12a,24-Trihydroxy-53-cholane (0.9 g.) on treatment with 
2-toluenesulphonyl chloride (l.2 mole) in pyridine (4 ml.) at room 
temperature (16 hr.) gave 7a,12g-dihydroxy-24-p-toluenesulphonyloxy-53- 
cholane , as needles from ether (l g.) m.p. 126-128%, [a] 4 15°
(c = 1.0). (Pound: G, 69.97; H, 9.01; G^^H^yO^S requires 0, 69.92;
H, 9.0^d). This 2-toluene sulphonate (0.5 g.) on reduction with excess 
of lithium aluminium hydride in refluxing ether gave 7a, 12o-dihydroxy-53- 
cholsLne (0.30 g.) m.p. 199-200%.
(d) 7a, 12a^Dihydroxy-53-cholane was also prepared via lithium 
aluminium hydride reduction of the noncrystalline 7a, 12a-dihydroxy-24-
methanesulphonyloxy-53-cholane - yield 85^ o.
12a-Hydroxy-53-Gholane (XXV) : (a) On treatment of a solution of 
5a, 12a,24-trihydroxy-53-cholane (2.5 g.) in pyridine (lO ml.) with 
methanesulphonyl chloride (2.15 mole) at 0°C for 16 hr., the gummy
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5a,24-dimethanesulphonyloxy-12a-hydroxy-6p-cholane (2.7 g.) was formed. 
Lithium aluminium hydride reduction of the crude dimethanesulphonate 
in refluxing ether (16 hr.) afforded 12a-hydroxy-5p-cholane (2.2 g.) 
m.p. 95-100%. Chromatography over alumina (gr. Ill 30 g.) using 
light petroleum as eluant gave pure 12a-hydroxy-5p-cholane (2.1 g.) 
m.p. 104-106% (reported--- 100.5-105.^.
(b) 3a, 12a,24-Trihydroxy-53-cholane (2.33 g.) on treatment with 
2"toluene sulphonyl chloride (2.2 mole) in pyridine (10 ml.) at room 
temperature (16 hr.) gave the noncrystalline 3a,24-dÎ2“toluenesulphonyloxy- 
12a-hydroxy-53-cholane (2.56 g.). Reduction with an excess of lithium 
aluminium hydride in refluxing ether (l2 hr.) yielded crude 12a-hydroxy- 
63"°^ olâ.ne Wiich after chromatographic purification over alumina
(gr. Ill 30 g.) gave pure material (1.2 g.) of m.p. 103-106%.
(c) 12a, 24-Dihydroxy-53-cholane was prepared by lithium aluminium 
hydride reduction of methyl-3a-2-toluenesulphonyloxy-12o-hydroxy- 
cholanate^"^^, m.p. 118-120%, [ a ] + 39.5° (c = 2.l). (Found: C, 79.93;
H, 11.48, C24H42G2 requires C, 79.56; H, 11.60/). This diol (2 g.)
on treatment with methanesulphonyl chloride (l.l mole) in pyridine (6ml.) 
at 0 %  for 15 hr. gave the ginmny 12a-hydroxy-24-methanesulphonyloxy-53- 
cholaine (2.2 g.) which on reduction with lithium aluminium hydride in 
refluxing ether (I6 hr.) afforded 12a-hydroxy-53-cholane (1.85 g.) 
m.p. 100-105%.
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7a-HydrQxy-53-Cholsune (XXVI) ; (a) 3a,7a,24-trihydroxy-53-cholane (l.O g.)
dissolved in pyridine (4 ml.) was treated with methanesulphonyl chloride 
(2.1 mole) at 0% for 16 hr. to yield the noncrystalline 3a,24- 
dimethanesulphonyloxy-7or*hydroxy-5p-cholane (l.l g.). Lithium 
aluminium hydride reduction of the dimethanesulphonate in refluxing 
etner (l6 hr.) gave a gum (800 ng.) wiiich after chromatography over 
alumina (gr. Ill 20 g.) using light petroleum as eluant gave crystalline 
7q.*hydroxy-53-cholane (785 mg.) m.p. 86-88%, [ a ] 4 19° (c = 2.1).
(Pound: C, 83.64; H, 11.89, C24H42O requires C, 83.21; H, 12.2^).
(h) 3a,7a,24-Trihydroxy-53-cholane (1.46 g.) on treatment with 
2-toluenesulphonyl chloride (2.2 moles) in pyridine (7 ml.) at room 
temperature (16 hr.) gave 3a,24-di-2-toluenesulphonyloxy-7oF-hydroxy-53- 
cholane as a gum. Reduction with lithium aluminium hydride employing 
the usual conditions and subsequent purification of the product on an 
alumina column (gr. Ill 30 g.) gave 7o-hydroxy-53-cholane (850 mg.) 
m.p. 81-86%.
(c) 7a-Hydroxy-cholanic acid (7.0 g.) (obtained by Wolff Kishner
144areduction of methyl 3,12,-dioxo-7o^acetoxy-cholanate ) was refluxed
with lithium aluminium hydride (3 g.) in ether (120 ml.) for 16 hr. 
to give 7a,24-dihydroxy-53-cholane (6.4 g.), Purification on a column 
of alumina (gr. V 60 g.) using ether as eluant gave pure 7a, 24-dihydroxy- 
53-cholane (5.6 g.) m.p. 86-90, [a ] = 2.0). (Pound: G, 79.80;
H, 12.0, C24H42G2 requires C, 79.56; H, 11.66/).
7a,24-Dihydroxy-53-cholane (4.4 g.) on treatment with methane-
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sulphonyl chloride (l.l mole) in pyridine (l5 ml.) at 0%  for 16 hr. 
gave the gummy 7a-hydroxy-24-methanesulphonyloxy-53-cholane (4.4 g.)
■which on reduction with lithium aluminium hydride in refluxing ether 
followed by chromatography on alumina in the usual way gave pure 
7a-hydroxy“53-cholane (3.8 g.) m.p. 80-85%.
Attempted Selective Hydrolysis of 3g, 24—di-Para-tolue ne sulphonyloxy- 
12a-Hydroxy-53-Cholane to 3a, 12g-Dihydroxy- 24-Para-toluenesulphonyloxy- 
53-Cholane. The method employed for the selective hydrolysis of the 
33-£-toluenesulphonate group in 5-androsten-33,173-di^-toluenesulphonyloxy- 
16-one^"^ when applied to 3a^  24-di-£-tolue ne sulphonyloxy-12a-hydroxy-53- 
cholane, failed to give selective hydrolysis. The crude hydrolysis 
product was reduced with lithium aluminium hydride in refluxing ether 
for 16 hr. The resulting material (0.5 g.) was then chromatographed 
over alumina (gr. I Woelm, neutral, 30 g. ). Ether/light petroleum 
(1:9) and pure ether fractions eluted 12o-hydroxy-53-cholane (180 mg. 
m.p. 104-106%). Ethanol/ether (1:49) eluted 231 iqg. of a material 
which on oxidation wi'th chromic oxide in acetic acid at room tenterature 
yielded a mixture of a neutral ketone and a keto acid (infrared spectrum) 
which were not characterised further.
Methyl 3,12*Dioxochol-4-enf-24-Carboxylate (XXVIl): A solution of
methyl-3,12-dioxo-cholanate (prepared by chromic oxide oxidation of 
methyl deoxycholate^^^ in acetic acid at room temperature for 16 hr.)
(I8.3 g.) in acetic acid (200 ml.) containing a drop of 48^ o aqueous
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hydrobromic acid was titrated with bromine (8.2 g.; 1 mole) dissolved 
in acetic acid (l20 ml.). After the addition of the bromine solution 
was complete, the mixture was stirred for 15 min. and diluted to large 
volume with water to yield a solid (22.0 g.). Recrystallisation from 
ether gave needles of methyl-4-bromo-5,12-dioxochol-24-carboxylate 
(20 g,) m.jj. 150-160% [ a] jj + 114.6- (c = 1.5).
The crude crystfiLlline 4-bromo conipound on taking up in ether left 
behind a crystalline material (rods), sparingly soluble in ether (ca 2^) 
m.p. 169%. This product would appear to be a 2,4-dibromo compound - 
cf. refs. 134, 148.
The me thyl-4-bromo-3,12-dioxochol- 24-carboxylate was highly 
soluble in ether and there was not any improvement in melting point 
after repeated crystallisations from ethanol. (Found; C, 62.36;
H, 7.68, Br requires C, 62.24; H, 7.88^ b).
The methyl-4-bromo-3,12-dioxochol-24-carboxylate (1.95 g.) was 
dissolved in freshly distilled collidine’'*' (60 ml.) and the solution 
refluxed under nitrogen for 35 min. After cooling under nitrogen 
the crystalline collidine hydrobromide was removed by filtration.
The dark coloured filtrate was distilled vacuo and the residue was 
chromatographed over alumina (gr. Ill, 100 g.) using ethyl acetate as 
solvent to yield methyl-3,12-dioxochol-4-en-24-caLrboxylate (l2 g.) 
m.p. 130% [ aj g + 136.6® (c = 2.1). U.V. spectrum in ethanol \  max = 236 mp
A parallel experiment using pyridine (2 hr.) gave a lower yield of dehydrobrominated product.
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( € = 13110). (Pound; G, 74.27; H, 8.67; G2^ ggO^ requires 
C, 75.00; H, 9.00^).
Mixture of 53>12a,24-Trihydroxy-5a^Cholane and 33,123»24-Trihydroxy- 
5q-Cholanet Methyl-3,12-dioxochol-4-en-24-carboxylate (2 g.) was 
dissolved in a mixture of ethanol and dioxane (20 ml. and 10 ml.) 
and diluted iR-ith ether (200 ml.). Liquid ammonia (50-60 mis.) was 
mixed with the ethereal solution in a flask fitted with an efficient 
mechanical stirrer. %ile the reaction mixture was continuously stirred, 
small slices of lithium metal (total c& 5 g.) were slowly added during 
a period of 3 hr., replenishing the ammonia as necessary. Excess of 
lithium was deconç>osed with ammonium chloride and the ammonia was 
allowed to distill at room temperature overnight. The residual mixture 
was treated with 4N HCl and the ethereal layer separated, washed (water), 
dried (anhydrous sodium sulphate) and distilled ^  vacuo to yield a 
white solid (1.4 g.) vdiich readily crystallised on trituration with 
ether containing traces of ethanol m.p. 175-185%. (infrared analysis 
indicated the complete reduction of the keto and ester groups and 
shewed no double bond absorption). (Found; 0, 76.40; H, 10.69,
C24H42O3 requires C, 76.19; H, ll.llyo).
The product vhich appeared homogeneous on chromatography over 
alumina was concluded to be a mixture of epimeric 12-hydroxy compounds 
by comparison with authentic 3p,12a,24-trihydroxy-5a-cholane (p. 62 ) 
and from the results of the experiments described immediately below.
—60—
Treatment of the Mixture of 53Tl2g,24- ajid 53>123,24-Trihydroxy-5a-Cholane3 
with Me thane sulphonyl Chloride and Subsequent Reduction with Lithium 
Aluminium Hydride: (a) The mixture of trihydroxy-5a-dholanes (700 mg«)
dissolved in pyridine (8 ml.) was treated with methane sulphonyl chloride 
(2.1 mole) at -5®C for 12 hr. 7/orking up the reaction mixture in the 
usual manner gave a cream coloured gumiuy rnuxtuie of me thane sulpho nates 
(725 mg.). Lithium aluminium hydride reduction of this crude material 
in refluxing ether/dioxane (9:1, 50 ml.) for 12 hr. gave 680 mg. of a 
gum. Treatment with light petroleum left a residue (30 iqg.) vAiich 
proved to be the starting triol mixture sls shown by m.p. (175-186®C) 
and infrared spectrum. The light petroleum extracts (650 mg.) on 
chromatography over alumina (gr. Ill 40 g.) gave three fractions. Light 
petroleum (lOO ml.) eluted a gummy hydrocaxbon fraction (infrared spectrum) 
(l45 mg.). Gas liquid chromatography on a column of ifo QF 1 on gas 
chrome P resolved this hydrocarbon fraction into six components. The 
two main components representing 80^ of the total material were identified 
as 5(3-cholane (comparison with authentic sample) and 5or-cholane (same 
difference in retention time as found for the pairs of 12-oxo- and 12o^ 
hydroxy-5a and 5p-cholanes in separate experiments). The four minor 
components were not identified but were concluded to be cholenes or 
jervicholenes. Elution with lO^ o and 20^ ù ether in light petroleum 
(200 ml. and 100 ml.) gave 12ob-hydroxy-5q-cholane (XXVIIl) (300 mg.), 
m.p. 125-127°C, [ o ] ^  + 4o“(c = 2.0). (Pound: C, 83.08; H, 11.54
^24^42^ requires C, 83.21; H, 12.24^). This product was characterised
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by comparison with authentic 12a-hydroxy-5o-cholane, the preparation 
of n^ich is described later. Pure ethyl acetate eluted a material, 
which on further investigation proved to be a mixture of 3,12 and 12,24- 
dihydroxy-5o-cholanes (130 rag.).
This diol mixture (60 ing.) on oxidation with chromic oxide in acetic 
acid afforded a crystalline solid (50 mg.) mich was separated into 
neutral and acidic components by extracting the ethereal solution of 
the oxidation product with dilute aqueous sodium hydroxide. The 
neutral product was identified as 3,12-dioxo-5g-cholane (25 mg.), 
m.p. 178-180%{ a] + 107.4° (c = 1.9). (Pound: 0 , 80.25; H, 10.47
^24^38^2 requires C, 80.44; H, lO.ôÇb). The acidic product was concluded 
to be 12-oxo-5a-cholanic acid (25 mg.) m.p. 183-186, [ct] ^  + 108 (c = 2.0). 
(Pound; C, 76.79; H, 9.05, C24H33O5 requires C, 77.00; H, 10.01$4) .
(b) Treatment of the mixture of 3p,12a,24- and 3p,12|3,24-trihydroxy- 
5o-cholanes (700 ng.) with ^ toluenesulphonyl chloride (2.1 mole) in 
pyridine at room temperature for 16 hr. followed by the reduction of 
the crude product (750 mg.) with lithium aluminium hydride gave, after 
chromatography over alumina (gr. Ill, 40 g.), analogous products to those 
obtained in the methanesulphonate case. These were (i) mixture of 
hydrocarbons (l30 mg.), (ii)l5a-hydroxy-5o-cholane (245 rag.) and (iii) 
mixture of 3,12- and 12,24-dihydroxy-5q-cholanes (105 mg.).
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5(3,12a, 24“Trihydroxy“5a“Cholane (XXXIII ) ; Methyl“12a“acetoxy“3-oxochol- 
4-en-24-carboxylate (prepared by the procedure of Keichstein et
m.p. 133-13490 (reported^^^ 132-134°), [a] + 112 (c = 1.0 acetone)20 D
(reported^^S + 114.2°) (lO.O g.) was subjected to reduction with excess 
of lithium in liquid ammonia in presence of ethanol as described for 
uieUriyi 3,12-dioxochol-4-en-24-carboxylate (p. 57). The crude reduction 
product gave crystalline 30,12a,24-trih.vdroxy-5a-cholane (4.23 g.) from 
ethyl acetate m.p. 186-188%, [aj^^ + S3.8”(c = 2.1). (Pound: C, 76.25;
H, lv.94, ^24^42^3 requires C, 76.19; H, ll.ll^ o).
The mother liquor on chromatography over alumina (gr. Ill, 40 g.) 
using ethyl acetate as eluant gave a further 1.52 g._ of the product.
12g-Hydroxy-5a-Cholane (XXVIII) : (a) 3j3,12a,24-Trihydroxy-5o-cholane
(1.64 g.) was treated with methanesulphonyl chloride (2.05 mole) in 
pyridine (8 ml.) for 12 hr. The noncrystalline 3p,24-dimethajiesulphonyloxy- 
12o-hydroxy-5a^cholane, on reduction with an excess of lithium aluminium 
hydride in refluxing ether gave the crude 12a-hydroxy-5o^cholane_ (1.3 g.). 
Chromatographic purification over alumina (gr. Ill, 30 g.) afforded pure 
product (1.2 g.), eluted with ether in light petroleum (1:9 and 1:4),
20 D
^24^42^ requires C, 83.21; H, 12.24^ o).
m.p. 126-127%, [ 0,] ^  + 40° (o = 2.0). (Pound: C, 83.1; H, 11.8,
(b) 3p,12a,24-Trihydroxy-5o-cholane (1.2 g.) was converted into 
3p- 24- di-2- toluene sulphonyl oxy-12o-hydr oxy- 5o-cholane by treatment with 
^toluenesulphonyl chloride (2.1 mole) in the usual manner to yield
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the non-crystalline di-p-toluenesulphonate (1.35 g.). Lithium 
aluminium hydride reduction in refluxing ether followed by chromatographic 
purification over alumina (grade III 30 g.) gave 12a-hydroxy-5c^-cholane 
(0.6 g.), m.p. 125-12700.
Attempted formation of 7a-Para-Toluenesulphonyloxy-50-Cholane: ^
solution of 7a-hydroxy-5p-cholane (lOO iqg.) in pyridine (3 ml.) was 
treated with 2- toluene sulphonyl chloride (1.2 moles) dissolved in 
pyridine (l ml.) and the mixture incubated at 370-40° for 16 hr. On 
working up the reaction mixture in the usual way 7a-hydroxy-5p-cholane 
(95 mg.) was obtained, m.p. and mixed m.p. 84-88° (infrared apectmm 
identical with that of 7o-hydroxy-5p-cholane).
7g-Me thane sulphonyloxy-50-Cholane ; 7o^Hydroxy-5p-cholane (lOO mg.) was 
dissolved in pyridine (2 ml.) and treated with methanesulphonyl chloride 
(1.2 mole) at 0% for 10 hr. On working up the reaction mixture in 
the usual way the gummy 7o-methanesulj^onyloxy-5p-cholane (l05 mg.) was 
obtained (infrared spectrum indicated complete estérification).
The non-crystalline 7o-methanesulphonate on taking up in methanol 
(5 ml.) deposited white crystalline material (80 mg.) mixture of plates 
and rods, m.p. plates 73-76% and rods 90-94°C. (Pound: 0, 87,24;
H, 12.19. C2^ ^ requires C, 87.80; H, 12.1£|^ ).
This material did not show the presence of any functional groups 
in the infrared spectrum and gave a positive test with tetranitromethane. 
Gas liquid chromatography indicated two components to be present in equal
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quantities. These had retention times very close to each other as 
well as to that of other C24 steroidal hydrocarbons (vide infra).
A freshly prepared specimen of 7a- me thane s ulphonyloxy- 5(3- cholane 
(104 mg.), on reduction with lithium aluminium hydride in refluxing 
ether gave pure 7o-hydroxy-5(3-cholane (92 mg.), m.p. 80-87%. The 
infrai'cd spectrum was identical with that of an authentic specimen.
7-Oxo-50-Cholane; 7a-Hydroxy-5p-cholane (360 mg.) dissolved in acetic 
acid (5 ml.) was treated with a solution of potassium dichranate (300 mg.) 
dissolved in water (0.4 ml.). The mixture was allowed to stand for 
16 hr. On slow dilution with water crystalline ' 7-oxo-53-cholane was 
precipitated. This was filtered, repeatedly washed with water and 
dried giving 364 rag. of m.p. 104-109%. Recrystallisation from methanol 
gave plates m.p. 108-109%, [a] 50° (c = 2.0). The infrared spectrum
showed strong carbonyl absorption (1700 cm~^) and no hydroxyl absorption. 
The constitution follows from its conversion into the epimeric 7-hydroxy- 
5p-cholanes (see below).
Oxidation of 7a-hydroxy-5p-cholane with chromic oxide in acetic 
acid in the usual way also gave the same 7-oxo-5p-cholane, in slightly 
lower yield.
73-Hydroxy-53-Cholane (XXIX) : 7-Oxo-5(3-cholane (200 mg.) dissolved in 
boiling ethanol (lO ml.) was treated with sliced sodium me tail (800 mg.) 
during a period of 1.5 hr. and allowed to cool. Dilution of the reaction 
mixture with water gave an oily ether soluble material (193 rag.).
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Chromatography over alumina (gr. Ill, 15 g.) using light petroleum as 
solvent (15 ml.) gave 7a-hydroxy-53-cholane (20 mg.) m.p. 80-86°C. 
Elution with ether/light petroleum (l:l) gave pure 70-hydroxy-53-cholane 
(l70 mg.) as a gum which resisted all attempts at crystallisation,
[a] 4 42.1° (c = 1.9). The material showed strong hydrogen bonded
iijdioxyl absorption in tire infra red at 3500 cra*'^ (cf. sharp band in 
the 7a-hydroxy epimer at 3600 cm"^) in nujol.
73-Me thane sulphonyloxy- 53-Cholane ; 7p-Hydroxy- 5p-cholane (lOO mg.) 
dissolved in pyridine (2.5 ml.) was treated with me thane sulphonyl 
chloride (1.2 mole) at 0 %  for 12 hr. Working up the reaction mixture 
gave the non-crystalline 73-methanesulphonyloxy-53-cholane (106 mg.) 
(infrared spectrum showed complete conversion of the 7(3-hydroxyl group 
into the methanesulphonate group) . The material did not decompose 
on treatment with methanol.
Reduction of the 7(3-methanesulphonate ester with lithium aluminium 
hydride in refluxing ether (16 hr.) and subsequent purification by 
chromatography over alumina (gr. Ill, 10 g.) gave 5(3-cholane (80 mg.) 
m.p. and mixed m.p. 85-87%. The infrared spectrum was identical with 
that of authentic 5p-cholane'^ ‘. Gas liquid chromatography further 
confirmed the identity.
53-cholane was prepared by Wolff-Kishner reduction of 12-keto-5p- cholane, following the method of Huang Minion^^ for reduction of steroidal ketones, (yield 8C^ o) m.p. 86-88% (reported^89-90°). Found: 0, 86.63; H, 12.86; Calculated for C9.H.9: C, 87.27;H, 12.7%;).
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73-lara-toluene sulphonyloxy- 53-Cholane : 7p-Kydroxy-5p-cholane (lOO iDg.) 
dissolved in pyridine (3 ml.) was treated with 2-toluene sulphonyl 
chloride (l.2 mole) and the mixture was incubated at 37-40% for 16 hr. 
Working up of the reaction mixture in the usual way gave the non­
crystalline 7p-2-toluenesulphonyloxy-5p-cholane (IO8 mg.) (infrared 
spectrum showed complete estérification). Further proof of complete 
estérification was obtained as follows. The 7p-2*-toluenesulphonate 
was treated with lithium aluminium hydride in refluxing ether for 16 hr. 
The crude reduction product on purification by chromatography over 
alumina (gr. I, 15 g.) gave 5p-cholane (70 mg.) m.p. and mixed m.p. 
86-88%. No 7p-hydroxy-5p-cholane was obtained.
Attempted Formation of 12g-Para-T oluene sulphonyl oxy- 53**Cholane ; 
12o-4iydroxy-5p-cholane (lOO g.) was treated with 2“ toluene sulphonyl 
chloride (1.2 mole) in pyridine (3 ml.). The mixture, after initial 
incubation at 60-65°C for 2.5 hr., was kept at 28-30% for 16 hr.
The solid reaction product showed only partial estérification (infrared 
spectrum showing both 12o-hydroxyl group and 2-1 olue ne sulpho na te group 
bands). Reduction of this product with lithium aluminium hydride 
in refluxing ether afforded solely 12a-hydroxy-5p-cholane (65 mg.) 
m.p. 100-106%.
12g>-Me thane sulphonyloxy-53-Cholane : 12a-Hydroxy-5p-cholane (l g.) was
treated with me thane sulphonyl chloride (l.l mole) in pyridine at 0 %  
for 16 hr. On working up the reaction mixture a gum was obtained which
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eventually crystallised after 18 hr. (1.2 g.). Recrystallisation from 
ethanol gave pure 12œ-me thane sulphonyloxy- 50-cholane (l.05 g.) 
m.p. 113-114°D, [ Q, ] + 40° (c = 2.0). (Pound; C, 70.86; H, 10.43,
C25H44O3 S requires C, 70.80; H, 10.38/o).
Pure 12o-methanesulphonyloxy-5p-cholane on heating at 60° in vacuo 
decon4)Osed into a colourless gum leaving behind a dark water soluble 
material. The gum gave intense yellow colour with te trani trome thane 
and there were no functional peaks in the infrared spectrum. Gas 
liquid chromatography showed very little component corresponding to 
Z\ll-5p-cholene, which increased in peak height on admixture with authentic 
A^^-5p-cholene, (vide infra). The major component had a lower retention 
time than A^^-5p-cholene. A pure sangle of A^^-5|3-cholene when re fluxed 
in benzene with 2 - toluene sulphonic acid for 1 hr. gave a non-crystalline 
product. Gas liquid chromatography of this product showed that a 
substantial amount of the A  ^ ^-5p-cholene was rearranged to give four other 
conç)onents with lower retention times than that of A^^-Sp-cholene.
Reduction of 12a-methanesulphonyloxy-5p-cholane (lOO mg.) with 
lithium aluminium hydride in refluxing ether gave 12o/-hydroxy-5p-cholane 
(89 mg.).
12-Oxo-53-Cholane : 12o-Hydroxy-5p-cholane (500 rag.) dissolved in acetic
acid (3 ml.) was treated with a solution of chromic oxide (200 mg*) in 
acetic acid/water (97:3) mixture (5 ml.) at room temperature and allowed 
to stand for 14 hr. The crystalline 12-oxo-53-cholane was removed by
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filtration and the residue repeatedly washed with water and dried 
(380 mg.) m.p. 118-120% (reported^^^ ii5_ n 70) ^ [o] ^  + 89°
(c = 2.0) (reported^52 * 89.^.
120-Hydroxy-53-Cholane (XXX); (a) 12-0xo-5p-cholane (500 ng.) dissolved
in ether (70 ml.) was slowly dropped into a refluxing slurry of lithium 
aluminium hydride (500 mg.) in ether(50 ml.). The reaction mixture 
was refluxed for 16 hr. and the excess of hydride decomposed with moist 
ether. The ethereal filtrate from the reaction mixture gave a gum 
(510 mg.) showing no carbonyl absorption in the infrared spectrum.
The crude mixture of epimeric 12-hydroxy-5p-cholanes was resolved by 
chromatography over a column of alumina (grade III, 20 g.) using light 
petroleum. 12a*-Kydroxy-5p-cholane (50 mg.) was quickly eluted with 
20 mis. of solvent. After an intermediate fraction (lO mg.), light 
petroleum (400 ml.) eluted 12p-hydroxy-5p-cholane (386 mg.) m.p. 93-95% 
(reported^^^ 91-92°) , [ a] + 33.4° (c = 2.2) (reported^+ 45%
(b) Reduction of 12-oxo-5p-cholane (500 mg.) with sodium metal 
in boiling ethanol (as described for the reduction of 7-oxo-5p-cholane) 
gave a mixture of epimeric 12-hydroxy-5p-cholanes (340 mg.) vdiich on 
chromatography over alumina (gr. Ill, 20 g.) using light petroleum as 
eluent gave 12o-hydroxy- 5p - cholane (l30 mg.) and 12p-hydroxy- 5p -ch olane 
(127 mg.).
123-Me thane sulphonyl oxy- 53-cholane : 12p-Hydroxy-5p-cholane (350 mg.) 
was treated with me thanesulphonyl chloride (l.l mole) in pyridine (2 ml.)
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at 0°C for 16 hr. The resultant gummy 12(3-me thane sulphonyloxy- 53-cholanB 
(380 rag.) resisted all attempts at ciystallisation, [ctj ♦ 39.1°
(c m 1.84). This product was stable if stored as a solution in non- 
hydroxylic solvents for indefinite periods (infrared spectrum).
A solvent-free specimen decon^osed on standing at room temperature 
for 48-72 hr., while another fresh specimen decanposed vrtien evacuated 
on a water-pump at room tenç>erature for 30-40 min. Both these decomposition 
products could be separated into a light petroleum-soluble colourless gum 
and a water soluble dark paste. The light petroleum-soluble gum gave 
an intense yellow colour on treatment with te trani trome thane but did not 
show any absorption for a double bond in the infrared spectrum (tetra- 
substituted?) nor for any other functional groups. Gas liquid chromatography 
showed very little material corresponding to A^^-5p-cholene. The main 
component had a lower retention time than that of A^^-5p-cholene.
Attempted crystallisation of a fresh specimen of the 12j3-methane- 
sulphonate from hot ethanol also caused decomposition of the product into 
a dark gum. Extraction with light petroleum gave a colourless gum leaving 
behind a dark tarry matter (water soluble). The petroleum-soluble gum 
showed a con5)lex pattern in its infrared spectrum with absorption peaks 
indicating a free hydroxyl group (3500 cm“^), a keto peak (1700 cra“ )^ and a 
peak at 1650 cm"^ (double bond?). Chromatography over alumina (gr. I, 10 g.) 
eluted an oily unsaturated hydrocarbon #iich gave an intense yellow colour 
with tetranitromethane and showed no other functional groups in the infrared 
spectrum. Gas liquid chromatography showed the presence of three main
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components, one of which proved to be A^^-Sp-cholene.
Reduction of freshly prepared 12(3-me thane sulphona te (lOO mg. ) 
with lithium aluminium hydride in refluxing ether gave a colourless 
gum, Tdiich on chromatography over alumina (gr. I Woelm, neutral 10 g.) 
using light petroleum as solvent gave 5p-cholane (70 mg.), m.p. and 
mixecL m.p. 65-87%. No 12p-hydroxy-6p-cholane was obtained.
120 -Para-T olue ne sulphonyl oxy- 53-Cholane : 12p -H ydr oxy- -cholane (lOO mg.)
was treated with 2" toluene sulphonyl chloride (1.2 mole) in pyridine 
(2.5 ml.) and the mixture incubated at 37-40% for 16 hr. The resultant 
product (solid 100 mg.) showed partial estérification (absorption bands 
for both the free hydroxyl group and 2“ toluene sulphona te group).
Reduction with lithium aluminium hydride in refluxing ether (16 hr.) 
gave a gum (75 mg.). Chromatography over ailumina (grade I, 10 g.) 
using light petroleum eluted Sg-cholane (41 mg.) m.p. and mixed m.p. 
85-87%. Ether/light petroleum (1:4) eluted unreacted 12p-hydroxy-53- 
cholane (23 mg.) m.p. and mixed m.p. 102-106%. _ _ _ . , _
Attempted Formation of 7a-Methanesulphonyloxy-12a-Hydroxy-50-Cholane: 
7a,12a-Dihydroxy-5p-cholane (200 mg.) was treated with me thanesulphonyl 
chloride (l mole) in pyridine (4 ml.) at 0 %  for 16 hr. The product 
(210 mg. solid) showed a sharp absorption in the infrared spectrum at 
3400 cm“*^  showing the presence of a free hydroxyl group (in the cholane 
series, axial diols do not give sharp peaks). Reduction of this 
sulphonate ester with lithium aluminiuna hydride in refluxing ether
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regenerated 7a,12a-dihydroxy-5p-cholane (l90 mg.).
Attempted Formation of 12a-Para-toluenesulphonyloxy-5c^-Cholane:
12a-Hydroxy-5a-cholane (lOO mg.) dissolved in pyridine (2 ml.) was 
incubated with jg-toluene sulphonyl chloride (1.2 mole) at 37-40°C for 
16 hr. Working up the reaction mixture in the usual manner gave 
unchanged 12a^hydroxy-5o-cholane (90 mg.) m.p. and mixed m.p. 125-127%.
12g-Me thane sulphonyloxy- 5af-Ch olane : 12or-Hydr oxy- 5a-cholane (l50 mg.) 
was treated with me thane sulphonyl chloride (1.2 mole) in pyridine (2 ml.) 
at 0°C for 16 hr. The reaction product recrystallised from ethanol 
gave 12a-methane3ulphonyloxy-5g-cholane (150 mg.), m.p. 103-105%,
[a] 20. 41.7°(c = 2.3). (Found; C, 71.08; H, 10.96. C25H44O3S
requires C, 70.80; H, 10.38^ o).
Reduction of the 12a^me thane sulphonyl oxy-5a-cholanc (50 mg.) with 
lithium aluminium hydride in refluxing ether for 10 hr. gave pure 
12o-hydroxy-5a-cholane (42 mg.) m.p. and mixed m.p. 123-125%.
3q-Lîethane3ulphonyloxy-Cholestane: Epicholestanol (XXXl) (15 mg.) dissolved 
in pyridine (0.5 ml.) was treated with me thane sulphonyl chloride (0.04 ml.) 
at 0°C for 12 hr. On working up the reaction mixture in the usual 
manner solid 3a-methanesulphonyloxy-cholestane (17 i%.) was obtained, 
recrystadlised from methanol, plates, m.p. 133%. The infreired spectrum 
showed the absence of any free hydroxyl group and characteristic bands 
for the me thane sulphonyl group .
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Lithium aluminium hydride reduction of the 3a-methanesulphonyloxy- 
cholestane (12 mg.) in refluxing ether gave a crystalline material 
(ca 10 mg.). Chromatography of this reduction product over alumina 
(gr. I, Woelm, neutral, 5 g.) using light petroleum as solvent gave 
cholestane (ca 3 qg.) m.p. 77-79% (reported^^^ 80°). The infrared 
spectrum was identical with that of choies tane Ethanol/ether
(1:19) eluted epicholestanol (ca 6 mg.) m.p. 176-180°C and mixed m.p. 
177-180°C. The infrared spectrum was identical with that of authentic 
epicholestanol.
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CONFIGURATION OF 12-AMINO-CHOLABES
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As mentioned in Section I of this thesis, unsuccessful attempts
to convert the trioxime of methyl dehydrocholate into the corresponding
3a,7a,12a-trifiLmino compound focussed attention upon the need to examine
conditions for the reduction of the steroidal 12-oximino function and
to establish the configuration of the resulting 12-amino group. In
contrast to tne situation pertaining with 2-, 3-, 4— , 6-, 7- or 11-
154oximino steroids where the steric course of reduction under a variety 
of conditions is firmly established, a survey of the literature (after 
elimination of studies reporting poorly characterised or impure specimens^^^) 
revealed là i& t at first sight appeared to be conflicting results in the 
reduction of 12-oximino steroids.
Thus Ivlacphillamy and Scholtz^^^ reduced the oxime of 3a-hydroxy-12- 
oxo-cholanic acid (XXXIV) by means of sodium metal and isoamyl alcohol 
to a 12-ajnino-3a-hydroxy cholanic acid in which the 12-amino function 
can be assigned the axial (a) configuration, since on quaternisation 
followed by Hofmann élimination^ *^^  they obtained 3a-hydroxy-ll-cholenic 
acid (Fig. 9). This was converted into methyl 3a-acetoxy-ll-cholenate 
having identical physical properties with those reported for authentic 
material prepared by the pyrolysis of desoxycholic acid^^®, although 
direct con^eirison of samples does not appear to have been made. The 
Hofmann elimination is well established as occurring by an E2 mechanism^^^ 
and as such requires that the quaternary ammonium groups and the proton
on the p carbon atom, v^ich are involved in the elimination, be trans
IfiOand antiparallel . The only way in Wiich these requirements can be
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met by a hydrogen atom on 0-11 and a quaternary ammonium function on 
0-12 is for the elimination to involve the Up-hydrogen atom and a 
12a-quaternary group. Hence the configuration of the amino group at
0-12 following the reduction of the oxime must be a (axial). This 
requirement of trans and antipsirallel elimination in the Hofmann 
degradation has been well illustrated in the steroid series by McKenna 
et al, who showed that axial quaternary amino functions at 0-3 or
0-6 (in 5a steroids)^^^ gave rise to olefines under Hofmann conditions, 
whilst the corresponding equatorial quaternary ammonium compounds 
regenerated the corresponding tertiary bases.
On the other hand Waid and Taurins^^^, without giving any structural 
proof, assigned the p (equatorial) configuration to the 12-amino group 
of the product resulting from the sodium metal and propanol or n-butanol 
reductions of 12-oximino-, 3,12-dioximino-and 7,12-dioximino-cholanic acids. 
The assignments were made on the argument that under equilibrating con­
ditions the equatorial epimer would be formed.
Finally Anliker et al^G4 reduced the oxime of hecogenin (XXXV) by 
means of sodium metal and propanol to a 12-arainospirostane derivative.
In this compound the 12-amino function must have the equatorial (p) 
configuration as, on diazotisation, they obtained the characteristic 
mixture of jervi steroids^®^ known to result from elimination of a 12p 
group with concurrent migration of the 13-14 bond of the steroid nucleus 
(Fig. 10). Since the conversion of the amino function into the diazonium 
group is well known to proceed with retention of configuration as it
HO
xxxyi
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involves an initial N-nitrosation followed by rearrangement of the 
nitrosamine to yield the diazonium ion viz.
R - NHg _____  ^ R - NH - N = 0 — Û— » R - N = N OH
i
R -  Ng ♦ CH"
it therefore follows that the amino group must also have been in the
12p-configuration. The formation of the two products 56-hydroxy- .jervi-
22a,5a-spirost-17(l3)-ene (X3CXVI) and 56-hydroxy-jervi — 22a,5g-spirost- 
13(l8)-ene (XXXVIl) in the ratio of £a 4:1 characteristic of such 
jervi rearrangements, arises from the alternate paths of proton elimination 
from C-17 or C-18 in the carbonium ion precursor.
The results of Anliker et al^^^ and of MacPillamy and Scholz^^^ 
thus appear at first glance to be directly contradictory as application 
of analogous reaction procedures (known normally to convert oximes and 
ketones into the thermodynamically most stable amine or alcohol^^^) to 
two different 12-oximino-steroids gave amines of opposite configurations 
for which the proof of structure in each case is convincing.- - -
As a first step in the present work it therefore appeared logical 
to prepare the epiraeric pair of 12-amino-5(3-cholanes and apply both the 
diazotisation procedure and the Hofmann elimination reaction (after 
quaternisation) to each epimer in order to eliminate the possibility of 
any discrepancy between the two procedures as applied to the determinations 
of configuration of the two different 12-amino compounds reported in the 
literature. For instance it was conceivable, though not probable, that
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a cis Hofmann elimination was occurring or that in the diazotisation 
reaction the migration of the 13-14 bond was not synchronous with the 
departure of molecular nitrogen from C-12, permitting the finite existence 
of a carbonium ion with consequent loss of stereochemical significance.
In actual fact it was not found possible to prepare both epimeric 
l2-aiïâno-5p-cholanes. Application of a variety of reduction procedures 
to 12-oxiinino-5p-cholane, vAiich was prepared in good yield from 12-oxo- 
5p-cholane (Section II) by the standard procedure, gave in all cases 
the same single epiraer. No attenqpt was made in the present work to 
separate the cis and trans forms of this oxime or of any of the other 
oximes described below.
Reduction of 12-oximino-5p-cholane by means of sodium and boiling 
alcohol, afforded a crude low melting solid #iich was separated by means 
of alumina chromatography into a single 12-amino-5|3-cholane and 12-oxo- 
5p-cholane. It would seem clear that the formation of the latter confound 
was not due to hydrolysis of the oxime during the reduction as the 
corresponding alcohol, not the oxo-conçjound, would have been isolated.
A likely explanation is that inconplete reduction to the imine had 
occurred and that this intermediate was protected from further reduction 
through complex formation. In the working up of the reaction mixture, 
the liberated imine would then be hydrolysed to the ketone,
Treatment of 12-oximino-5j3-cholane with lithium aluminium hydride 
in boiling ether afforded in 90/j yield a single 12-amino-5p-cholane idiich 
proved to be identical with that obtained from the sodium and ethanol
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reduction (mixed m.p. ,[a]g and infrared spectrum). Not only was there 
no evidence of the formation of the epimeric amine but there was no 
evidence of the production of any 12-hydroxy-compound, which is of interest 
in view of the report^^S that the action of lithium aluminium hydride 
on 3,12-dioximino-cholanicacid leads to the formation of a cholane- 
3,12,24-triol.
Catalytic hydrogenation of 12-oximino-5p-cholane in acetic acid 
proceeded poorly, but in the presence of a trace of perchloric acid or 
at 100-110 atmospheres, a good yield resulted of the same single 
12-amino-5p-cholane as was obtained by the other procedures.
Treatment of 12-oximino-5p-cholane with lithium metal and liquid
ammonia yielded only a mixture of hydrocarbons (one of which proved to
be 5p-cholane) and unreacted starting material, there being no detectable
amount of amine in the product. Similarly attempts to convert 12-
nitrimino-5p-cholane (prepared from 12-oximino-5g-cholane by the action
of nitrous acid following the method of Schenck^^® for the synthesis of
other 12-nitrimino-cholanes) into a 12-amino-5p-cholane were unsuccessful.
Unlike 2-nitriminobornane, which liberates 2-iminobornane on treatment
169with 880 ammonia , 12-nitrimino-5p-cholane gave rise only to 12-oxo- 
cholane on treatment with 880 ammonia or with liquid ammonia, and no 
imine could be isolated. This is of significance in connection with 
the formation of 12-oxo-5(3-cholane in the sodium and ethanol reduction 
of 12-oximino-5p-cholane already discussed (p. 76).
In connection with the formation of the same single 12-amino-5p-
-78-
cholajie by the reduction procedures described above, it is of considerable
170significance that Shoppee ^  ^  were able to obtain only the one
1-amino-5o/-cholestane (to which no configuration was assigned) by 
catalytic hydrogenation, treatment with lithium aluminium hydride or 
sodiun^alcohol reduction of 1-oximinocholestane. It would appear
therefore that an analogous situation to that at C-12 in the cholane 
series pertains at C-1 in the cholestene series.
Configurational studies were then commenced on the 12-amino-5p- 
cholane, and these conclusively showed that it possessed the a ie 
axiaJ. configuration.
Thus deamination of 12-amino-5p-cholane with nitrous acid in 80^ 
aqueous acetic acid (according to the method described by Anliker _et al^^^ 
for the deamination of 3p-hydroxy-12p-amino-22a,5o-spirost8Lne) gave a 
neutral noncr^^stalline product, the infrared spectrum of which showed 
absorptions characteristic of a 12o-hydroxyl group (3540 cm"^), a 
carbonyl group (1700 cm” )^ and of double bonds (1600 and 1630 cm"^). 
Chromatographic fractionation of this product over alumina afforded a 
mixture of unsaturated hydrocarbons (the infra red showing double bond 
absorptions at 1600 and 1630 cm”^), 12<Ko-5p-cholane and 12o-hydroxy-5p- 
cholane in the ratio of 2:3:5. Gas liquid chromatography of the hydro­
carbon fraction indicated the presence of four components which could 
be divided into tv\^o pairs on the basis of their retention times. One 
con^onent of the pair having the lower retention time, and idiich 
constituted _ca 7(ÿü of the total, was identified as A^^-5p-cholene by
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admixture witii an authentic sample. The second pair which heid retention 
times c& twice that of the first pair appeared to be a mixture of 
unsaturated jervi hydrocarbons. These could have arisen through loss 
of stereochemical significance consequent upon carbonium ion formation 
at C-12. That the components of each pair differed only in the position 
of the double bonds a m  not in basic skeleton followed from the results 
of catalytic hydrogenation of the hydrocarbon mixture. The resulting 
mixture of saturated compounds (infrared spectrum and negative tetra- 
nitromethane test) on gas liquid chromatography showed only two components - 
one corresponding to each of the pairs of the unsaturated compounds.
The component with the lower retention time was identified as 5p-cholane 
by comparison with an authentic specimen.
The 12-0X0-5p-cholane was concluded to have arisen from 12a-hydroxy- 
5p-cholane under the reaction conditions, as it was demonstrated in a 
separate experiment that 12o-hydroxy-5p-cholane, on treatment with 
nitrous acid in 80^ axjuous acetic acid, was partially oxidised to 12-oxo- 
5p-cholane. On the other hand 12(3-hydroxy-5(3-cholane formed an unstable 
nitrite ester under the same conditions and this readily regenerated 
12p-hydroxy-5p-cholane in quantitative yield upon attempted recrystallisation 
from ethanol. Thus isolation of 12a-hydroxy-5p-cholane together with 
12-oxo-5p-cholane from the reaction product in ca 8CÇ0 combined yield 
with no trace of the 12p-epimer showed the 12-amino-5p-cholane to have
the a (axial) configuration since replacement of the diazonium group
X7Tby the hydroxyl group proceeds with retention of configuration .
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Quaternisation of the 12-amino-5p-cholane proved difficult but was 
achieved on heating the N,N-dimethylamino-5p-cholajie (prepsired by
adaptation of the formic acid/formaldehyde method used by Dodgson and
172 \Haworth for the preparation of other steroidal tertiary amines)
with methyl iodide in a sealed tube at 100% for 5 hr. (6C^ o). It has
been established that the formation of the tertiary amine by the formic
acid/formaldehyde method does not produce racémisation of the resultant
dimethylamino group^^^*^^^. Application of the quaternisation procedure
174of Woodward ^  ^  , even after prolonged re fluxing, gave low yields.
Sepsiration of the quaternary iodide from the tertiary atmine was readily 
achieved by taking the tertiary amine into light petroleum after removal 
of the solvent from the alkaline reaction mixture.
Hofmann degradation of the quaternary base under the conditions 
described by MacPhillamy and Scholz^^^ yielded an unsaturated hydrocarbon 
in 80^ yield and a tertiary base (ca 10^1) vdiich was identified as 
12a-diméthyl£Linino-5p-cholane by conparison of [ aj jj*s and through mixed 
m.p. of its hydrochloride with authentic 12a-dimethylamino-5p-cholane 
hydrochloride.
The unsaturated hydrocarbon was concluded to be A^^-sp-cholene 
as the Hofmann degradation requires trans elimination^®^. Gas liquid 
chromatography indicated one ccmiponent having a retention time very close 
to that of 5p-cholane. Catalytic hydrogenation afforded pure 5p-cholane, 
whose identify was proved by gas liquid chromatography enploying authentic 
5p-cholane. This formation of 5p-cholane showed that the Hofmann
12a - a m m o  - 5/5- c h o la n e
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elimination occurred without rearrangement of the carbon skeleton of 
the molecule.
The products obtained on deamination of the primary amine and on 
Hofmann degradation of the corresponding quaternary ammonium base 
therefore show conclusively that the configuration of the 12-amino 
group must be a (axial).
The position of the double bond in the compound designated
-5p-cholene was not rigorously proven in the present work. The 
obvious method to follow would involve epoxidation of the double bond 
followed "by treatment of the product with (a) lithium aluminium hydride 
and (b) lithium aluminium hydride in the presence of aluminium chloride. 
These reagents are known^ *^  ^to open epoxides in the opposite senses 
and one of the resultant alcohols would have to correspond to a known 
12-hydroxy-6j3-cholane. As the compound has already been shown
to give 5p-cholane on reduction thus demonstrating that there has been 
no rearrangement, the above experiments would give conclusive proof 
that the double bond is in the 11-12 position.
Having thus established the fact that reductions of 12-oximino-5(3- 
cholane, all lead to the sole formation of 12ck-aunino-5p-cholane, attempts 
were made to obtain the 12p-SLmine by procedures involving Sj^ 2 attack on 
12a-methanesulphonyloxy-5p-cholane. Treatment of this compound with 
sodium azide gave rise to the expected displacement but the resulting 
12|3-azide could not be converted into the desired amine by the accepted 
reduction procedures employing lithium aluminium hydride^ *^ ,^ sodium
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hydrosulphite^ *^ *^  or catalytic hydrogenation^*^®. Instead, the first 
two methods yielded a noncrystalline unsaturated hydrocarbon mixture 
(tetranitromethane test) which after gas liquid chromatography was 
concluded to be an equiproportional mixture of A^^-5p-cholene and 
another compound with very close retention time to that of other C24 
steroidal hydroceirboris, not belonging to the jervi series. CateuLytic 
hydrogenation of the 12j3-azide afforded a noncrystalline saturated 
hydrocarbon mixture (negative te tranitrome thane test) . Gas liquid 
chromatography showed that the product was a complex misture of five 
components, with 5p-cholane constituting ca 50^ of the total product.
Similar formation of hydrocarbons was observed on reduction of 
12o^azido-5P”Cholane prepared by a displacement reaction on 12p-methane- 
sulphonyloxy-5p-cholane. Once again no amine could be isolated.
The unsaturated hydrocarbon mixture obtained by lithium aluminium 
hydride reduction of the 12c^ -azide, on gas liquid chromatography was 
shown to consist of six components. The two main components, which 
constituted ca of the total, were concluded to be A^^-5(3-cholene 
and a jervi hydrocarbon, by conpaxison with the hydrocarbons obtained 
on diazotisation of 12a-amino-5p-cholane. The jervi hydrocarbon could 
have arisen through partial rearrangement during the 12o”azide formation. 
As the p-methanesulphonate group was leaving C-12 the 15-14 bond could 
migrate with synchronous attack by azide ion at 0-15 instead of the 
normal S|^ 2 attack on 0-12 (Fig. 10a) (cf. ref. 165).
The saturated hydrocarbons obtained on catalytic hydrogenation of
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12o-azido-5p-cholane, gave two main components on gas liquid chromato­
graphy, corresponding, in retention time, to the 5(3-cholane and jervi- 
cholane conçonents of the hydrogenated hydrocarbons obtained from the 
diazotisation reaction (p.79 ).
The action of sodamide on 12a-methanesulphonyloxy-5|3-cholane also 
failed to afford any l2p-amino compound. The sole products of the reaction 
were 12-oxo-5p-cholane and 12o-hydroxy-5p-cholane. It is of interest
that the action of sodium iodide in acetone on 12a-methane-sulphonyloxy- 
5p-cholane gave an extremely unstable iodo compound, Wiich on standing 
liberated free iodine and formed a mixture of hydrocarbons (gas liquid 
chromatography) giving a positive test for unsaturation with permanganate, 
bromine or te tranitrome thane. One possible interpretation of the
instability of this iodo derivative is that it is sterically unfavoured. 
Attempts to convert a freshly prepared sample of the 12p-iodo compound
into 12a-amine by means of sodamide in xylene were unsuccessful.
17QApplication of the Leuckart reaction to 12-oxo-5p-cholane 
afforded a 12-formylamino-5p-cholane in good yield. Hydrolysis of this 
derivative yielded 12a-amino-5p-cholane (m.p. infrared spectrum) together 
with trace amounts of two unsaturated hydrocarbons in equal quantities 
(tetranitromethane test and gas liquid chromatography).
In view of these unsuccessful attempts to secure 12p-amino-5p-chol8ine, 
a further possibility was to attempt the preparation of 12p-M-dimethylamino- 
5p-cholane by an 8^2 displacement with dimethylamine on 12a-methane- 
sulphonyl oxy-5p-ch olane , as quaternisation of the dime thylamino conç)Ound
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would at least permit of an investigation of the Hofmann elimination 
on the corresponding 12(3-quaternary amnonium salt even although a study 
of the diazotisation of the corresponding primary amine would not be 
possible. This approach was not investigated, however, after careful 
consideration of steric interactions at C-12.
Examination of models shows that there are differences in the steric 
hindrance occurring at C-12 in the cholane series and the spirostane 
series. Thus in the latter, the oxygen bridge between C-16 and C-22 
ensures that C-21 (the side chain methyl group) is held spatieilly well 
removed from C-12 and offers little hindrance to this last position.
In the cholane series, on the other hand (with the same configuration 
at C-20, as both the bile acids and the spirostanes arise in nature 
from lanosterol^®® and so retain the same stereochemistry at C-20), it 
is not possible for the 12p position to be without steric hindrance 
from C-21 or C-22 without there being serious non-bonded interactions 
within the side chain or between the side chain and C-16. It must be 
assumed that the side chain will adopt a conformation in vdiich a compromise 
is made between all possible non-bonded interactions, but in idiich there 
is greater steric hindrance at the 12p position than occurs in the 
spirostane series.
The shielding of the 12p position in the cholane (and by extension, 
the choiestane series) by the C-17 side chain can be regarded as a type 
of long range effect if such shielding is ascribed to reduction of non- 
bonded interactions involving C-16 and the side chain. Barton^®^ has
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introduced the concept of long range effects in a somev^at narrower sense 
to explain differences in reactivity between different steroids at the 
same position in the nucleus, but in the case of C-12, the long range 
effect actually reverses the normal relative stability of the epiraers.
It is to be noted that a steric interaction similar to that just 
descid-bed for the 12p-position and the cholane side chain, also occurs 
between the 1^-position and 0-11 in the steroid nucleus (Fig. ll) and 
it is therefore tempting to assign the axial (a) configuration to the
1-aminocholestane prepared by Shoppee et by analogy with the axial
configuration of 12-Euaino-5(3-cholane. It is to be noted, however, that 
reduction of 5a-cholestane-^one with sodium and alcohol gives the ip 
and la hydroxy compounds in the ratio of ca 2:1^®^. A similar steric 
interaction is found between 0-19 and 0-12 in the triterpene nucleus 
and it is therefore of considerable interest that sodium and alcohol 
reduction of certain 19-keto triterpenes is known to give the corresponding 
axial alcohol^®
The experimentally observed fact that reduction under equilibrating 
conditions (sodium and alcohol) of 12-oximes in the spirostane series 
gives solely the equatorial amine whilst 12-oximes of the cholane series 
afford solely the axial amine would therefore be accommodated if the 
increased steric hindrance of the 12p position occurring in the cholanes 
were sufficiently great to actually render the axial configuration 
thermodynamically more stable than the equatorial configuration. Such 
a reversal of the normal stabilities was not envisaged by Waid and Taurins^^^
Fig . 12.
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ajid so inversion of their assignments of configuration gives a conç)letely 
rational picture of sodium and alcohol reduction of 12-oximino steroids.
The results obtained on lithium aluminium hydride reduction of 12- 
oximino- 5p-cholane are somewhat more difficult to explain. With 
steroidal 5, 6 and 7-oximes, lithium aluminium hydride usually gives 
tt mixture of epimers with the most hindered amine predominating'*'^ >^ 
although instances are known #iere a single epimer only is formed^®^^ 
or where the more stable epimer is formed^®^. In the case of conqplex 
metal hydride reductions of ketones, an explanation of the relative 
proportions of the epimeric alcohols formed has been advanced^®^ on the 
grounds that two effects are operative. These are the ease of formation 
of the complex between the carbonyl group and the complex hydride (steric 
approach control) and the relative energies of formation of the 
products once the initial conç)lex is produced (product development control). 
However, more recently certain anomalies, vhich could not be accommodated 
by this theory, have been eliminated by the postulate^®? that two distinct 
reaction pathways exist for the reduction of carbonyl groups by conç>lex 
metal hydride. These are (i) a direct attack on the carbonyl carbon 
by the metal hydride anion (Fig. 12) giving a large proportion of the 
unstable alcohol owing to the preferred approach of the hydride ion from 
the less hindered side of the molecule; (ii) the formation of a conç)lex 
between the Lewis acid formed by dissociation of the metal hydride and 
the carbonyl oxygen -which adopts the most stable conformation and is 
then reduced (Fig. 13).
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When different complex metal hydrides are considered, the second 
mode of attack will be dependent upon the chemical nature of the actual 
hydride employed as this will influence the dissociation of the conçlex 
metal hydride.
In the case of the oximino group the situation is much more conçlex 
than with the carbonyl group as flirther modes of reaction are possible 
which involve the OH function (Fig. 14) and so there is little point 
in attempting to interpret the formation of the 12-amines in terms of 
mechanisms. That the path shown in Fig. 14(a) may veil be involved 
is perhaps indicated by the results of Waid and Taurins^®^ vAio interpreted 
the conversion of a 12-oximino-cholanic acid into the corresponding 
12-hydroxy compound as proceeding via the imine.
Examination of models shows that it is extremely difficult to 
introduce a trivalent atom such as nitrogen into the 12p position of 
the cholane nucleus although a divalent atom such as oxygen can be 
relatively easily accommodated, and it nay well be this trivalent nature 
of the amino group which determines its omorientation as lithium aluminium 
hydride reduction of 12-oxo-5p-cholane gives predominantly the 12(3-hydroxy 
compound (XXIX) (p. 68 ) .
The steric course of the catalytic hydrogenation of 12-oximino-5p- 
cholane cannot be used in support of the theoretical arguments since it 
is not fully understood exactly ^ »diat factors determine the direction of 
hydrogenation. It is clear, however, that the relative orientations 
of the molecule undergoing reduction in relation to the catalyst surface
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and in relation to the number of molecules of hydrogen available for 
reaction must both play in^ortant roles.
If the conclusion that the 12 axial position is thermodynamically 
more favoured than the 12 equatorial position in the cholane series is 
correct, further supporting evidence should be available from reduction 
studies of 12-keto steroids. Accordingly a careful study of the reductions 
of 12-oxo-5p-cholane was undertaken.
After this work had been completed a paper^®® appeared having 
inportant hearing on the results to be discussed below. The authors 
obtained results in excellent agreement with those of the present work, 
but they offered the explanation that neither metal in ammonia nor 
sodium in alcohol, reduction of ketones are thermodynamically controlled.
In the present work, sodium and ethanol reduction of 12-oxo-5(3- 
cholane (p.68 ) afforded a mixture of 12a and 12p-hydroxy-5p-cholanes 
which were present in equal amounts as shown by alumina chromatography.
The formation of both epimers in equal quantities in the cholane series 
is in striking contrast to the situation encountered on sodium and alcohol 
reduction of 3p-hydroxy-12-oxosolanid-5-ene which gives solely the 12p- 
hydroxy compound^^^ indicating that v^ilst the equatorial position in the 
solanidane series is definitely favoured it is not so favoured in the 
cholane series. Similarly sodium and alcohol reduction of hecogenin 
gives a higher preponderance of the equatorial epimer^®®. Huffüian ^  al^®® 
found that reduction of 12-oxo-5(3-cholane with sodium and n-propanol 
gave Cl^ j 12a-hydroxy-5p-cholane.
-89-
Lithium aluminium hydride reduction of 12-oxo-5p-cholane (p. 68 ) 
gave a mixture of epiraers with the 12(3-hydroxy compound predominating 
(60-80^ j of the product) as shown after alumina chromatography vÈiilst 
lithium aluminium tritertiaryhutoxy hydride gave a mixture of epimers 
with the 12o-hydroxy conpound predominating (ca 80/- of the product).
As tiiis last reagent is assumed to act by the mechanism shown in 
Fig. 14(b) (i.e. dissociation to lithium hydride and aluminium tri- 
tertiarybutoxide) with the bulky tritertiaryhutoxy aluminium group 
adopting the less hindered position^®^, these observations support the 
contention that the 12 axial position is less hindered than the 12- 
equatorial position in cholanes.
It is to be noted that lithium aluminium hydride reduction of 
hecogenin has been reported to give a mixture of 12a and USp-hydroxy 
compounds , and that the 12-oxo-compound derived from polyp or enic acid A 
(12o-0H) has been shown to regenerate polyp ore nic acid A on treatment 
with the same reagent^^^.
Catalytic hydrogenation of 12-oxo-5(3-cholane with platinum oxide 
in acetic acid in the absence of added hydrogen ions proceeded poorly 
and the only products isolated were 12a-hydroxy-5p-cholane aiid unchanged 
starting material. In the presence of added perchloric acid, hydrogen 
uptake was rapid yielding a mixture of 12o-hydroxy-5p-cholane (80/o) and 
5(3-cholane (20^ o) which must be assumed to have arisen via dehydration 
of a proportion of the 12o-hydroxy-5p-cholane formed followed by saturation 
of the double bond so introduced. In the case of Sp-hydroxy-12-
—90“
oxo-solanid-5-ene catalytic hydrogenation is known to give the 12(3- 
epimer^BG, The situation with 3p-hydroxy-l2-oxosolanid-5-ene is thus 
completely in line with that found for agavogenin^^^, mannogenin^^^ emd 
mexogenin^^^ where both sodium/alcohol reduction and catalytic hydrogena­
tions give the same epimer (the 12p compound)•
It may be noted, in passing, that originally the hydroxyl group 
at C-12 in the bile acids was assigned the p configuration following 
an erroneous interpretation of X-ray data^^ and much of the work before 
1947^^^ when reassignment was made^^ therefore needs careful re­
interpretation. Even as late as 1956 a review^G? of the reduction of 
oxo-steroids erroneously shows the catalytic hydrogenation under acid 
conditions of 12-oxo-cholanes as yielding the 12p-hydroxy compound.
In the cis A/B steroids the 7a-position is sterically hindered 
by non-bonded interaction with C-4 and in this connection it is interesting 
that 7-0X0“5p-cholane on reduction with sodium and ethanol (p. 64) gave 
a mixture of 1£^ û of the 7a-hydroxy compound and 85^ 4 of the 7p-hydroxy 
derivative. Lithium aluminium hydride reduction of the same ketone 
(p.no) afforded the a and p epimeric alcohols in the ratio of 19:1, 
whilst prolonged catalytic hydrogenation with platinum oxide in acetic 
acid with added perchloric acid present, gave 5p-cholane, 35^ 0 7a- 
hydroxy-5p-cholane and 35^ 0 unreacted starting material (cf. catalytic 
reduction of 12-oxo-5p-cholane p.llO). The hydrocarbon presumably 
arose via hydrogenolysis or by dehydration followed by the reduction 
of the mixture of the olefins so formed. These results are adso of
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interest in connection with the known greater case of oxidation of the
1 QR7o-alcohol than the 12o-alcohol
One other difference between compounds of the spirostane series and 
the naturally occurring cholane derivatives is that the former possess 
a trajis A/B ring junction whilst the latter possess a cis A/B ring junction. 
This difference would also be expected to influence the thermodynamic stability 
of the 12a configuration, but closer examination shows that the 12a position 
is less favoured in the cis A/B series than in the trans A/B series 
(a 1, 3 non-bonded interaction between C-4 and the axial hydrogen atom 
on C-9 giving a greater butressing effect to the non-bonded interaction 
between the axial 0-9 hydrogen and the 12a-position than is produced in 
the interaction of the 5a and 9a hydrogen atoms in the trans A/B series).
Nevertheless in order to adduce further evidence that the 12o^ 
configuration is the preferred one in steroids possessing an acyclic 
side chain of more than two carbon atoms at 0-17, it was decided to 
include the reduction of 12-oximino-5a-cholane in the present studies.
12-0ximino-5a-cholane was prepared from 12-oxo-5a-cholane (p.Ill) 
employing the usual procedure in ca yield.
The reduction of 12-oximino-5a^cholane employing the usual procedures 
i.e. sodium ethanol, lithium aluminium hydride and catalytic hydrogenation 
in presence of added hydrogen ions gave rise to one single 12-amino-5a- 
cholane. Characterisation of the product proved difficult, the base 
being nonelystalline and affording an ether soluble hydrochloride.
The noncrystalline base, after chromatography on grade I alumina, however.
12a- a m in o  - 5 a -  c h o la n e
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could "be easily crystallised as its hydrochloride on treatment vrith 
ca 6^ methanolic hydrochloric acid.
Diazotisation of 12”amino-5a-cholane (according to the method 
described by Anliker al^^^) afforded a mixture of unsaturated 
hydrocarbons, 12-oxo-5a-cholane and 12a-hydroxy-5o-cholane, separable 
on chromatography over alumina in the usual manner. The unsaturated 
hydrocarbon fraction was smaller in proportion than that obtained on 
diazotisation of 12a-amino-5p-cholane. These observations prove that 
the 12-oximino group in the 5a series is also reduced solely to the 
a (axial) compound. Hence it was concluded that the nature of the 
A/B ring junction has no effect on the course of reductions at C-12.
The quaternisation of 12-amino-5a-cholane was more facile than 
that of 12a-ainino-5p-cholane as under similar reaction conditions the 
conversion of 12-amino-5o^cholane to 12-dimethylajnmoniunwda-cholane 
methiodide was £a &0/o while that of 12a-amino-5p-cholane was only 50^ o. 
This result would be expected on the argument that the trans A/B ring 
junction favours the axial substitution at C-12 (p.91 )• Hofmann 
elimination proceeded as expected to give A^^-5a-cholene.
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EXPERIMENTAL
12-Oxlmino-56-Cholane; 12-0xo-5p-cholane (p.67 ) (l.O g.) in ethanol 
(20 ml.) was refluxed with a solution of hydroxylamine hydrochloride 
(0.33 g.) and sodium acetate (0.66 g.) in ethanol (20 ml.) containing 
water (l ml.) for 6 hr. The reaction mixture was distilled in vacuo 
to one Uiird of its volume and allowed to stand overnight. The inorganic 
material was removed by filtration, and the filtrate on evaporation at 
room temperature yielded 12-oximino-53-cholane (0.925 g.), recrystallised 
from methanol, rods m.p. 141-142° C, [ a] ^  + 152*^  (c = 2.0). (Pound:
G, 80.04; H, 11.36; N, 4.32. C24H41ON requires C, 80.22; H, 11.51;
N, 3.9C^Q.
Reduction of 12-0ximino-53-Gholane with Sodium and Ethanol:
A boiling solution of 12-oximino-5p-cholane (l.O g.) in ethanol (40 ml.) 
was treated with sliced sodium metal (4.0 g.) during a period of one hr. 
The cooled reaction mixture was diluted with water and the precipitated 
white semicrystalline solid was removed by filtration (925 mg.) m.p. 
85-95%. The infrared spectrum showed a carbonyl peak (1700 cm“ )^ and 
an amino peak (1605 cm"^). (a) The reduction product (530 mg.) was
chromatographed over alumina (grade III, 30 g.) using light petroleum 
as eluant. Light petroleum (70 ml.) eluted 12-oxo-5j3-cholane (l03 mg.) 
m.p. and mixed m.p. 118-120°C. Subsequent elution with light petroleum 
(50 ml.) gave very little material. Ether (70 ml.) eluted 12g^amino- 
56-cholane (414 mg.), recrystallised from methanol, m.p. 106-10793,
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[ a ] + 45.5°(c = 2.0). (Found: C, 83.42; H, 12.48; N, 4.21.
^2^43^ requires C, 83.72; H, 12.31; N, 4.07/i»).
(b) The reduction product (lOO mg.) dissolved in ether (10 ml.), 
was stirred with N HCl (lO ml.) resulting in the formation of a middle 
layer of solid 12a-ajnino-5p-cholane hydrochloride. The ethereal filtrate 
after removing tiie solvent gave cmde 12-oxo-5j3-cholane (ca 20 mg.) 
m.p. 116-1199]. The crystalline hydrochloride was combined with the 
residue obtained on distilling the aqueous layer iji vacuo (80 mg.) and 
recrystallised from methanol giving 12o-ajnino-5p-cholane hydrochloride, 
needles, double m.p. 160: 205-2079]. Treatment of this hydrochloride
with 2N sodium hydroxide followed by extraction with ether yielded the 
free base m.p. 100-1049].
Reduction of 12-Oximino-56-Cholane with Lithium Aluminium Hydride :
12-Oximino-5p-cholane (500 mg.), dissolved in ether (25 ml.) was treated 
with a slurry of lithium aluminium hydride (500 i%.) in ether (25 ml.) 
and the reaction mixture was re fluxed for 16 hr. The excess of hydride 
was decon^osed with moist ether and the ethereeJ. filtrate therefrom, 
after removal of the solvent, gave white needles (461 mg.) (the infrared 
spectrum showed complete conversion of the oximino-group into the amino 
group, and the spectrum was identical with that of 12a-amino-5p-cholane 
obtained by the reduction with sodium and ethanol).
The crude base (350 n%.) on chromatography over alumina (grade III 
20 g.) using ether as eluant gave pure 12a-amino-5|3-cholane (340 mg.)
-95-
m.p. 105-1079]. Repeated attempts to fractionate the base into the 
possible epiraeric products failed. The free base and its hydrochloride 
had physical constants (m.p. [ aJ -q , and infrared spectra) identical with 
the 12a-amino-5(3-cholane obtained on reduction of 12-oximino-5p-cholane 
with sodium and ethanol.
Catalytic Hydrogenation of 12-0ximino-53-Cholane:
(a) 12-0ximino-5p-Cholane (200 mg.) was added to a pre-reduced suspension 
of platinum oxide (40 mg.) in acetic acid (10 ml.) containing a drop 
of perchloric acid, and the mixture was allowed to shake under hydrogen 
at room temperature and atmospheric pressure. The uptake of the cal­
culated amount (2 moles) of hydrogen was complete within one hour but 
the shaking was continued for two hours more. The catalyst was removed 
by filtration and the filtrate was distilled vacuo to yield a colourless 
solid. The infrared spectrum showed traces of oximino-compound to be 
present. Purification of the amino-compound was achieved by means of 
chromatography over alumina (grade I 20 g.) in the usual manner.
Elution with ether/light petroleum (l:19) yielded 12a-araino-5p-cholane 
(160 mg.) m.p. and mixed m.p. 103-10695 (correct infrared spectrum)
[a] ^9 ^ 43^(c = 1.9). Hydrochloride, needles from methanol, double
m.p. and mixed m.p. 158-160°: 204-20795. Elution with ether/light
petroleum (2:3, 100 ml.) gave a noncrystalline gum (30 mg.) lih lc h  contained 
both the 12-oximino- 5(3-cholane and the 12o/-amino-5(3-cholane (infrared 
spectrum).
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Hydrolysis of this gum (30 mg.) in boiling ethanol (20 ml.) 
containing 6N sulphuric acid (5 ml.) for 16 hr. gave a solid consisting 
of a mixture of 12-oxo-5p-cholane and the sulphate of 12o-amino-5p-cholane 
(infrared spectrum). Treatment of this mixture with sodium hydroxide, 
followed by chromatography over alumina (grade I 5 g.) gave 12-oxo-5p- 
cholane (15 mg.) and 12o^amino-5p-cholane (lO mg.)
(b) Catalytic hydrogenation of 12-oximino-5p-cholane (l g. ) in acetic 
acid (40 ml.) containing platinum oxide (200 mg.) at 100-120 atmosphere 
at room tençerature for 72 hr. gave a noncrystalline solid #iich was 
chromatographed over alumina (grade I 30 g.). Ether/light petroleum 
(l;19) (500 ml.) eluted 12a-amino-5p-cholane (650 mg.) m.p. and mixed 
m.p. 102-107°C. Ether/light petroleum (2:3) (500 ml.) eluted a mixture 
of 12o-amino-5p-cholane and 12-oximino-5p-cholane (300 mg.) &s a gum 
(infrared spectrum). The 12a-amino-5p-cholane could be isolated from
this mixture after acid hydrolysis of the oxime into the ketone as described 
in (a).
(c) Catalytic hydrogenation of 12-oximino-5p-cholane with platinum oxide 
in acetic acid at atmospheric pressure without the presence of perchloric 
acid proceeded very poorly. After prolonged shaking (48 hr.) the product 
still contained 12-oximino-5p-cholane as the major component as demonstrated 
by acid hydrolysis of the mixture. The amine could not be obtained in 
more than l^o yield.
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Reduction of 12-Oximino-5(3-0holane with Lithium in Liquid Ammonia;
A suspension of 12-oximino-5p-cholane (lOO mg.) in liquid ammonia (ca 15 ml.) 
was treated with thin slices of lithium metal (ca 500 mg.) during a period 
of one hr. Wiile the reaction mixture was efficiently stirred. The 
ammonia was allowed to distil at room ten^erature overnight and the 
residue was extracted with light petroleum to yield a gum (96 mg.). 
Chromatography over alumina (grade III 30 g.) using light petroleum 
as eluant gave 5p-cholane (**0 mg.), reciystallisation from methanol 
afforded needles (30 i%.) m.p. and mixed m.p. 88-9195. (infrared spectrum 
identical with that of the 5p-cholane). Ethanol eluted unchanged 
12-cximino-5p-cholane (46 mg.) m.p. and mixed m.p. 139-141°C (infrared 
spectrum identical with that of the authentic specimen).
12-Nitrimino-53-Cholane; A solution of 12-oximino-5p-cholane (lOO mg.) 
in acetic acid (25 ml.) containing crystalline sodium acetate (50 mg.) 
was treated dropwise with a solution of sodium nitrite (75 mg.) in water 
(0.5 ml.) in the cold. The turbid mixture was made homogeneous by the 
addition of more acetic acid (8 ml.) but soon a v^ite crystalline material 
was thrown out of solution. After allowing the reaction mixture to stand 
at room temperature for 3 hr. the 12-nitrimino-53-cholane was removed 
by filtration, washed with dilute acetic acid and dried (80 i%. ) m.p. 
120-12295. Reciystallisation from methanol gave needles, m.p. 122-12395,
19 D
^24^40^2 ^2 quires C, 74.22; H, 10.31; N, 7.22gb) .
[a]^9 ^ 143.3° (c = 2.0). (Found; C, 74.01; H, 10.23; N, 6.36.
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A solution of 12-nitrimino-5p-cholane (25 mg.) in ether (5 ml.) 
was stirred with 880 ammonia (ca 2 ml.) for 4 hr. On removing the 
solvent after washing (water), the gum was recrystallised from methanol 
to yield needles of 12-oxo-5p-cholane (20 mg.) m.p. and mixed m.p. 
112-1189]. The ketone was further characterised by infrared analysis.
A solution of 12-nitrimino-5p-cholane (100 mg.) in ether (20 ml.) 
was treated with an excess of liquid ammonia for 12 hr. The residue 
was digested with light petroleum to yield a crystalline material (90 mg.) 
showing a carbonyl absorption (1700 cm*"^ ) and a bajid at 1630 cm"^. 
Chromatographic fractionation of this product over alumina (grade I 10 g.) 
using light petroleum as eluant gave a hydrocarbon (infrared spectrum)
(ll mg.) : reciystallised from methanol, plates m.p. 90-91%. Elution
with ether/light petroleum (1:9) gave 12-oxo-5p-cholane (75 mg.), 
recrystallised from methanol, needles, m.p. and mixed m.p. 120-1219] 
(infrared spectrum identical with that of an authentic specimen).
Diazotisation of 12a-Amino-53-Gholane: A solution of 12o-amino-5p-cholane
(900 mg.) in 9Q^ g aqueous acetic acid (70 ml.) was treated with a solution 
of sodium nitrite (900 mg.) in 80^ o aqueous acetic acid (20 ml.) at 0°C.
The mixture, #iich threw down a semicrystalline precipitate, was kept 
at 0%  with frequent stirring for 2 hr. After storing at 0°C for 24 hr. 
the temperature of the reaction mixture was raised slowly to 229] Wien 
brown fumes were evolved. Dilution of the mixture with water yielded 
further solid material, Wiich was extracted with light petroleum, washed
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(water), and dried (anhydrous sodium sulphate)• The solvent was removed 
in vacuo to yield a gum (860 mg.). The infrared spectrum of this gum 
showed absorption characteristic of the 12o-hydroxyl group (3570 cm“^), 
a carbonyl group (1700 cm"^) and double bonds (902, 1600 and 1630 cm"^).
The gum (800 mg.) was subjected to chromatography over alumina (grade I 
Woelm, neutral 45 g.). Light petroleum (20 ml.) eluted an unsaturated 
crystalline hydrocarbon fraction (158 mg.) (infrared spectrum and 
tetranitromethane test). Elution with ether/light petroleum (1:19,
80 ml.) gave 12-oxo-5p-cholane (225 mg.) m.p. and mixed m.p. 118-120°C 
(infrared spectrum correct). Progressively increasing concentrations 
of ether in light petroleum (300 ml.) slowly eluted 12a-hydroxy-5p-cholane 
(l81 mg.) and ethanol/ether (l:49, 50 ml.) eluted the residual 12o-hydroxy- 
5p-cholane (180 mg.). Elution with higher concentrations of ethanol 
in ether yielded a very small quantity of gummy material.
Gas liquid chromatography of the unsaturated hydrocarbon fraction 
indicated the presence of four conponents, divisible into two pairs on 
the basis of their retention times. The pair having the lower retention 
times, and which were calculated to be ca 7Q^ of the total material, had 
retention times very close to that of 5a and 5(3 cholanes. A specimen 
mixed with authentic A^^-5p-cholene, showed a sharp increase in the 
height of the first component belonging to the pair with lower retention 
times. The pair with the higher retention times were concluded to be 
jervicholenes. The infrared spectrum of the mixture of hydrocarbons 
showed absorption of moderate intensity at 902 cm”^ Wiich is characteristic
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of a vinylic methylene group. As no such function is possible in the 
unrearranged steroid nucleus but is present in one of the jervi 
hydrocarbons resulting from the jervi rearrangement, this absorption 
in the infrared gives good support for the conclusion that the two 
hydrocarbons with the high retention times are indeed jervicholenes.
The unsaturated hydrocarbon fractions, after complete (negative 
tetranitromethane test and infrared spectrum) hydrogenation in acetic 
acid with platinum oxide as catalyst (24 hr.) showed only two components 
on gas liquid chromatography, each component corresponding approximately, 
in retention time, to one pair of the unsaturated hydrocarbons. The 
component of lower retention time gave a significant increase in peak 
height on admixture with authentic 5p-cholane and showed a split peak 
on admixture with A^^-5p-cholene.
Action of Nitrous Acid on 12a-Hydroxy-53-Cholane : A solution of 120-
hydroxy- 53-cholane (200 mg.) in 8(y/o aqueous acetic acid (25 ml.) was 
treated with a solution of sodium nitrite (200 mg.) in 80j^o aqueous acetic 
acid (8 ml.) at 0 %  and the mixture was allowed to stand at 0°C for 24hrs, 
Dilution of the reaction mixture with water yielded a light petroleum 
soluble gum which showed the presence of both a carbonyl group and the 
12a-hydroxyl group in the infrared. Chromatographic separation over 
alumina (grade I, 25 g.) using light petroleum (300 ml.) as eluant gave 
12-0X0-53-cholajîe (56 Tag.), Ether/light petroleum (l;l, 100 ml.), 
ether (lOO ml.), and ethanol/ether (1:40, 50 ml.) eluted 12o^hydroxy-5p- 
cholane (135 mg.).
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Action of Nitrous Acid on 123-Hydroxy-53-Cholane : 12p-Hydi'oxy-5p-cholane
(lOO mg.) was treated v/ith sodium nitrite (lOO mg.) exactly as described 
for 12a-hydroxy-5p-cholane. The product (108 iqg.) readily crystallised 
on standing, m.p. 52-53°C. The infrared spectrum showed the absence 
of 123-hydroxyl absorption but an absorption at 1630 cm"^ (nitrite ester). 
The product also gave a positive test for nitrogen on sodium fusion. 
Recrystallisation from hot ethanol quantitatively regenerated 12p-hydroxy- 
53-cholane.
12cL-Dimethylamino-53-Cholane : ; A solution of 12o-amino-5p-cholane (200 mg. ) 
dissolved in formic acid (4 ml.) was treated with a aqueous solution 
of formaldehyde (4 ml.). The turbid mixture, which became homogeneous 
on warming, was re fluxed for 15 hr. Removing the solvent vacuo gave 
a solid, Yhich turned oily on treatment with ammonia. Extraction with 
ether afforded the gumny 12g-dimethyleimino-53-cholane (no N-H absorption 
in the infrared spectrum). The tertiary base, vhich resisted crystallisa­
tion on repeated chromatography over alumina, gave a crystalline hydro- 
bromide on treatment with 4.8^0 hydrobromic acid in ether/ethanol (3:7): 
recrystallised from ethanol, needles, m.p. 280-300°C (decomp.). (Pound:
C, 68,79; H, 10.58; N, 3.07. C26H47N HBr requires C, 68.72; H, 10.35;
K, 3.0^ 0) [ a ] of the free base 4^ 70.4° (c = 2.4).
12q-Dimethylamino-53-Cholane Methiodide : (a) 12a-Dimethylamino-5p-cholane
(300 mg.) dissolved in methyl iodide was sealed in a Carius tube and heated 
at 100°C for 6 hr. After cooling, the tube was broken and the methyl
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iodide removed by evacuation of the amber coloured solution. Extraction 
of the residue with light petroleum removed unquatemised material (25 mg.). 
The light petroleum insoluble residue (296 mg.) was taken up in hot 
methanol (ca 20 ml.) and the solution was decolourised with activated 
charcoal. The methanolic filtrate was taken to dryness vacuo. 
Recrystallisation from ethyl acetate gave colourless rods of 12gr-dimethyl- 
amino-53-cholane methiodide (combined crops 260 i%.) m.p. 290-300% decomp. 
(Found; G, 62.97; H, 9.39; N, 2.88, C27H5QI N requires G, 63.03;
H, 9.70; N, 2.7l/).
(b) A solution of 12a-amino-5p-cholane (500 mg.) in anhydrous ethanol 
(25 ml.) was refluxed with methyl iodide (3 ml.) in the presence of 
anhydrous potassium carbonate (2 g.) for 48 hr. Fresh small quantities 
of methyl iodide (total 2 ml.) and anhydrous potassium carbonate (total 2 g.) 
were added during the period of reflux. The ethanolic filtrate from 
the reaction mixture was taken to dryness ^  vacuo and the residue was 
taken up in chloroform, the inorganic material was removed by filtration, 
and the chloroform was distilled vacuo to yield a semi-solid material 
(640 mg.). Extraction of the semi-solid material with light petroleum 
yielded a white residue of 12a-dimethylamino-5p-cholane methiodide (270 mg») i  
recry^stallisation from ethyl acetate m.p. and mixed m.p. 290-300°G (decomp.). 
The light petroleum extract after removal of the solvent vacuo gave 
unquaternised 12a-dimethylamino-5p-cholane (361 mg.) (infrared spectrum 
and [a]x)). Further 12o-dime thy lamino-5p-cholane methiodide was obtained 
on recycling the tertiary base through the quaternisation procedure.
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Hofmann Degradation of 12a-Dimethylamino-53-Gîholane Methiodide; 
12a-Dimethylamino-5p-cholane methiodide (200 mg.) was thoroughly mixed 
with a paste of sodium hydroxide (l g.) in water (1 ml.) in a pyrex 
tube,which was inserted into a metal bath at 90%. The temperature 
was allowed to rise to 160% over a period of 30 min. and maintained 
there for 30 rain, when a strong smell of t rime thy lamine was detected.
After allowing, the reaction mixture to cool slowly, it was diluted with
•wKu’Vvwater and the oil^separated was taken into light petroleum. Washing 
the ethereal layer with 2N HCl gave the white crystalline 12o-dimethyl- 
amino-5p-cholane hydrochloride (20 mg.) (m.p. and mixed m.p. with authentic 
12a-dimethylamino-5p-cholane hydrochloride, 217-220%). The ethereal 
layer after removal of the solvent vacuo gave an unsaturated hydro­
carbon (tetranitromethane test and. infrared spectrum) . Recrystallisation 
of the hydrocarbon from ethanol yielded A^^-Sp-cholene, rods m.p. 77-79%.
Catalytic hydrogenation of the A^^-5p-cholene (40 n^ g.) in acetic 
acid ( 8 ml.) with platinum oxide (15 ing.) at roan temperature and 
atmospheric pressure for 20 hr. gave a saturated product (negative tetra- 
nitromethane test). Recrystallisation from ethanol afforded 5p-choleme, 
needles, m.p. 87-89% (reported^99 gg^gQO).
Gas liquid chromatography of the A^^-5p-cholene showed one single 
component, while the 5p-cholane obtained on catalytic hydrogenation of 
the A  5p-cholene on admixture with authentic 5p-cholane also showed 
one component to be present.
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12.6-Azido-53-Cholane: Finely powdered sodium azide (220 mg*) was added
to a hot solution of 12a-methanesulphonyloxy-5p-cholane (220 mg*)
(p. 66 ) in ethanol (20 nil.) containing water (4 ml.),and the mixture 
was refluxed for 8 hr. The solvent was removed from the reaction 
mixture ^  vacuo and the residue was extracted with ether. The ethereal 
layer on removal of the solvent gave the gumny 123-axido-53-cholane 
(the infrared spectrum showed a strong absorption at 2075 cm“^ and no 
absorption for a methanesulphonyloxy group or a free hydroxyl group).
Attempted Formation of 123-Amino-53-Cholane by Reduction of 123-Azido- 
53-Cholane;
(a) 12p-Azido-5p-cholane (50 mg.) was refluxed with lithium aluminium 
hydride (ca 100 mg.) in ether (20 ml.) for 10 hr. Working up of the 
reaction mixture in the usual manner afforded a noncrystalline unsaturated 
hydrocarbon fraction (40 mg.) (tetranitromethane test and infrared spectrum). 
Chromatographic purification over alumina (grade l) gave a gum (35 mg.)
(b) A solution of 12p-azido-5p-cholane (200 mg.) in ethanol (lO ml.) 
was re fluxed with a solution of sodium hydrosulphite (40 mg.) in 4N 
sodium hydroxide (4 ml.) for 2 hr. Dilution of the reaction mixtui-e 
with water gave a gumny precipitate, which was extracted with ether, 
washed (water), and dried (anhydrous sodium sulphate). On removing the 
solvent ^  vacuo a gummy unsaturated hydrocarbon fraction was obtained 
(l60 mg.) vdiich resisted crystallisation. It gave a positive tetra- 
nitromethane test.
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(c) 123-Azido-5p-cholane (lOO mg.) was hydrogenated at room 
tenperature and atmospheric pressure in acetic acid (lO ml.) with platinum 
oxide (20 mg.) for 16 hr. The resultant hydrogenation product (80 mg.)
W8LS obtained as a gum showing no azide absorption in the infrared and 
a broad low absorption in the carbonyl region (1700 cm”^). The material 
showed no basic properties and on chromatography over alumina (grade III,
10 g.) using ether as eluant gave a saturated hydrocarbon (46 mg.)
(negative tetranitromethane test and infrared spectrum). No other fraction 
could be eluted with ether or ethanol/ether (l:4).
Separate gas liquid chromatography of the unsaturated hydrocarbons 
from procedures (a) and (b) showed in each case the presence of several 
components with two components accounting for o& 75^ o of the total.
These major components had very close retention times and the component 
with the higher retention time showed a sharp increase in intensity on 
admixture with A^^-5p-cholene. Gas liquid chromatography of the 
saturated hydrocarbon obtained from procedure (c) showed five components, 
with one component predominant {bO/o of the total). This conpound showed 
a sharp increase in intensity on admixture with 5p-cholajie.
12g-Azido-53-Gholane: Treatment of 12p-methanesulphonyloxy-5p-cholane
(p. 68) with sodium azide in the same manner as described for the 
preparation of the 12p-azido-53-cholane yielded 12a-azido-53-cholane 
in comparable yield. This azido compound was also obtained as a gum 
and showed characteristic azide absorption at 2075 cm~^ in the infrared
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spectrum.
Lithium aluminium hydride reduction of the 12a-azido-5p-cholane 
employing the usual procedure gave a neutral gum #iich gave a positive 
test for unsaturation with te tranitrome thane. Gas liquid chromatography 
of this product showed six components to be present, with two representing 
ca 80/ of the total material, having retention times similar to those 
of A^^-53-cholene and the jervi hydrocarbons obtained "by diazotisation 
of 12a-amino-53-cholane (p. 98). The component with the lower retention 
time showed an increase in peak-height on admixture with A^^-53-cholene.
Action of Sodamide on 12a-Methanesulphonyloxy-53-Cholane : A solution of
12o-methanesulphonyloxy-53-cholane (100 rag.) in toluene (lO ml.) was 
re fluxed with sodamide (75 mg.) for 4.5 hr. The excess of sodamide was 
decomposed with water, and the ethereal layer separated, washed (water) 
and dried (anhydrous sodium sulphate). The residue obtained after 
removing the solvent in vacuo (80 mg.) was chromatographed over alumina 
(grade III, 10 g.). Ether/li^t petroleum (l:9) eluted 12-0x0-53-cholane 
(30 mg.) (mixed m.p. and infrared spectrum). Etlier/light petroleum(l:l) 
eluted 12a-hydroxy-53“Cholane (45 mg.) (m.p. and mixed m.p. and infrared 
spe ctrum).
123 -1 odo- 53 -Gholane : A solution of 12o-me thane s ulphonyloxy- 53 - ch olane
(20c mg.) in acetone (5 ml.) was heated with sodium iodide (200 mg.) 
in a sealed Carius tube at 100% for 4 hr. After cooling, the tube 
was broken and the vdiite crystalline material was removed by filtration.
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The acetone filtrate was decolourised with charcoal and on removing 
the solvent ^  vacuo gave 123-iodo-53-cholane as a colourless gum.
A solvent free specimen on keeping at room temperature, slowly 
liberated iodine. Extraction of the dark coloured material with 
light petroleum and removal of the solvent yielded an unsaturated 
hydrocarbon mixture (tetranitromethane test, bromine decolourisation 
test, potassium permanganate test and infrared spectrum). Gas liquid 
chromatography indicated that this gum was a mixture of several components.
A freshly prepared specimen of 12p-iodo-53-cholane #ien treated 
with sodamide in toluene under reflux for 6 hr., gave a saturated
ondnoncrystalline hydrocarbon (infrared spectrum^a negative tetranitro­
me thane test).
A solution of 123-iodo-53-cholane in ether, on standing at room 
temperature for several days, did not show any signs of decomposition.
Leuckart Reaction on 12-0xo-53-Cholane; A solution of 12-oxo-53-cholane 
(250 mg.) in formamide (lO ml.) containing formic acid (0.25 ml.) was 
refluxed at 200% for 5 hr. The dark reaction mixture on dilution 
with methanol gave a dark tarry precipitate, which was removed by 
filtration. The combined methanolic filtrates, after removal of the 
solvent ^  vacuo yielded a brown solid, which was repeatedly washed 
with water and dried (200 mg.). Crystallisation from methanol gave 
colourless rods of a formyl derivative of an amine, m.p. 210-220%
(infrared spectrum). This formyl derivative was not characterised
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further and was directly hydrolysed to the free primary amine as described 
below.
The formyl derivative (lOO mg.) dissolved in methanol (l8 ml.) 
containing 3^6 aqueous hydrochloric acid (2 ml.) was re fluxed for 2 hr.
8ind then allowed to cool overnight. The deposited white needles were 
removed by filtration, washed (methanol) and dried, m.p. 76-82%. This 
material gave a positive test with the te trauiitr ome thane. Gas liquid 
chromatography showed the presence of two components in equal amounts 
and having very close retention times. The methanolic filtrate, on 
removing the solvent yielded crystalline 12o-amino-53-cholane hydrochloride 
(61 mg.). l^ecrystallisation from methanol gave needles. The hydro­
chloride was treated with aqueous ammonia in the presence of ether and 
the ethereal layer containing the free base was washed (water) and dried 
(anhydrous sodium sulphate). On removal of the solvent, 12a^ £unino- 
53-cholane was obtained, and recrystallised from methanol, m.p. and 
mixed m.p. 102-106% (the infrared spectrum was identical with that of 
an authentic specimen).
Reduction of 12-0xo-53-Cholane with Lithium Aluminium Tri-tertiary- 
butoxy-hydride: A solution of 12-oxo-53-cholane (lOO mg.) in ether (lO ml.)
was refluxed with a suspension of lithium aluminium tri-tertiarybutoxy- 
hydride in ether for 16 hr (the tri-tertiarybutoxyhydride was prepared 
by treating a suspension of lithium aluminium hydride in ether wdth 
three moles of tertiary butanol, the suspension being used directly for
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the reduction). On working up the reduction mixture in the normal 
manner a crystalline solid (95 mg.) resulted. Chromatography over 
alumina (grade I, Woelm, neutral, 10 g.) with ether/light petroleum 
(l;4) as eluant gave 12o-hydroxy-53-cholane (80 mg.) (identified by 
comparison with an authentic specimen). Ether eluted 123-hydroxy-53- 
cholane (15 mg.).
Catalytic Hydrogenation of 12-0xo-53-Cholane; A solution of 12-oxo- 
53-cholane (300 mg.) in acetic acid (13 ml.) containing perchloric acid 
(0.1 ml.) was added to a suspension of prereduced platinum catalyst (50 mg.) 
in acetic acid. The mixture was allowed to shake under hydrogen at 
room temperature and atmospheric pressure. The calculated volume of 
hydrogen was taken up within 30 min. After 1 hr. the catalyst was 
removed by filtration. The filtrate was distilled to yield a gum (283 mg.) 
(the infrared spectrum was identical with that of 12o-hydroxy-53-cholane). 
Chromatography of this product over alumina (grade V, 20 g.) using light 
petroleum as eluant (20 ml.) gave a noncrystalline^hydrocarbon (40 mg.) 
(infrared spectrum and negative tetranitromethane test). Ether/light
petroleum (l;9) eluted 12o-hydroxy-53-cholane (203 iqg.). îiirther elution
with ethyl acetate/ether (1:5) and ethyl acetate gave only trace amounts 
of noncrystalline material.
(b) In another experiment, employing the same conditions as above 
but without the presence of perchloric acid, the rate of hydrogenation 
was extremely slow. The reduction product isolated after 24 hr. shaking
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under hydrogen still contained unreduced ketone (infrared spectrum). 
Chromatographic separation over alumina in the usual manner gave 12-oxo- 
53-cholane and 12or'hydroxy-53-cholane in the ratio of 5:4.
Reduction of 7-oxo-53-Cholane with Lithium Aluminium Hydride ; A solution 
of 7-0X0-53-cholane (200 mg.) in ether (20 ml.) was refluxed with a slurry 
of lithium aluminium hydride (300 mg.) in ether (30 ml.) for 16 hr.
Working up of the reaction mixture in the usual manner gave a gum (200 mg.) 
which was chromatographed over alumina (grade V, 20 g.). Ether/light 
petroleum (1:1, 100 ml.) eluted 7a-hydroxy-53-cholane (165 mg.) m.p. and 
mixed m.p. 83-87°G. (The infrared spectrum was identical with that of 
an authentic specimen). Elution wdth e thylace t at e/e the r (1:1, 50 ml.) 
gave 7-3-hydroxy-53-cholane (7 mg.) (identified by its infrared spectrum).
Catalytic Hydrogenation of 7-0x0-53-Cholane : A solution of 7-0x0-53-
cholane (200 mg.) in acetic acid (5 ml.) was added to a prereduced suspension 
of platinum catalyst (40 mg.) in acetic acid (5 ml.) containing perchloric 
acid (0.1 ml.) and the mixture wras allowed to shake under hydrogen at 
room temperature and atmospheric pressure. The uptake of hydrogen wras 
extremely slow and the shaking was continued for 16 hr. During this 
time a crystalline material appeared in the reduction mixture, which 
was removed by filtration along with the catalyst. Extraction of the 
crystalline material from the catalyst wdth ether and subsequent removal 
of the solvent gave 53-cholane (60 mg.) m.p. and mixed m.p. 86-88%  (the 
infrared spectrum was identical with that of authentic 53-cholane).
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Removal of the solvent vacuo from the filtrate of the hydrogenation 
mixture gave a gum (150 mg.). Chromatographic separation of this gum 
over alumina (grade V, 20 g.) using light petroleum as eluant gave 
7-0X0-53-cholane (71 mg.) whilst ether/light petroleum (1:9) gave 70- 
hydroxy- 53-cholane (68 mg.). Both these products were identified by 
comparison with authentic specimens.
12-Oximino-Sg^Cholane : 12o-Hydroxy-5a-cholane (p. 60 ) (l g.) on oxidation
with chromic oxide in acetic acid as described for the oxidation of 
12o-hydroxy-53-cholane (p.67 ) gave 12-oxo-5g-choIane (920 mg.) m.p. 
164-1659],[ a] ^  4 95.0^  (c = 2.0). (The infrared spectrum showed
strong absorption for the carbonyl group (1700 cm"’^) and total absence 
of hydroxyl absorption).
Treatment of a solution of 12-oxo-5o-cholane (900 mg.) in ethanol 
(I6O ml.) with hydroxylamine hydrochloride (350 mg.) and sodium acetate 
(700 mg.) in water (3 ml.) in the same way as described for 12-oximino- 
53-cholane yielded 12-oximino-5a-cholane (810 mg.) recrystallised from 
ethanol, needles, m.p. 90-91%, [ a,] ^  + 151.0° (c = 2.0). (Found:
C, 80.32; H, 11.80; N, 4.06, Cg^^^^O N requires G, 80.22; H, 11.5Ç;
N, 3.90/).
12a-Amino-5g^holane: (a) A solution of 12-oximino-5a-cholane (500 mg.)
in ether (30 ml.) was re fluxed with a slurry of lithium aluminium hydride 
(ca 500 mg.) in ether (25 ml.) for 16 hr. After working up the reaction 
mixture in the usual manner the crude amine was obtained as a gum.
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This gum (showing couple te conversion of the oximino group into the 
amino group from its infrared spectrum) was chromatographed over alumina 
(grade I Woelm, neutral, 20 g.). Light petroleum (lOO ml.) eluted 
a neutral gum (32 mg.). Ether/light petroleum (300 ml.) eluted 
12g-amino-5a-cholane as a gum (590 mg.), [ a,] + 42° (c = 2.1).
Treatment of the nonciystalline base with methanolic hydrochloric acid 
(Sj£) gave needles of 12o-amino-5o^cholane hydrochloride, recrystallised 
from methanol, m.p. 140% (Pound: C, 75.04; H, 11.01, C24H43N HCl
requires C, 75.40; K, 11.51^ j). The hydrochloride was soluble in ether.
Elution of the alumina column with ether (200 ml.) gave a gum 
(90 mg.) Wiich contained further 12a^amino-5a-cholane, separable as 
the hydrochloride (24 mg.) after treatment of the crude gum with 
methanolic hydrochloric acid followed by extraction of the neutral 
conponent with light petroleum.
(b) A solution of 12-oximino-5o-cholane (500 mg.) in boiling 
ethanol (20 ml.) was treated with sliced sodium metal (3 g.) during a 
period of 1 hr. The resulting base was isolated as a gum (480 mg.). 
Chromatography over alumina (grade I Woelm, neutral 20 g.) using ether/ 
light petroleum (l:3, 250 ml.) gave 12a-amino-5a-cholane as a gum (300 mg.), 
[a] + 41.5°: hydrochloride, needles from methanol, m.p. and mixed
anm.p. 138-140% (the infrared spectra of both the base^its hydrochloride 
were identical with those of authentic specimens). Elution with ether 
(200 ml.) gave a gum (lOO mg.) "which showed the presence of the same
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amino-corapound in the infrared spectrum and vhich did not show any 
absorption from an oximino group.
(c) 12-Oximino-5o-cholane (200 mg.) dissolved in acetic acid
(lO ml.) was added to a prereduced suspension of platinum catalyst 
(50 mg.) in acetic acid (3 ml.) containing perchloric acid (O.l ml.).
The mixture was shaKen under hydrogen at room tenperature and atmospheric 
pressure for 24 hr. Working up of the reaction mixture gave a gum (200 mg.)
(the infrared spectrum of which showed absorption attributable to an 
oximino group and to an amino group). Chromatography over alumina 
(grade I Woelm, neutral, 15 g.) using ether/light petroleum (l;3, 150 ml.) 
eluted 12a-amino-5a-cholane (61 rug.) (identified as the free base and 
as the hydrochloride). Elution with ethanol/ether (l:9) gave unchanged 
12-oximino-5o-cholane (85 mg.). No evidence was obtained for the formation 
of 123-araino-5a-cholane.
Diazotisation of 12a-Amino-5g-Cholane : A solution of 12a-amino-5o-cholane
(lOO mg.) in acetic acid (8 ml.) was diluted with water (l ml.). This 
mixture was treated with a solution of sodium nitrite (lOO mg.) in 80^ o 
aqueous acetic acid (6 ml.) at 0%, ajid the mixture was allowed to stand 
at 0 %  for 20 hr. The temperature was then raised slowly to 22°C viien 
the reaction mixture was diluted with water. The "v^ ite precipitate was 
extracted with ether, and the ethereal extract washed with water and 
dried over anhydrous sodium sulphate. The gummy residue (80 mg.) obtained 
after removing the ether vacuo showed absorption characteristic of
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the 12o-hydroxyl group (3400 cm-l), a carbonyl group (1700 cm and 
a double bond (1660 cm”^). Chromatography over alumina (grade I, Woelm, 
neutral 30 g.) using light petroleum as eluant (250 ml.) gave an unsaturated 
hydrocarbon fraction (7 mg.). Ether/light petroleum (l:3, 100 ml.) 
yielded 12-oxo-5o^cholane (18 mg.) contaminated with some unsaturated 
compound (infrared spectrum). Ether (lOO ml.) gave pure 12-oxo-6o- 
cholane (27 mg.). Ethanol/ether (l;19, 50 ml.) eluted 12o/-hydroxy-5a- 
cholane (28 mg.) containing a trace of 12-oxo-5ofcholane. Both the
12-oxo-5a-cholane and the 12a-hydroxy-5o-cholane were characterised by 
means of mixed m.p. with authentic specimens and by the comparison of 
infrared spectra.
12a-Dimethylamino-5g-Cholane Methiodide and 12a-Dimethylamino-5g-Cholane ; 
12d-Amino-5o-cholane (ll7 mg.) was refluxed with methyl iodide(2.5 ml.) 
in anhydrous ethanol (15 ml.) containing anhydrous potassium carbonate 
(480 mg.) for 72 hr. Small quantities of methyl iodide (total 1.5 ml.) 
and potassium carbonate (total 200 iqg.) were added to the reaction 
mixture during the refluxing period. Potassium carbonate was removed 
from the reaction mixture by filtration and the filtrate was distilled 
in vacuo. The residue was digested with chloroform to remove any 
inorganic material. The chloroform soluble material, after removing 
the solvent, was extracted with light petroleum. The light petroleum 
insoluble residue was recrystallised from ethanol, to yield plates of 
12g-dimethylamino-5g-cholane-methiodide (lOl mg.) , m.p. 225-235% decomp.
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(Found: C, 65,74; H, 9.39; N, 2.50; N requires C, 63.03;
H, 9.70; K, 2.71/). The light petroleum soluble gum (30 mg.) on 
treatment with a solution of hydrobromic acid in methanol (4.5/) gave 
white needles of 12g-dimethylamino-5cu-cholane hydrobromide, recrystallised 
from methanol, needles, m.p. 190-205% decomp. (Found: C, 68.79;
H, 10.58; N, 3.07. HBr requires C, 68.72; H, 10.35; N, 3.0S^ o).
Hofmann Degradation of 12g-Dimethylamino-5q-Gholane Methiodide: 
12a-Dimethylamino-5a-cholane methiodide (15 mg.) was mixed with a paste 
of sodium hydroxide (400 mg.) in water (ca .5 ml.) in a pyrex tube,#iich 
was inserted in a metal bath at 90% and the tenperature raised to 160% 
during a period of 10 min. The mixture was heated at 160% for 30 min., 
during which time the mixture gave a strong smell of trimetirgrlamihe. .
After cooling, the reaction mixture was diluted with water and the 
precipitated material extracted with ether. The ethereal extract 
after washing with water, was extracted with 2N HCl. The acid extract 
on treatment with sodium hydroxide did not give any precipitate or 
turbidity. The ethereal layer on removing the solvent yielded a gunnmy 
hydrocarbon (7 mg.).
5q-Cholane: This compound was prepared by application of the Huang
150Minion procedure to 12-oxo-5o-cholane as described for the preparation 
of 53-cholane from 12-oxo-53-cholane (p. 65). 12-oxo-5a-cholane (lOO mg.) 
afforded ca 60 ng. of 5q-cholane, recrystallised from ethanol, m.p.
68-70% (the infrared spectrum showed absence of the carbonyl absorption).
SECTION 17
SINTEESKS OF STEROIDAL 
BISQUATERNART SALTS.
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In view of the considerations outlined on pp.16-2$
(Section l) attention was concentrated on securing the syntheses
of the three compounds $a,7oc-bis(dimethylamino)-5<x-cholestane
dimethiodide, $a,12a-bis(dimethylamino)-$P-cholane dimethiodide
and $a, 17a-b is (dimethylamino )-5o£-and.rostane dimethiodide. These
compounds which should have a favourable lipophilic-hydrophilic
balance (believed to be a primary factor in determining neuro-
200 .muscular blocking potency ) will be discussed In turn.
$g,7a-Bis(Dimethylamino)-5g-Cholestane Dimethiodide:
The attempted preparation of this compound appeared to be 
of some importance since models show the intergroup distance 
(as measured from the centres of the atoms concerned) between 
axial substituents on C-$ and C-7 in trans A/B steroids to be
oca.5.1A. whilst the effective radius of the trimethylammonium
ogroup is ca. $A. This would be expected to make $a,7a-bis
(dimethylamino)$a-cholestane dimethiodide subject to steric strain,
in addition to unfavourable charge repulsions, and so the very
possibility of the existence of the compound was questionable.
Difficulties in achieving complete quaternisation of non-
rigid compounds of the type -N-(CHg )^-X-(CHg)g-N- where n is less
2 01than 5 have been reported in the literature although trisammonium 
compounds of this type where n = 2 or $ have been prepared^
In such compounds both steric strain and charge repulsions can of 
course be relieved by rotation about carbon-carbon bonds. It is
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to be noted, however, that the low activity in polymethylene 
bisquatemary compounds ^N-(CBg where n = 2,5 or 4 has been
203ascribed to onium group interaction.
Attempted préparation of 5#f7#-3tamino-5#-cholestane by 
reduction of $,7-dioximino-5a-cholestane was limited to the 
catalytic hydrogenation procedure as sodium ethanol reduction would 
afford the 5P>7P-diajnino compound whilst lithium aluminium hydride 
reduction would be expected to give a complex mixture of four 
compounds due to the formation of epimeric amines at both C-5 and 
C—7 •
Catalytic hydrogenation using prereduced platinum oxide 
catalyst in acetic acid in the presence of perchloric acid failed 
to give complete reduction of 5>7-dioximino-5a-cholestane as 
evidenced by the appearance of oxime absorption at $200, 16$0 
and 950-960 c m . i n  the infrared spectrum of the crude product. 
Application of alumina chromatography using a variety of grades 
of alumina resulted in the loss of almost all of the material 
which could not be eluted from the column. Presumably this lost 
material was in fact the desired 5G,7a-diamino compound which was
204chelating on the alumina. Similar chelation was observed with 
2-endo-hydroxy-5-endo-aminobornane which could not be eluted from 
alumina columns.
N H
H
F’iq. 15
m
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All attempts to separate 5a,7a-diamino-5a-cbolestane from 
unreacted or partially reduced 3>7-cLioximino-5a-cholestane by 
means of bishydrochloride formation were unsuccessful*
It is to be noted that extreme difficulty was observed in 
the catalytic hydrogenation of 7-oximino-5P-cholane and in no case 
could any basic product be isolated. In this case, however, an 
amino group in the 7«-configuration would be expected to be greatly 
unfavoured sterically since the cis A/B ring junction introduces a 
non-bonded interaction between the l a  substituent and C-4 kFig.15) - 
an interaction which is absent in 5® steroids* In this connection,
205it is to be noted, however, that it has been claimed that 
)a-hydroxy-7-oxo-5P-cholanic acid yields solely the 7&-hydroxy 
compound on reduction with sodium in butanol or ethanol, or on 
reduction with sodium borohydride, whilst reduction with sodium 
and propanol gave the 7P-epimer*
These observations would seem erroneous in view of the 
results obtained in Section II of this thesis where it was shown 
that 7-oxo-5P-cholane on treatment with sodium and ethanol gave 
ca* 6^fo of the p-hydroxy compound whilst reduction with lithium 
aluminium hydride gave 90^ of the a-hydroxy compound*
An alternate route to $a,7G-bis(dimethylamino)-5a- 
cholestane dimethiodide was then investigated* Thus 3P,7P-dihydroxy- 
5a-cholestane, prepared by the lithium liquid ammonia reduction of
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7-oxo-cholesteryl acetate, was converted into the di-methane-
sulphonate ester and this latter compound was heated in a sealed
tube with dimethylamine to achieve S^2 displacement at both C-3
and C-7• Such nucleophilic displacements by dimethylamine with
inversion of configuration have previously been performed at C-5 
206in steroids. Heating )p,7P-dimethane8ulphonyloxy-5a-cholestane
with dimethylamine in a sealed tube at 100*C for 5 hours failed
to give nucleophilic displacement and unchanged starting material
was reclaimed in 75^ yield. However heating the dimethanesulphonate
2 06in ethanol-dimethylamine with added p-toluenesulphonic acid
in a sealed tube at 100*C for 20 hours afforded the bis-dimethyl-
amino compound in good yield as a gum. It is possible that the
reaction was not purely S^2 at C-7 giving a mixture of epimers at
this position, but the displacement at C-5 is known to proceed with 
211inversion. The gum showed no hydroxyl absorption between 5600- 
_i5100 cm. in the infrared and no absorption due to residual 
methanesulphonyloxy groups but gave prominent peaks at 2825 and 
278O cm."^ (N-CH5 groups). It was insoluble in water but soluble 
in dilute hydrochloric acid.
Without further characterisation the gum was heated in a 
sealed tube with excess of methyl iodide at 100*0 for .5; hours.
The reaction mixture became very dark and the brown product 
obtained was divisible into a non-bitter water insoluble fraction 
and a smaller bitter water-soluble fraction which showed hydroxyl
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absorption and evidence of double bond absorption in the infrared.
It was therefore concluded, in view of the ease of 
formation of 5G,12a-bis(dimethylamino)-5P-cholane dimethiodide 
on quaternisation of the corresponding diamine under the same 
conditions, that steric strain was indeed too great at an interonium
odistance of 5*lA.or less to permit the existence of rigid 
bisquaternary salts and that all compounds listed on page 21 of
osection I which would have interonium distance of 5.IA. or less 
would be incapable of preparation.
3a»12a-Bis(Dimethylamino)-5P-Cholane Dimethiodidei
Preparation of this compound was attempted from 5,12- 
dioximino-5P-cholane through reduction to the 5a*12a-diamino 
compound by lithium aluminium hydride. This reagent is known 
to give solely the 5ot-amine from the 5-oxime in steroids possessing
207a cis A/B ring fusion and it was also established (section III 
of this thesis) to give solely the 12a-amine from the 12-oxime in 
the cholane series.
The 5G;12a-diamino-5P-cholane resulting from the reduction 
could not be eluted from an alumina column on attempted chromato­
graphic purification, and was directly subjected to vigorous 
quaternisation conditions, without intermediate conversion into the 
bis-dimethylamino compound, giving the water-soluble bitter-tasting 
bisquaternary compound in high yield.
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5g,17g-Bis(Dimethylamino)-5g-Androstane Dimethiodide.
The attempted preparation of this compound appeared to
he oi some theoretical importance in view of the current trend
towards a more rational basis for the design of new biologically
active compounds. Application of the receptor theory of drug
action and the theory of metabolite displacement has, to a
certain degree, eliminated some of the purely empirical approach
to the synthesis of new drugs capable of exerting specifically
desired effects, and indeed application of the second theory
208has given rise to what has been termed *the revolution in 
pharmacology*. Moreover an inspired application of the receptor 
theory of drug action has recently led to the synthesis of a new
209class of anabolic steroids. It was assumed that the receptors 
concerned with the androgenic and anabolic properties of the 
natural male hormones differ somewhat in their nature and accordingly 
attention was concentrated on securing an alteration of the inter­
group distance between the substituents at C-5 and C-17 with an 
accompanying change in the nucleophilicity of the C-5 substituent. 
These considerations led logically to the preparation of pyrazolo 
and isoxazolo steroids which showed a very high anabolic to
209 *210androgenic ratio.
Since the completely rigid t»xLferin I with its fixed
o 62 *64interonium distance of 9.7 A. is a powerful neuromuscular
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blocking agent as are other non-rigid bisquaternary compounds
whose interonium distance is also believed to lie in this 
60*61 *62 *63region, it was of considerable interest that the
rigid 5a,17a-bis(dimethylamino)-5a-androstane dimethiodide with an
*interonium distance of 9«5A. he made available for pharmacological 
study.
The known steroids possessing nitrogen functions in the
2113 and 17 positions viz. 17^ -diamino-5a-androstane, 3§>17P-
212 2 11 diaminoandrost-4-ene and 17^ -bis(dimethylamino)-androstane
can safely be concluded to have the amino functions of unassigned
stereochemistry in the p configuration as these amino groups resulted
from reduction of the corresponding oximes under equilibrating
conditions.
In order to obtain the 3 and 17 nitrogen functions in the 
oc configuration, therefore, it was necessary to convert 3P,17P- 
dihydroxy-5a-androstane (prepared by the reduction of 3*17-dioio-5@- 
androstane with sodium in ethanol) into the dimethanesulphonate ester, 
upon which the requisite nucleophilic displacements could be 
performed. Application of the normal procedure for preparation of 
methane-sulphonates (methanesulphonyl chloride in pyridine at 0*C 
for 16 hours) failed to give complete estérification as shown by 
the presence of hydroxyl stretching in the infrared spectrum of the 
product. However treatment of the diol with excess of methane- 
sulphonyl chloride in pyridine at room temperature for 12 hours gave
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a satisfactory yield of the disulphonate ester as shown hy the
complete lack of OH absorption in the infrared spectrum of the
crystalline product.
Nucleophilic displacement of the methanesulphonyloxy group
2 06 >211in the 3P-position was not expected to involve any complications
213but in view of the known difficulties involved in effecting such 
reactions in the neopentyl type system at C-17, it was concluded 
that vigorous conditions would be needed in order to secure intro­
duction of the 17a-dimethylamino group. Indeed heating the di­
methanesulphonate of 3P,17P-dihydroxy-5a-androstane in ethanol/ 
dimethy lamine in the presence of ja-toluenesulphonic acid, in a 
sealed tube at 100*0 for 20 hours failed to effect displacement of 
both methanesulphonyloxy groups as evidenced by the infrared spectrum
of the product (insoluble in aqueous hydrochloric acid) which showed
C-H _iboth N-CH^^stretching at 2750 cm.” and sulphonate ester absorption
at 960, 1170 and I24O cm.”
214Application of the recently introduced method for 
effecting nucleophilic displacements of 17P substituents through 
the use of N-methylpyrrolidone/tert.-butyl alcohol (19:l) was 
therefore investigated. Heating 3P,17P-dimethanesulphonyloxy-5a- 
androstane with dimetbylamine in N-methylpyrrolidone/tert.-butyl 
alcohol in a sealed tube for 60 hours at 100*C however still gave 
replacement of only one methanesulphonyloxy group (concluded to be
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at the ^-position), a final attempt using added sodium acetate 
to promote a *pull* mechanism was made. This also failed to 
effect the required displacement of both methanesulphonyloxy 
groups to afford the desired bis-dimethylamino compound. Infrared 
analysis and direct comparison of the product with the compound 
obtained in the previous experiment showed the formation of the 
same mono-dimethylamino derivative.
EXPERIMEUTAL
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3P,7P"DihydrQxy-5g-*cholestanei A solution of 7-keto-cholesteryl 
acetate (l.O g.) in a mixture of ether, dioxane and ethanol 
(30 ml. 30 ml. and 20 ml.) was placed in a round bottom flask 
fitted with an efficient stirrer and containing liquid ammonia 
(ca. 50 ml»). Sliced lithium metal (ca.3g») was added to this 
mixture during a period of 2.5 hr. with constant stirring. The 
ammonia was allowed to distil at room temperature overnight. The 
residual material was taken up in dilute hydrochloric acid and the 
ethereal layer was repeatedly washed with water and dried. On 
removing the solvent ^  vacuo, the ethereal layer yielded crude 
3P,7P-dihydroxy-5oc-cholestane (0.8 g. ), m.p. 145-155** A solution 
of this material in ethyl acetate, on filtration through a column 
of alumina (grade III, 20 g.) gave pure diol (O.67 g.), m.p. 
160-166*C (reported  ^ 166*C). (the infrared spectrum showed
complete reduction of the carbonyl functions of the starting 
material).
3,7-Dioxo-5a-cholestane: 3P>7P-Dihydroxy-5of-cholestane (200 mg.) 
dissolved in acetic acid (5 ml.) was treated with a solution of 
chromic oxide (125 mg. ) in S&fo aqueous acetic acid (3 ml.) and 
allowed to stand at room temperature for 16 hr. Dilution with 
water gave a white precipitate (180 mg.). Recrystallisation from
methanol gave plates (I40 mg.) of dioxo-cholestane, m.p. 188-190*0
/ 216  ,(reported 190*).
126
3.7-Dioximino-5g-cholestane; 3,7-Bioxo-5®-cholestane (l40 mg.) 
was refluxed with hydroxylamine hydrochloride (105 mg*) and 
sodium acetate (210 mg.) in ethanol (22ml.) containing water
(0.5 ml.) for 6 hr. The reaction mixture was then concentrated by 
distillation invacuo to ca. 4 ml. and the crystalline material was 
collected by filtration (145 mg.) m.p. 255-265*0 (decomp.). 
Recrystallisation from methanol gave pure 3,7-&ioximino-5a- 
cholestane (I30 mg.), m.p. 260-265*0 (decomp.). (Found: 0,75*06; 
H,10.57» N.6.70. Cg^H^gOgNg requires 0,75.35» H,10.69l N,6.51^). 
Attempted Oatalytic Hydrogenation of 3,7-Dio%imino-5a-Gholestane*
3.7-Dioximino-5a-androstane (70 mg.) was shaken with a pre-reduced 
suspension of platinum catalyst (35 mg.) in acetic acid (12 ml.) 
containing a drop of perchloric acid under hydrogen at atmospheric 
pressure and room temperature for 4® hr. The uptake of hydrogen 
during this period was extremely slow .but the theoretical volume 
was consumed. The catalyst was removed by filtration and the 
filtrate, on taking off the solvent in vacuo gave a colourless glass 
(ca. 00 mg.). This *glass' was freely soluble in water and gave a 
copious precipitate on treatment with alkali. The precipitated base 
was extracted with ether, and on removal of the solvent a gum
(61 mg.) resulted. This material showed absorption characteristic 
of the oximino group in the infrared spectrum and also a weak band 
characteristic of an amino group between I65O-I6OO cm. The
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gummy base formed a solid hydrochloride which could not be 
converted into a well defined crystalline form. The free base 
(50 mg.) on attempted chromatography over a column of alumina 
(grade V, 10 g.) could not be eluted.
7-0zimino-5P-cholane; A solution of 7-oxo-5p-cholane (500 mg.) 
in methanol (25 ml.) was treated with a solution of hydroxylamine 
hydrochloride (I50 mg.) and sodium acetate (500 mg.) in water 
(1.5 ml.). After heating the mixture at 100*0 for 5 min,, it was 
allowed to stand at room temperature (24 hr.). Dilution of the 
reaction mixture with water (25 ml.) gave a white precipitate 
which was collected by filtration, washed with water and dried 
(500 mg.). A concentrated methanolic solution of this material 
deposited a white non-crystalline solid (405 mg.) m.p. 60-65*0. 
(Found: 0,79.97$ H,11.51$ N,4.C8. Og^H^^ON requires 0,80.22$ 
H,11.51$ N,5.90fo).
Attempted Formation of 7G-Amino-5P-cholane: (a) A solution of
7-oximino-5P-cholane (100 mg.) in ether (I5 ml.) was refluxed with 
a suspension of lithium aluminium hydride (ca. 200 mg.) in ether 
(10 ml.) for 16 hr. Working up of the reaction mixture afforded 
a neutral gum (85 mg.) which showed the absence of any functional 
groups in the infrared spectrum nor would it afford a hydrochloride.
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No crystalline material resulted after chromatography over alumina, 
(h) 7-Oximino-5P-cholane (50 mg.), dissolved in acetic acid (5 ml.), 
was shaken under hydrogen with a suspension of prereduced platinum 
catalyst (20 mg,) in acetic acid (1*5 #1$) for 24 hr* at room 
temperature and atmospheric pressure. The uptake of hydrogen was 
extremely slow. Working up of the reaction mixture in the usual 
manner afforded a neutral gum which showed a broad shallow band 
between I8OO-I7OO cm. in the infrared spectrum. Repeated attempts 
to purify this product by chromatography over alumina were unsuccess­
ful. No hydrochloride was formed on treatment with hydrochloric 
acid.
5P,7P-Dimethane8ulphonyloxy-5a-oholestane: 5P,7P-Dihydroxy-5a-
cholestane (500 mg.) was treated with methanesulphonyl chloride 
(2.5 mole) in pyridine (5 ml.) at 0*0 for 16 hr. Dilution of the 
reaction mixture with ice and an excess of cold 5N HCl gave a white 
precipitate which was removed by filtration, washed (water) and 
dried (520 mg.). Recrystallisation from methanol or ether gave 
cubes of 5P;7P-dimethanesulphonyloxy-5G-cholestane (290 mg.) m.p* 
146-147*0; 58.6* (c = 1.5). (Found; 0,61.75; H,9.00,
OggHggOgSg requires; 0,62.14; H,9.28^). Infrared analysis showed 
complete sulphonation of both the 5P an<i 7P-by&roxyl groups.
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Action of Dimethylamine on 3P>7P“Pimethanesulphonyloxy-3g-cholestane; 
5P, 7P-Diûiethanesulphonyloxy-5«-cholestane (I50 mg.) was heated 
with dimethylamine (2 ml.) and p-toluenesulphonic acid (40 mg.) 
dissolved in ethanol (2 ml.) in a sealed tube at 100*C for 20 hr.
The reaction mixture was diluted to large volume with water, and 
the oil which separated was extracted with ether after addition 
of dilute ammonia to the aqueous layer. The ethereal extract after 
removing the solvent in vacuo afforded a gum (IO5 mg.). This gum 
was insoluble in water and formed a water soluble salt on treatment 
with dilute hydrochloric acid. The infrared spectrum showed no 
hydroxyl nor methanesulphonyloxy absorption but showed prominent 
peaks at 2825 and 2780 cm. (N-methyl groups). The compound was 
accordingly assumed to be 5a,7a-bis-dimethylamino-5a-cholestane.
Attempted Formation of 5a,7&-Bis-dimethylamino-5a-cholestane 
Dimethiodide; A solution of 5G,7G-bisdimethylamino-5a-cholestane 
(90 mg.) in anhydrous ethanol (2 ml.) was heated with methyl iodide 
(2 ml.) and anhydrous potassium carbonate (100 mg.) in a sealed 
tube at 100*0 for 5 hr. During the time of heating the reaction 
mixture gradually developed an amber colour. The potassium carbonate 
was removed by filtration and the filtrate was distilled vacuo 
to yield a coloured residue. Inorganic material was removed by 
dissolving the residue in chloroform followed by filtration. The
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chloroform extract then afforded a dark reddish brown solid 
(88 mg.). This material on digestion with water gave a dark 
water insoluble residue (45 mg.). The frothy aqueous extract on 
removal of the solvent vacuo afforded a yellow coloured bitter 
tasting solid (40 mg.) whose infrared spectrum showed hydroxyl 
and double bond (C*C) absorptions.
5.12-Dioximino-5P-choiane: 5,12-Dioxo-5P-cholane (200 mg.) watt 
refluxed with hydroxylamine hydrochloride (120 mg.) and sodium 
acetate (24O mg.) in ethanol (I5 ml.) containing water (l ml.) 
for 6 hr. The reaction mixture was concentrated vacuo to 
ca. 5 ml. Dilution with water gave a white precipitate of
3.12-dioximino-5P-cholane, which was collected by filtration, 
washed with water and dried (220 mg.). This material showed 
complete conversion of the keto groups into oximino groups as 
evidenced by the infrared spectrum, but could not be obtained in 
crystalline form. (Pound: 0,73.50; H,10.09$ N,7*29- Og^ ^Og Ng 
requires 0,74.22; H,10.30; N,7*21^).
3a,12a-Diamino-5P-cholane: A solution of 5,12-dioximino-5P-cholane
(211 mg.) in ether (30 ml.) was refluxed with a slurry of lithium 
aluminium hydride (50O mg.) in ether (25 ml.) for 24 hr. The 
reaction mixture was worked up in the usual manner to yield a gum 
(180 mg.). The infrared spectrum of this material showed complete
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conversion of the oximino-groups into amino groups (strong 
absorption at 1570 cm. and N-H stretching between 2500-5200 cm.”^). 
The base readily formed a solid hydrochloride on treatment with 
dilute hydrochloric acid, but this salt could not be obtained 
in crystalline form. * Chromatography over alumina of a sample of 
the free noncrystalline base resulted in loss of about 80^ of the 
material. The eluted 15% material was oily and would not form a 
hydrochloride. The noncrystalline 5G,12a-diamino-5P-cholane was 
accordingly used directly for quaternisation.
5a,12a-Bis-dimethylamino-5P-cholane Dimethiodide: A solution of 
5a,12a-diamino-5P-cholane (10^ mg.) in anhydrous ethanol (2 ml.) 
was heated with methyl iodide (2 ml.) and anhydrous potassium 
carbonate (100 mg.) in a sealed tube at 100®C for 5 hr. The 
potassium carbonate was removed by filtration and the pale yellow 
filtrate was distilled in vacuo. The residue was digested with 
chloroform and the inorganic material still present removed by 
filtration. Removal of the chloroform from the filtrate gave 
pale yellow ^ a ,12a-bisdimethylamino-5P-cholane dimethiodide 
(190 mg.). This quaternary compound was freely soluble in water 
giving a strongly bitter-tasting solution, which did not give any 
precipitate on treatment with ammonia or sodium hydroxide solution.
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5Pf 17P-Dihydro3cy-3«"Androstane> A solution of 5» 17-dioxo-5ot-
androstane (l g.) in boiling ethanol (50 ml.) was treated with 
sliced sodium metal (ca. 4 g«) under reflux during a period of 
? hr. The amber coloured reaction mixture wae cooled and diluted 
with water, and the granular precipitate collected by filtration. 
Chromatography of this product which was free from carbonyl 
absorption (infrared spectrum) over alumina (grade III 20 g.) 
using ethyl acetate as eluant (90 ml.) gave 5P,17P-dihydroxy-5®-
217androstane (790 mg.), m.p. 159-165*0 (reported I64*). Elution 
with ethanol/ethyl acetate (1:4, 200 ml.) yielded more of the 
diol (50 mg.).
5P,17P-Dimethane8ulphonyloxy-5a-Androstane: 5P,17P-Bihydroxy
5%-androstane (500 mg.), dissolved in pyridine (5 ml.) was treated 
with methanesulphonyl chloride (5 mole) at 0*C. and the mixture 
was allowed to stand at room temperature for 16 hr. Dilution of 
the dark brown reaction mixture with ice gave a cream coloured 
precipitate, which was collected by filtration after acidifying 
the reaction mixture with cold 4N HCl. The precipitate was taken 
up in ether and decolourised with charcoal. A concentrated 
solution of the dimethanesulphonate in ether afforded needles of 
5P,17P-dimethanesulphonyloxy-5a-&ndrostane (500 mg.), mp.149-150*0,
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1 7[a]^ 0® (c *= 1.2) (intramolecularly compensated). (Found:
0,56.20; H,7.86. Cg^HggOgSg requires: 0,56.25; H,8.05%). The
infrared spectrum showed absorption characteristic of methane­
sulphonyloxy groups and the absence of free hydroxyl groups.
Attempted Formation of 5a,17g-Bis(dimethylamino)-5g-aPdrostane:
(a) A solution of 5P;17P-dimethanesulphonyloxy-5a-andro8tane
(150 mg.) in anhydrous ethanol (1.5 ml.) was heated with
dimethylamine (1.5 ml.) in the presence of p-toluenesulphonic acid
(ca. 40 mg.) in a sealed tube at 100*0 for 20 hr. The mixture was
diluted with water, basified with 4N sodium hydroxide and extracted
with ether. The ethereal layer was washed (water) and dried
(anhydrous sodium sulphate) and after removal of the solvent in vacuo
afforded a crystalline material (115 mg.), recrystallised from
methanol, m.p. 155-140*C. The infrared spectrum of this materialC-H
showed absorption for N-CHg^stretching at 2750 cm. as well as the 
usual sulphonate ester absorptions at 96O, 1170 and I24O cm. .
The material was not soluble in cold dilute hydrochloric 
acid (although soluble in hot dilute hydrochloric acid), and the 
suspension in warm hydrochloric acid, when treated with an excess 
of 2N sodium hydroxide followed by extraction with ether, regenerated 
the same material (infrared spectrum and mixed m.p.)
(b) A solution of the 5P,17P-&im@thanesulphonyloxy-5a-androstane
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(130 mg.) in N-methyl pyrrolidone/^-butanol mixture (19:1 1.5 ml.) 
was heated with dimethylamine (1.5 ml*) iu a sealed tube at 100*C 
for 60 hr. Working up of the reaction mixture as described in
(a) afforded a crystalline compound (^a. 100 mg.) identical with 
the product obtained in (a) (infrared spectrum and mixed m.p.).
(c) A solution of the product obtained in (b) (60 mg.) in 
N-methyl pyrrolidone/t-butanol mixture (19:1, 1 ml.) was heated 
with dimethylamine (1.5 ml.) and anhydrous sodium acetate (50 mg.) 
in a sealed tube at 100*0 for 26 hr. Working up of the reaction 
mixture yielded unchanged starting material (57 mg.) (infrared 
spectrum and mixed m.p.).
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R E V I E W  A R T I C L E
BIOLOGICAL ACTIVITY IN  STEROIDS POSSESSING
NITROGEN ATOMS.
P a r t  I. S y n t h e t ic  N i t r o g e n o u s  S t e r o id s  
B y M . A la u d d in ,*  B.Pharm. a n d  M . M a r t in - S m it h ,!  M .S c ., Ph.D .
Division o f  Experimental Pharmacology^ Institute o f  Physiology, The University,
Glasgow, W.2.
T h e broad spectrum of biological activity found within the group and the 
multiphcity of actions displayed by certain individual members, make the 
steroids one of the most intriguing classes of biologically-active compounds. 
Structural modification studies, whose extent is unequalled in any other 
area of medicinal chemistry, have not only furnished so many steroidal 
derivatives that structure-action relationship studies are possible to a 
degree undreamt of in other fields, but they have also led to the intro­
duction of several cheaper, safer, more specific and more potent thera­
peutic agents. Among the many steroidal derivatives now known, are 
a number of compounds which incorporate nitrogen atoms in their 
molecular structure, and it is the purpose of the present review to indicate 
the importance of these nitrogenous steroids and to evaluate, where 
possible, the influence of the nitrogen atoms upon the biological activity 
displayed. Certain aspects of the subject have been reviewed previously, 
particularly the pharmacology of the veratrum alkaloids—for more 
recent reviews see Abreu (1959), Hoobler and Dontas (1953), Krayer 
(1958), Stoll (1954). The earlier work is exhaustively reviewed by Krayer 
and Acheson (1946) who refer to previous review articles. A brief survey 
of the biological properties of nitrogenous steroids in general has also 
been published (Voigt and Kallistratos, 1957).
To set the field in perspective the present review will consider nitro­
genous steroids in several contexts. Suitable examples, chosen mainly 
from the synthetic derivatives, will be used to illustrate how the group 
fits in with modern concepts of drug action and a brief survey will then 
be given of the biological properties of the rapidly expanding group of 
known steroidal alkaloids. With the large number of nitrogenous 
steroids now known, it is quite impossible to achieve a complete coverage 
of the pertinent literature, but a serious attem pt has been made to make 
the survey as representative as possible.
Clinical Implications
At the present day chnical apphcation of steroids possessing nitrogen 
atoms is very limited, although there are several indications that the full 
potentialities have not yet been realised. This is particularly true in the 
field of synthetic derivatives, as it is only within the past few years that
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the intensive search for modified steroidal hormones, showing high 
specificity or accentuating a minor or secondary biological characteristic 
of the natural analogue, has been extended to include more than a handful 
of nitrogenous derivatives. It does not therefore seem unreasonable to 
anticipate that among new nitrogenous steroids will be found compounds 
exhibiting clinically desirable carcinolytic properties, improved anabolic 
to androgenic ratios or superior lipodiatic to oestrogenic indices. Indeed 
certain steroidal [3, 2-c]-pyrazoles (Clinton and others, 1959, 1961b) and 
[2, 3-d]-isoxazoles (Clinton and others, 1961a) are already known to 
possess very favourable anabolic to androgenic ratios. Moreover, as 
these derivatives are active by the oral route and one representative, 
17 - hydroxy -17% - methylandrostano - [3,2 - c] - pyrazole (I), has shown
OH
HN
III
promise on preliminary chnical trial (Howard and others, 1959), such 
compounds may well find a permanent place as therapeutic agents. 
AnaboUc properties are also present in other nitrogenous steroids in­
cluding 17j3-hydroxy-17a,2'-dimethylandrostano-[3,2-b]-thiazole, certain 
iV-substituted 2-aminomethylene-17a-methyldihydrotestosterones (Zderic 
and others, 1960) and various substituted 16a-aminopregnenes (Rhone- 
Poulenc, 1960).
The possibility of securing new therapeutic agents amongst nitrogenous 
steroids is by no means confined to synthetic derivatives, however, and 
naturally-occurring compounds may also have their role to play. Thus 
the recently characterised bisquatemary steroidal alkaloid, malouetine 
(II), which occurs in Malouetia bequaertiana (Janot, Laine and Goutarel,
1960), has been shown in preliminary experiments to possess competitive 
neuromuscular-blocking potency equal to that of (+)-tubocurarine whilst 
being only one third as toxic (Quévauviller and Laine, 1960) and so this 
compound or related drugs could conceivably offer alternatives to tubo- 
curarine as an adjunct to surgery. The three possible isomers of maloue­
tine involving the configurations of the nitrogen atoms, namely the diqua- 
temary bases in which the nitrogen atoms are in the 3)8-20^8-, 3a-20a- and 
3a-20j8-configurations have been prepared synthetically (Goutarel, 1961) 
and it will be of some interest to leam of their relative potencies. Again, 
the steroidal alkaloid funtumidine, on the basis of motility tests in rats, 
has been claimed to possess tranquillizing properties comparable to those 
of reserpine (La Barre and Desmarez, 1959) and so alkaloids of this type 
may have a role to play in this area of clinical medicine.
326
STEROIDS POSSESSING NITROGEN ATOMS
Certain clinically acceptable nitrogenous steroids are found in nature 
but are not used because cheaper or superior agents are available. Ex­
amples are the suberylarginine derivatives of the bufadienolides, such as 
bufotoxin and gamabufotoxin (III), which are constituents of the poison
0-C0[CH2|^C0NHCH'[cHjiNH-CNH, 
COgH NH
III
secreted by the parotid glands of the toad, and which have similar activity 
to the plant cardenolide and scilladienolide glycosides employed clinically 
in the treatment of congestive heart failure. It is of some interest that 
the toxic principles secreted by the salamander are also nitrogenous 
steroid derivatives (Schopf, 1961) although these compounds are of a 
different chemical type and are without potential clinical application.
Nitrogenous derivatives of cardenolides are also found in plants. 
Examples are uscharine (IV) (Hesse and Mix, 1959) and its dihydro­
derivative voruscharine (Hesse and Ludwig, 1960) which occur in the latex
O H
p H
O H
IV
of Calotropis procera. Thèse, compounds do not appear to have seen 
clinical trial but uscharine has been shown to have a potency 58 per cent 
of that of ouabain in the etherised cat (Chen, Bliss and Robbins, 1942).
The nitrogenous steroids which have seen the most extensive clinical 
application are the steroidal alkaloids of the protoveratrine type which 
produce a reflex fall in blood pressure through a generalised vasodilatation 
and fall in heart rate. Crude and complex mixtures of these alkaloids 
saw a certain amount of clinical use around the turn of the century, but 
their toxicity and unpleasant side effects brought them into disfavour. 
The use of the purified principles saw a resurgence of popularity several
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years ago with the heightened interest in the problem of hypertension 
(see for example Meilman and Krayer, 1952; Meilman, 1959; Robson 
and Keele, 1956), especially as they produce vasodilatation in all peri­
pheral circuits including the brain and kidneys, and are free from the 
disturbance of the postural reflexes produced by ganglion-blocking agents. 
Unfortunately these highly desirable physiological properties are more than 
offset by the narrow margin between the therapeutic and toxic doses and 
the fact that emesis nearly always occurs with therapeutic doses. Hence 
these alkaloids have been virtually eliminated from clinical use, although 
they may still find occasional application in the treatment of certain 
toxaemias of pregnancy (see for example Finnerty and Fuchs, 1953; 
Meilman, 1953; Krupp and others, 1956).
The fact that the protoveratrine group of alkaloids afford such a 
clinically desirable integrated response, and yet cannot be employed 
because of their side effects, has presented a most tantalising challenge to 
the medicinal chemist and numerous attempts have been made to prepare 
synthetic nitrogenous steroids retaining the hypotensive properties, but 
devoid of the side effects. So far these efforts have met with little success. 
Among the compounds prepared are numbered several cholylamine esters 
(Fieser and Wei-Yuan Huang, 1953), certain ternorcholanylthiazoles 
(Dodson, 1955a), various 16a-aminopregnenolones (Rhone-Poulenc, 
1960 ; Gould and others, 1956), some aminoalkanol esters of 17a-hydroxy-3- 
ketoandrost-5-en-17^-carboxylic acid (Bloom, 1956) and two 17- 
imidazolylandrostenes (Sturtevant, 1958).
Other steroidal alkaloids have seen limited clinical trial in the treatment 
of conditions other than hypertension. For example the “Kurchi” 
alkaloids from various Holarrhena spp. have been employed in the treat­
ment of amoebic dysentery, both free and in the form of bismuth iodide 
complexes (see for example Acton and Chopra, 1933; Tanguy, Robin 
and Raoult, 1948; Lavier, Crosnier and Merle, 1948) and Solanum 
alkaloids were once used in the treatment of asthma and neuralgia 
(Leclerc, 1938), but neither class is of any great value.
SYNTHETIC NITROGENOUS STEROIDS AND THEIR PLACE IN MODERN THEORY
The lack of knowledge of the principles by which biological activity is 
related to chemical structure has necessitated numerous tedious structural 
modification studies in which the medicinal chemist has sought to improve 
upon known drugs of proven efficacy, and many steroids possessing nitro­
gen atoms have played their role in this work. Usually the preparation 
of such compounds has been conducted on purely empirical grounds but 
occasionally it has followed from the application of theoretical concepts 
such as the receptor theory of drug action, the theory of metabolite dis­
placement, the concept of bioisosterism or the supporting moiety theory. 
In the following sections examples will be given of nitrogenous steroids 
which have either been prepared from consideration of these concepts or 
which can be discussed in retrospect in terms of these concepts. It is 
felt that this treatment will place the compounds in their correct perspective 
and at the same time afford a comprehensive survey without giving rise
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merely to a catalogue of the various synthetic nitrogenous steroids which 
have been studied biologically.
Receptor Theory
Although very little is known of the intimate nature of the hypothetical 
“drug receptors’* in the tissues, the receptor theory has proved an extremely 
useful aid to the medicinal chemist in his attempts to rationalise drug 
action in so far as it stresses the importance of the 3-dimensional geo­
metrical shape and electronic distribution of the drug molecule. It was 
consideration of the receptor theory which led to the planned synthesis 
of the anabolic steroidal [3,2-c]-pyrazoles and [2,3-d]-isoxazoles, where 
it was assumed that the receptors concerned with the androgenic and 
anabolic properties of the natural male hormones differed in their nature 
(CUnton and others, 1961b). Attention was concentrated on securing an 
alteration of the intergroup distance between the substituents at C(3) 
and C(17), with an accompanying change in the nucleophilicity of the 
C(3) substituent, and satisfaction of these requirements led logically to 
the preparation of the pyrazole and isoxazole derivatives.
After oral administration 17j8-hydroxy-17a-methylandrostano-[3,2-c]- 
pyrazole (I) proved to be some 30 times as potent as 17a-methyltesto- 
sterone in the rat nitrogen retention test, whilst it was only one quarter 
as androgenic in the ventral prostate weight gain test (Arnold, Beyler 
and Potts, 1959). In the levator ani muscle test in immature cas­
trated male rats it proved to be twice as myotrophic when given by the 
oral route as 17a-methyltestosterone (Potts, Beyler and Burnham, 1960), 
and it also proved effective in reversing the catabolic actions of cortisone 
acetate in the same animals (Beyler, Potts and Burnham, 1960). Sur­
prisingly, acylation of the pyrazole ring imparted some oestrogenicity to 
the pyrazole series and a 6%-methyl group decreased both the androgenic 
and anabolic properties (Clinton and others, 1961b).
The isoxazole derivatives show broadly similar activity to the pyrazole 
compounds (Clinton and others, 1961a ; Zderic and others, 1960) although 
one, 17^-hydroxy-17a-methyl-19-norandrost-4-eno-[2,3-d]-isoxazole (V), 
showed a conspicuous lack of specificity. Thus it exhibited progestational
OH
V
activity equal to progesterone on intramuscular administration and to 
ethisterone on oral administration, as well as showing anabolic, myo­
trophic, androgenic and oestrogenic properties (Clinton and others, 
1961a).
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In their visualisation of drug-receptor interaction Van Rossum and 
Ariens (1957) suggest that the “drug-receptor complex” is basically an 
interaction of fields of force originating in the drug molecule and in the 
tissue. Electrostatic and van der Waals forces play the dominant role, 
and it is postulated that certain specific interactions within the general 
field determine the intrinsic activity or ability of the drug to evoke the 
biological response. If this representation is correct then maintenance of 
the general interaction with concurrent variation in electron density at 
certain specific areas might be expected to produce large changes in 
intrinsic activity without appreciable changes in the affinity for the 
receptor. In the glucocorticoid field such a situation would appear to 
arise from the introduction of an electron-withdrawing substituent in the 
form of a 9a-fluorine atom which greatly enhances potency. The spec­
tacular success of this introduction of a 9a-fluorine atom has logically led 
to investigations of the effect of introducing other electron-withdrawing 
groups at various positions in the steroid nucleus and among the com­
pounds so prepared are several with groups containing nitrogen. Thus 
several 5a-, 7a-, 9a- and 11 /S-thiocyanato-steroid hormone derivatives have 
been synthesised (Kawasaki and Mosettig, 1959 ; Schaub and Weiss, 1961 ; 
Takeda, Kubota and Kawanami, 1960) and it was discovered that 3,20-, 
dioxo-5a-thiocyanatopregnane (VI) and 17a-ethynyl-17j8-hydroxy-3-oxo- 
5a-thiocyanato-19-norandrostane (VII) were approximately equal in
NCS
VI
progestational activity to their parent compounds progesterone and 
19-norethynyltestosterone respectively. Similarly the 4,^-dihydro-5a- 
thiocyanato-analogue of cortisone acetate showed comparable activity 
to cortisone acetate (Takeda, Kubota and Kawanami, 1960) although the 
4,5-dihydro-5a-thiocyanato-derivative of hydrocortisone acetate showed 
little or no activity. Doubt is expressed, however, whether the thio- 
cyanato-derivatives were themselves active in view of their ready recon­
version into the parent hormone.
Other steroid hormone analogues with electron-withdrawing groups in 
the molecule include various 5- and 6-cyano-derivatives (Bowers, 1961 ; 
Bowers and others, 1959) and several 6-nitro compounds (Bowers, 
Ibânez and Ringold, 1959; Bowers, Sanchez and Ringold, 1959). Of 
these, 6a-nitro-17a-acetoxyprogesterone was found in the Clauberg assay, 
oral route, to be 3-4 times as active as 17a-acetoxyprogesterone as a 
progestational agent (Bowers, Ibanez and Ringold, 1959). On the other
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hand both 6a- and 6 |3-nitrotestosterone were inactive as myotrophic, 
androgenic or gonadotrophin-suppressing agents in the parabiotic rat 
(Bowers, Sanchez and Ringold, 1959). The isomeric 6a- and 6^-nitro- 
progesterones exhibited less than one eighth the progestational activity 
of progesterone in the guinea-pig copulatory assay (Bowers, Sanchez and 
Ringold, 1959) and 21-nitroprogesterone was inactive (Bowers and 
Ringold, 1959).
The 2-nitro-, 4-nitro- and 2,4-dinitro-derivatives of oestrone (Werbin 
and Holoway, 1956) and oestradiol (Patton, 1959b) are known, but like 
the 16-isonitroso-derivative of oestrone-3-methyl ether (Litvan and 
Robinson, 1938) they do not appear to have been tested biologically.
Various nitrogenous steroids, where the nitrogen forms part of an 
electron-donating group, have also been studied. In particular con­
siderable attention has been paid to derivatives of oestrone and oestradiol. 
Amongst such compounds may be mentioned 2-amino-4-methyloestra- 
l,3,5(10)-trien-17/S-ol (Dannenberg and others, 1960), 3-amino-4-methyl- 
oestra-l,3,5(10)-trien-17jS-ol (VIII) (Dannenberg and others, 1959) and
O H
HgN
VIII
certain 2-dialkylaminomethyl derivatives (Patton, 1959a; I960) which all 
proved devoid of activity. It is claimed however that a derivative of 
oestrone thought to possess the 17-spiro-oxazolidine structure IX exhibits 
aTi oral activity ten times that of oestrone (Hebo, 1951).
NH
HO'
IX
Several synthetic steroids possessing the provitamin D 5,7-diene system 
with a terminal tertiary amino-function in the side chain have been 
prepared but on irradiation, only slight anti-rachitic activity was observ­
able in the most fhvourable substance (Louw, Strating and Backer, 1955). 
The amides from which these amines were prepared were also inactive on 
irradiation.
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Other examples of the introduction of an electron-donating nitrogen 
function into the steroid side chain are afforded by a number of A-sub- 
stituted 21 -amino-11 j8,17a-dihydroxypregna-1,4-diene-3,20-dione com­
pounds of type X, which have been shown to retain the glucocorticoid
CH,NRR
•^OHHO,
X
activity of prednisolone from which they are derived, as evidenced by the 
results of liver glycogen accumulation and rat foot oedema tests (Toth, 
Tuba and Szporny, 1961).
More complex structural modification studies involving nitrogen have 
been reported in the cardenolide field. Thus strophanthidin reacts with 
primary and secondary amines to form nitrogenous derivatives (Bembry, 
Elderfield and Krueger, 1960), one of which, tryptamine-strophanthidin, 
not only retains a typical digitalis-like action on the isolated papillary 
muscle of the cat (Greiner and Reilly, 1952), but unhke the glycosides of 
the strophanthus series, it is active by the oral route in man (Otto and 
others, 1953). Unfortunately, however, it often produces emesis. The 
structure originally assigned to this compound (Otto and others, 1953) 
has since been retracted (Bembry and others, 1960) and it is now believed 
to be that shown in XI. Other cardenolide derivatives which have been
CHO
OH
HO
OH
XI
studied biologically include the 3-diethylaminoacetate and the 3-nico- 
tinate of strophanthidin (Kiissner, 1939 ; Steldt, Anderson and Chen, 
1944). In the cat the diethylaminoacetate proved more potent than the 
parent aglycone, but the nicotinate was less active (Steldt and others, 1944).
Two /7-dimethylaminophenylnitrones related to cortisone and hydro­
cortisone, viz. 17a-hydroxy-3,11,20-trioxopregn-4-en-21 -/?-dimethylamino- 
phenylnitrone (XII) and the corresponding lljS-hydroxy compound,
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XII
have been shown to retain glucocorticoid activity as demonstrated in 
the liver glycogen deposition assay (Leanza and others, 1954), but several 
21-pyridinium salts derived from cortisone and hydrocortisone were 
inactive, as was the iminolactone XIII.
OHOH
=  NH
XIII
There are a number of references in the literature to the screening of 
various nitrogenous steroids only remotely related structurally to steroid 
hormones, and as might be expected, in most tests these compounds 
proved inactive, as, for example, the series of 24-amino-derivatives pre­
pared from bile acids which showed no antirheumatic activity (Wessely 
and Swoboda, 1951). It is therefore a little surprising that certain 
substituted amino-alkanol esters of bile acids appear to exhibit some anti­
inflammatory activity based on claims of their efficacy in the treatment 
of fibrositis and certain types of arthritis (Burtner, 1951).
Considerable attention has been devoted to structural modifications of 
the steroid nucleus itself and a number of these studies have been concerned 
with the introduction of nitrogen atoms into various ring positions. At 
the present time, in addition to several homoaza-steroids, aza-steroids 
are known in which each secondary carbon atom of the steroid nucleus, 
with the exceptions of C(l) and C (ll), has been replaced by nitrogen 
(see for example Doorenbos and Mu Tsu Wu, 1961 ; Gut and Uskokovic, 
1961 ; Knof, 1961 ; Kutney and Johnston, 1961 ; Jacobs and Brownfield, 
1960; Shoppee and Krueger, 1961). Little work appears to have been 
published on the biological properties of these compounds so far, but 
they can be expected to provide interesting information in terms of the 
receptor theory with their regions of high electron density actually incor­
porated in the nucleus. Certain oxygenated 12a-aza-C-homo-steroids
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have been reported (Mazur, 1957a,b) to inhibit the harmful deposition of 
liver glycogen occurring as an untoward effect in cortisone therapy and 
4-aza-pregn-5-en-3,20-dione is claimed to exhibit marked anti-inflam­
matory activity in rats (Wildi, 1959). Weak androgenic properties and 
anti-oestrogenic activity are present in certain lactams belonging to the 
4-aza-androstane series (Doorenbos and Huang, 1961). Several bis- 
dehydrodoisynolic acid analogues possessing the 1,2,3,4-tetrahydro- 
benz-[f]-isoquinoline nucleus were inactive as oestrogens and also failed 
to exhibit any androgenic or anti-inflammatory activity (Nelson and Hsi, 
1961).
Nitrogenous Steroids as Antimetabolites
Where the affinity for a receptor fitted by a normal metabolite of a 
living organism is also present in a synthetic analogue of the metabolite, 
but the analogue exhibits a greatly reduced intrinsic activity, then the 
analogue is hkely to function as an antagonist of the metabolite. Recently 
there has been an intense interest in the planned synthesis of antimeta­
bolites, and this has been referred to as “the revolution in pharmacology” 
(Woolley, 1960). In the steroid field, several antimetabolites, such as 
the spirolactone antagonists of aldosterone (Atwater and others, 1961 ; 
Barter, 1960) are well estabhshed whilst other compounds, such as the 
halogenated analogues of the corticoid steroids (Fried, 1957) and the 
dihydrocardenolides (Cosmides, Muja and Carr, 1956) are believed to 
competitively antagonise their parent compounds. Yet nitrogen-contain­
ing steroids seem to have been httle investigated as metabolite-displacing 
agents. Cholesterylamine, however, has been demonstrated to be a weak 
inhibitor of the use of cholesterol by the cockroach (Noland, 1954) and 
there are claims in the patent literature (Dodson, 1955b ; Rorig, 1953) that 
certain nitrogenous steroids possess antihormonal activity. It is also 
possible that the antimicrobial activity displayed by various nitrogenous 
steroids may be due to antagonism towards steroidal metabolites of the 
organism, although it is clear that many of these compounds act by virtue 
of their surface-active properties (Stacey and Webb, 1947a). Such 
surface activity is widespread within the steroid field, and is particularly 
pronounced in the saponins, cardiac glycosides, various steroidal alkaloids, 
and the bile acids. In addition to conferring antimicrobial properties, 
the surface activity also confers haemolytic properties and it is therefore 
not unexpected that 3,6-diaminocholestane is a haemolytic agent (Stück- 
radt, 1939).
A large number of nitrogenous steroids have been tested for antibacterial 
and antifungal activity. These compounds cover a wide range of chemical 
complexity and include both synthetic compounds and alkaloids. Among 
the simpler synthetic compounds may be mentioned the epimeric 7-amino- 
cholesterols (Barnett, Ryman and Smith, 1946a), various mono- and di- 
aminocholestane derivatives with the nitrogen functions in the 3-, 6- or 
7-positions (Barnett, Ryman and Smith, 1946b) and several hydroxylated 
23-aminonorcholane derivatives, including 23-guanido-3,7,12- trihydroxy- 
norcholane (James and others, 1946). The monoaminocholestane
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derivatives shoAved some activity against Gram-positive organisms 
(Barnett and others, 1946a,b) and the potency is increased in the diamino- 
compounds which in addition, showed some activity against Gram- 
negative organisms (Barnett and others, 1946b).
Amino-steroids prepared from bile acids in which the nitrogen atom 
is attached directly to the steroid nucleus exhibit but weak antibacterial 
properties (Hilton, Jones and Westwood, 1955; Jones, Webb and Smith, 
1949; Redel and others, 1951) but where the amino-group is in the side 
chain, the potency is higher (Hilton and Webb, 1951 ; Stacey and Webb, 
1947b).
Among the more complex synthetic nitrogenous steroids which have 
been shown to exhibit antibacterial properties are a number of A-sub- 
stituted 16-amino-derivatives (Sobering, 1955) and 3,3-di(A-acetyl-p- 
aminophenylmercapto)-?, 12-diketocholanic acid (Jones, Smith and 
Webb, 1948). Several A-substituted 22-aminobisnorcholanes and their 
derived quaternary methiodides were found to possess antifungal activity 
in tests with Candida albicans (Herzog, Payne and Hershberg, 1955), but 
the amides from which they were derived showed little or no activity. 
Various aminopregnane derivatives of varying chemical complexity also 
possess antimicrobial activity (Kull, Castellano and Mayer, 1953 ; Micheli 
and Bradsher, 1955). The anti-amoebal properties of the steroidal 
alkaloid conessine inspired the screening of several synthetic nitrogenous 
steroids (Dodgson and Haworth, 1952), but none was more active than 
conessine itself. Certain compounds of this type showed antibacterial 
activity of about one twentieth that of streptomycin (Joska, Cerny and 
Sorm, 1954).
Of a series of quinolino-, indolo-, pyrrolo-, thiazolo- and triazafluoreno- 
steroids prepared as potential antimicrobial agents only one, XIV, was
XIV
sufficiently soluble to be tested and it proved inactive (Antaki and Petrow, 
1951). A-Phenyl-3j8-cholestanamine and A-p-tolyl-3,8-cholestanamine, 
wliich were prepared during a search for drugs effective in leprosy and 
tuberculosis, also proved to be inactive (Buu-Hoi and Cagniant, 1944).
Bioisosterism
Certain nitrogenous steroidal derivatives are of particular interest in 
terms of the concept of bioisosterism (Schatz, 1960; Friedman, 1951) 
which postulates that compounds in isosteric relationship should possess 
either similar or opposite biological activity. This behaviour can be 
rationalised in terms of the receptor theory of drug action since the great
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similarity in chemical and physical properties shown by isosteres should 
ensure similar affinities for the same receptors, mimicry or antagonism 
then being determined by the intrinsic acitivities of the individual isosteres. 
In the extended definition of isosterism (Erlenmeyer, 1948), functional 
groups which are related by the Hydride Displacement Law of 
Grimm (1934 and earlier refs.) are considered to be isosteric and so such 
a relationship will pertain for steroids related by the substitution of the 
-NH-group for the -O- function. Unfortunately, however, this particular 
isosteric relationship is complicated by the greater willingness of the 
nitrogen atom to enter salt formation and so strictly comparable biological 
activities are not necessarily to be expected. At physiological pH tlic 
amino-steroids will be ionised and so may have difficulty in penetrating 
permeability barriers (Brodie and Hogben, 1957) and may not reach the 
receptor. Although most of the amino-isosteres of steroidal hormones 
which have so far been tested are inactive and lack the ability to antagonise 
their natural analogues, potent oestrogenic activity is present in 17j3- 
acetamido-3-acetoxyoestra-l,3,5(10)-triene (XV) (Dannenberg, Scheurlen
XV
NHCOMe
and Simmer-Riihle, 1956) in which salt formation at the nitrogen atom is 
prevented by the amide function. The activity of'this compound is also 
of interest in connection with the suggestion that oestrogenic activity is 
associated with the presence in the molecule of two groups capable of 
entering into hydrogen-bonding and which are held in a certain steric 
relationship (see for example Fisher, Keasling and Schueler, 1952; 
Macovski and Georescu, 1946; Oki, 1952). It has been further suggested 
that the distance between the two groups is a multiple of the “identity 
distance” (Long and Schueler, 1954) which is - the distance between 
peptide links in a polypeptide chain.
The inactive oestrogen isosteres which have been reported are the 
3-amino-isostere of equilenin(Bachmann and Dreiding, 1950) the 3-amino-, 
17j8-amino- and the 3,17j8-diamino-isosteres of oestradiol and the 3-amino- 
isostere of oestrone (Hecker and Walk, 1960; Gold and Schwenk, 1959).
In the androgen series 3,17^-diaminoandrost-4-ene, 3-amino-17^- 
hydroxyandrost-4-ene and 3-oxo-17j8-aminoandrost-4-ene have been 
reported to be devoid of male hormone activity (Joska and §orm, 1956), 
but the analogue of testosterone, 17jS-amino-3-oxo-androst-4-ene (XVI), 
although showing no activity in male rats, produced a pronounced increase 
in kidney weight and lesser increases in the liver and adrenal weights of 
female rats (Gaunt and others, 1954).
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Replacement of the oxygen atom in the lactone ring of scillaren A by 
the-NH-group gave rise to a very sparingly soluble isostere which showed 
no cardiotonic activity when tested on the isolated guinea-pig auricle at 
a concentration of 10~®m (Uhle and Schroter, 1961).
Drug Latentiation
Nitrogenous steroids have played a small but nevertheless significant 
role in drug latentiation (Harper, 1959) where a chemical derivative of an 
active drug is administered to overcome unfavourable rates of biotrans­
formation or unfavourable solubility, distribution, transport and absorp­
tion characteristics—the active drug being regenerated in vivo. The 
steroidal moiety has sometimes functioned as the latentiating agent and 
at other times an active steroid has been latentiated.
Examples of the use of steroids as latentiating agents include the pre­
paration of insoluble steroidal amine salts of penicillin capable of main­
taining prolonged therapeutic concentrations of the antibiotic in the 
bloodstream (Coghill, Weston and MacCorquodale, 1950; Madinaveitia, 
1955; Vaidya and Boyce, 1959) and the application of the cholesterol-6- 
sulphonate anion to yield an insoluble thiamine salt with which to enrich 
cereal flour (Mima, 1955). Another example is afforded by the choline 
salts of cholic acid and desoxycholic acid which exert actions typical of 
both moieties on the guinea-pig intestine (Meyer and McEwen, 1948). 
Attempted latentiation of 3-indolylacetic acid by the formation of steroid 
esters failed, however, to enhance parthenocarpic fruit induction in the 
tomato (Hofert and Sell, 1960).
Examples of nitrogenous moieties being used to latentiate biologically- 
active steroids are far more numerous. For instance much attention has 
been devoted to the preparation of amine salts of steroid hormone sulphate 
esters to increase the water solubility of the parent hormone. Among 
such compounds can be listed the ethylenediamine salts of the sulphate 
esters of oestrone, oestradiol, equilenin, androsterone and pregnenolone 
(Abbot, 1954a,b); the piperazine salts of the sulphate esters of oestradiol 
and equilenin (Hasbrouck, 1953); and the procaine (Deans and Scarrow, 
1951), amphetamine (Grant, Glen and Barker, 1950) and 2-aminopyridine 
(Beall and Grant, 1952) salts of the sulphate esters of various steroidal 
oestrogens. Of these compounds piperazine oestradiol sulphate (XVII) 
has been used clinically. Dehydroandrosterone and androstenediol lose 
their biological activity if administered as dialkylamino sulphuric ester 
derivatives (Goisis and Polvani, 1955). Various quaternary ammonium
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derivatives of hydrocortisone, prednisolone and dexamethasone retain 
activity (Mori and Nakagawa, 1961).
Latentiation of steroids may also be a natural phenomenon since 
amino-acid conjugates of steroidal hormones have been discovered 
in aqueous adrenal cortical extracts (Voigt and Schroeder, 1956 and earlier 
refs.) in urine (Eades, Pollack and King, 1954; Schneider and Frahm,
1955) in blood (Hudson arid Lombardo, 1955) and in liver (Butenandt,
1956) and chorion-gonadotrophic extracts (Schneider and Frahm, 1956; 
Schneider and Birtel, 1956). These discoveries prompted Schroeder and 
Voigt (1958) to investigate the efficacy of glycyltestosterone in the survival 
test on adrenalectomised golden hamsters, but the compound was inactive 
and also devoid of androgenic properties (Overbeck, 1957). Nevertheless 
certain steroids in the form of amino-acid esters do appear to retain their 
activity (Organon, 1960), and latentiation of hydrocortisone by conversion 
to the more soluble diethylaminoacetate hydrochloride has been used in 
dermatology (Welsh, 1956; Kuhn, 1959). Prednisolone and dexa­
methasone have also been administered as their diethylaminoacetates 
(Dom er and Hohlweg, 1961 ; Zicha and others, 1960). The ^-diethyl- 
aminoethyl ester of dehydrodesoxycholic acid was found to have one- 
quarter of the potency of dehydrocholic acid as a choleretic agent oh a 
molar basis (Gunter and others, 1950).
Recently interest has been aroused in the preparation of steroidal 
nucleotides like XVIII (Oertel and Agashe, 1960; Riess and Ourisson,
1961) and in the preparation of the nicotinic esters of male, female 
and adrenocorticoid hormones (Weichsel and Zirm, 1961), the synthesis of
0~ P”0
O-p-o— CH,ilo
)H OH
XVIII
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the latter being inspired by the fact that favourable analgesic activity was 
retained in the bisnicotinic ester of morphine (Skursky, 1957).
An important example of drug latentiation in the steroid field is provided 
by the general anaesthetic hydroxydione which is the sodium salt of the 
hemisuccinate of 21-hydroxypregnane-3,20-dione. In this compound 
the hemisuccinate moiety confers increased water solubility on a pre­
dominantly lipid soluble molecule and rapid hydrolysis by the non­
specific esterase of the serum regenerates the parent compound which then 
crosses the blood-brain barrier and quickly builds up an anaesthetically 
active concentration in the brain (Figdor and others, 1957 ; Jakoby and 
Tomkins, 1956). There would seem to be no a priori reason why other 
readily hydrolysed water-solublising groups could not be employed in 
place of the sodium hemisuccinate moiety and indeed a series of sub­
stituted aminoacetates, tertiary amine hemisuccinate salts and a substituted 
ammonium phosphate salt of 21-hydroxy-pregnane-3,20-dione have been 
tested for anaesthetic potency (Fidgor and others, 1957). Also included 
in the study were the hemisuccinates of two 3-spirothiazolidine derivatives 
of 21-hydroxy-20-oxo-5a-pregnane. The results showed that the nature 
of the solubilizing group could markedly influence the activity displayed. 
The aminoacetates exhibited high potency and high toxicity. Within 
the series there was much variation in the time of onset of anaesthesia.
Although anaesthetic properties are associated with many steroids 
(Figdor and others, 1957; Selye, 1942) the phenomenon appears a struc­
turally specific one as nuclear substitution profoundly alters activity 
(Figdor and others, 1957). Moreover if the action was simply an exten­
sion of the properties of the gaseous general anaesthetics whose activity 
can be related with their thermodynamic activities and hence with their 
concentration in the central nervous system (Ferguson, 1939), one would 
expect other predominantly lipid soluble molecules of intermediate 
molecular weight to form a connecting bridge between the simple anaes­
thetics on the one hand and the steroids on the other. The sodium hemi­
succinates of representative mono- and di-terpenoids, however, proved 
inactive (Ahmad and others, 1961).
Little attention would appear to have been given to the possibility of 
improving the solubility, absorption and transport properties of nitro­
genous drugs by forming inclusion compounds with desoxycholic acid, 
although it has long been recognised that various alkaloids do form choleic 
acids (Wieland and Sorge, 1916)—that is, inclusion compounds with 
desoxycholic acid. Inclusion compounds in which steroid hormone 
molecules are the entrapped species have, however, excited some interest 
and recently investigations of this kind of compound have been made 
with phenylurethane and hippuric acid as models for the study of the 
interaction of proteins with steroids (Dirscherl and Gerhards, 1961).
Supporting Moiety Theory
Nitrogenous steroids played an important part in the development of 
the supporting moiety theory which contends that the molecules of pharma­
cologically active substances consist of a radical moiety determining the
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type of activity displayed and a supporting moiety conferring affinity 
for the site of action. Cavallini and his colleagues who were the first to 
formally state this theory (Cavallini, 1955 ; Cavallini and Massarani, 1959) 
employed such compounds in their early experiments. The actual 
compounds included the j3-diethylaminoethyl ethers of oestrone, testo­
sterone and 3a-hydroxy-17-oxoandrost-5-ene (XIX), and the bis j8-diethyl-
XIX
aminoethyl ethers of oestradiol and 3,17-diliydroxyandrost-5-ene (Cavallini 
and Massarani, 1951b). The combination of “stripped down” drug 
molecule (Gero and Withrow, 1957) or radical moiety (diethylamino- 
ethanol) and the steroidal supporting moiety produced drugs with potent 
coronary vasodilatator properties (Cavallini and Massarani, 1951b, 1959) 
whilst the bisqüaternary salts derived from the two di-ether compounds 
showed curare-like properties (Cavallini and Massarani, 1959; Cavallini 
and others, 1951). These quaternary salts also showed in vitro anti­
cholinesterase activity (Cogni and Salvaneschi, 1951). Quaternary 
salts derived from the mono-diethylaminoethyl ethers exhibited ganglion- 
blocking activity (Cavallini and Massarani, 1959).
Couphng to the predominantly lipid soluble steroid nucleus would be 
expected to confer upon a radical moiety not only different solubility 
characteristics but perhaps also more favourable adsorption properties. 
Since the plasma proteins are of such a nature as to readily bind cholesterol, 
it is conceivable that such compounds could use an existing transport 
mechanism.
Application of these ideas was independently made by several groups 
of workers in the sulphonamide field, who attempted to overcome the 
unfavourable lipid solubility characteristics of this group of antibacterials 
by preparing sulphonamido derivatives of cholesterol (Lieb, 1947; 
Kwartler, 1948) or the bile acids (Redel and others, 1951 ; Haslewood, 
1941). Sulphacholazine (XX,R =  NH NH SOg CGH^-p-NHg) was found
OH
COR
OHHO
XX
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to possess in vitro activity against streptococci and moreover on intra­
venous administration to rabbits it was demonstrated to gain access to 
the bile (Barber, Dible and Haslewood, 1943). It was unfortunate that 
the compound showed little activity against the coliform group of or­
ganisms. More recently steroidal 4-amino-2-methoxyphenyl ethers 
have been prepared with the object of using the bile acid transport system 
to bring schistosomicidal amines in contact with the adult schistosomes 
residing in the portal veins (Davis, 1962).
The 7V^-hydroxycholanyl-/7-aminophenylsulphonamides (e.g. XX,R =  
NH'SOs'CgH^-p-NHg) are claimed to exhibit antibacterial and antiviral 
properties (Berczeller, 1948) but where the sulphonamide moiety is 
attached directly to the steroid nucleus as, for example, at position 7, the 
compounds show little or no activity (Redel and others, 1951).
The rigid nucleus of steroids which possess a benzenoid ring A or a 
trans A/B ring junction is of interest as a supporting moiety from another 
point of view, since it can function as a skeletal framework upon which 
two or more radicals can be held in fixed spatial relationship to one 
another. Such a function for the steroid nucleus has been suggested to 
be involved in the activity displayed by the natural oestrogens where the 
oxygen functions at C(3) and C(17) are held at a rigid intergroup distance 
(see for example: Fisher, Keasling and Schueler, 1952; Macovski and 
Georéscu, 1946; Oki, 1952). Other supporting moieties would be 
expected to be able to fulfil this role and in this may lie at least a part 
explanation for the potent oestrogenic properties displayed by such 
chemically diverse molecules as certain isoflavoncs, chlorotrianisene, the 
oestrogenolic acids and the oestrogenic stilbenes. Relatively little success 
has been achieved in securing alternative supporting moieties to replace 
the steroid nucleus in the androgenic and corticosteroid fields, although 
several attempts have been made (e.g. Clarke and Martini, 1959).
The hypothesis, first advanced by Raton and Zaimis (1949, 1951), that 
bisqüaternary ammonium neuromuscular blocking agents interact by a 
two point attachment with anionic sites, normally involved in the physio­
logical functioning of acetylcholine, has led to a number of attempts to 
define closely the actual interonium distance at the time of drug-receptor 
complex-formation. Unfortunately most compounds tested are confor- 
mationally non-rigid and so incapable of affording the desired information, 
as there is no reason to suppose that the thermodynamically most stable 
conformation of the isolated molecule is that actually adopted at the 
receptor. Whether various rigid bisqüaternary ammonium salts in 
which the steroid nucleus functions as the supporting moiety will provide 
further information remains to be discovered. Although the receptor 
itself could conceivably be non-rigid, demonstration of activity in one 
rigid bisqüaternary salt and absence of activity in another with a different 
interonium distance would represent a great advance.
Such steroidal bisqüaternary ammonium salts will also be of interest in 
terms of Gill’s hypothesis (1959) that completely rigid molecules should 
prove to be inactive due to variability in the receptors. This generalisa­
tion, which Tests on the absence of ganghon-blocking activity in a limited
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number of compounds, such as the completely rigid ##Æ W -tetram ethyl- 
/7-phenylenediamine dimethiodide (Wien and Mason, 1953) and certain 
virtually rigid furan derivatives still retaining a limited degree of rotational 
flexibility (Gill and Ing, 1958), certainly requires further substantiation. 
That there is a strong possibihty that the molecules chosen do not 
possess a suitable interonium distance is indicated by the fact that other 
rigid molecules do indeed exhibit pronounced pharmacological activity. 
Examples are afforded by the natural oestrogens, testosterone, and the 
virtually rigid cis l-hydroxy-2-trimethylammoniumcyclopentane, which 
shows marked depolarizing properties on the kitten phrenic nerve 
diaphragm (Standaert and Freiss, 1960).
Moreover, the two-point attachment theory is by no means universally 
accepted. Loewe and Harvey (1952) have postulated a one-point attach­
ment theory in which the bulk of the molecule shields the receptor—the 
so-called “adumbration theory”—and their ideas have been extended by 
Fakstorp and others (1957). Again, conductimetric experiments have 
shown the extreme stability of the ion pair involving a single anion and 
a bisqüaternary ammonium cation (Brody and Fuoss, 1956) which raises 
the possibility that the receptor-complex could be of type A, rather than 
type B (Cavallito and Gray, 1960).
> N  r \ N <
BA
In view of all these facts, steroidal bisqüaternary ammonium salts may 
well prove, to be of great importance in distinguishing between the various 
possibihties.
It is to be noted that malouetine (11) is not fully rigid, due to rotation 
about the C(17)—C(20) bond and to the possibility of chair to boat 
conformational isomerism in ring A, and these effects perrnit some varia­
tion in the interonium distance.
The discovery that marked antituberculous properties were present in 
various 4,4'-diaminodiphenylsulphone derivatives, thiosemicarbazones 
and hydrazones, resulted in the synthesis of many related compounds, 
including several steroidal derivatives in which the steroidal portion can 
be regarded as a supporting moiety. Some of these compounds proved 
to have a high activity, especially the bile acid amide derivatives of 
diaminodiphenylsulphone (Berczeller, 1949; 1958). One compound in 
this series, 4-(3-hemisuccinyldesoxycholylamino)-4'-hemisuccinylamino- 
diphenyl-sulphone (XXI) also proved to be an active inhibitor of the 
multiplication of the PR8 strain of influenza virus A in the chick embryo 
(Berczeller, 1958-59).
The hydrazones and isonicotinylhydrazones of testosterone, oestrone 
and dehydroandrosterone all proved active against the tubercle bacillus 
in vitro (Cavallini and others, 1952; Mantegazza and Tommasini, 1952)
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as did the thiosemicarbazones of testosterone, progesterone and dehydro­
androsterone (Mantegazza and Tommasini, 1951). These derivatives 
are virtually devoid of the physiological properties of the parent steroids 
(Cavallini and Massarani, 1951a; Ercoli, Koller and de Ruggièri, 1951). 
Dehydroisoandrosteryl-thiolpyrazinoate which was prepared as an ana­
logue of the antituberculous ethylthiolpyrazinoate proved inactive 
(Kushner and others, 1955) as did the benzoylhydrazone of cholestenone 
(Offe, Siefken and Domagk, 1952). Cholesteryl p-nitrobenzoate, unlike 
certain other esters of /?-nitrobenzoic acid was inactive against pneumo­
cocci (Mayer and Oechslin, 1939).
The promise shown by the nitrogen mustards as potential anti-cancer 
agents inspired the utilisation of the steroid nucleus as a supporting moiety 
in this field as well, and several mono- and bis-(2-chloroethyl)amino- 
steroids have been synthesised (Burstein and Ringold, 1961 ; Gensler and 
Sherman, 1958; Havranek and Doorenbos, 1960). Only three of these 
compounds appear to have been tested for anti-tumour activity, however, 
and these proved inactive (Havranek and Doorenbos, 1960). Added in 
proof: A more recent investigation has shown that antitumour activity is 
present in certain steroidal nitrogen mustards (Rao and Price, 1962).
The potent positive inotropic cardiac activity present in both the 
steroidal cardiac glycosides and the erythrophleum alkaloids led two 
groups o f workers to prepare steroidal analogues of the latter, in which 
bile acids were used to replace the diterpenoid acids as supporting moieties 
(Ruzicka, Plattner and Engel, 1944; Uhle, Mitman and Krayer, 1956), 
but the new compounds were virtually inactive. It will be interesting to 
see whether steroidal esters of pyrrole -a-carboxylic acid will be prepared 
as analogues of the diterpenoid alkaloid ryanôdine (Valenta and others,
1962) which exhibits such a remarkable pharmacological action on 
muscle (Hillyard and Procita, 1959 and refs, cited).
Several groups of naturally-occurring nitrogenous steroids can probably 
be quoted as exemplifying the supporting moiety theory, although in some 
cases it is difficult to distinguish a supporting moiety function from a 
latentiation function. A good illustration of this situation is afforded by 
the taurine and glycine conjugates of the bile acids whose anions are the 
true bile salt anions. Another example is afforded by the readily hy­
drolysed veratrum ester alkaloids, such as protoveratrine, which is some 
6,000 times as toxic on a molar basis as is its alkamine, protoverine 
(Krayer, Moe and Mendez, 1944).
343
'M . ALAU DD IN A N D  M. MARTIN-SMITH
It is also possible to consider the suberylarginine radical of the toad 
poisons as a supporting moiety, but the position with the cardiotonic 
steroids is particularly complex. It is generally held that the strong positive 
inotropic action is intimately linked with the unsaturated lactone function 
(Chen and Elderfield, 1940; Goodman and Gillman, 1955) but to regard 
this group as the active moiety is a gross oversimplification, as varying 
degrees of positive inotropic action are shown by the dihydrocardenolides 
(e.g. Jacobs and Hoffmann, 1927; Vick, Kahn and Acheson, 1957), the 
bile acids (e.g. Wakim, Essex and Mann, 1939), certain steroidal alkaloids 
(Benforado, 1957; Krayer, Moe and Mendez, 1944; Quévauviller and 
Blanpin, 1958), cortisone (Fleischhacker, 1956) and various other steroids 
(e.g. Abrams and Harris, 1951 ; Hajdu and Szent-Gyorgyi, 1952; Tanz 
and Kerby, 1961) none of which possess an unsaturated lactone. Indeed 
it is tempting to regard the lactone as a supporting moiety intensifying an 
activity associated with a hydroxylated steroid nucleus (Craig and Jacobs,
1943). A supporting moiety role can probably be assigned to the sugar 
residues of the cardiac glycosides since they have a marked influence on 
distribution and solubihty properties and so affect the time of onset and 
duration of action (Chen,, Henderson and Anderson, 1951; Keyl and 
Dragstedt, 1954). Although some scilladienolide genins show some 
potency in bioassays, the duration of action is transitory and so it is 
concluded that the sugar moieties play an indispensable role in deter­
mining the activity of the glycosides (Stoll, 1956). The effect of varying 
the number and nature of the sugar residues on the activity displayed 
has been summarised in several places (Chen, 1945; Fieser and Fieser, 
1959; Oettel, 1947; Tamm, 1957).
The pharmacological actions of the suberylarginine conjugates of the 
bufadienolides were studied by Gessner (1926) and his work was followed 
by an elegant series of papers by K. K. Chen and his colleagues (e.g. 
Chen and Chen, 1934). The results of these and other studies (Arora, 
1953 ; Chen, Anderson and Rose, 1952) would indicate that the compounds 
possess broadly similar pharmacological properties to the cardiac glyco­
sides, but that the suberylarginine moiety does affect the rate of penetra­
tion into and removal from the myocardial tissue, thus producing differ­
ences of a quantitative nature.
Other Theoretical Interests o f  Nitrogenous Steroids
Several isolated examples are known in which nitrogenous steroids have 
played minor roles in studies designed to throw more light on the intimate 
nature of biological processes. One such instance involves the application 
of complex steroid derivatives in the study of artificial antigens (Grob 
and Goldberg, 1949).
The interesting hypothesis has put forward that certain steroids may 
interact with enzymes and other proteins by formation of spirothiazo- 
lidines since 3-oxo-steroids lacking a 4,5-double bond were shown to form 
such compounds under a variety of conditions with cysteine (Lieberman, 
1946), but this suggestion is in need of further substantiation.
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R E V I E W  A R T I C L E
BIOLOGICAL ACTIVITY IN  STEROIDS POSSESSING 
NITROGEN ATOMS
P a r t  II. S t e r o i d a l  A lk a lg id s J  
By M . A la u d d in * , B.Pharm. a n d  M . M a r tin -S m ith I , M .S c ., Ph.D.
Division o f  Experimental Pharmacology, Institute o f  Physiology, The University,Glasgow, W.2
C h e m ic a lly  the steroidal alkaloids form a complex group, the individual 
members displaying much diversity in molecular structure (Fieser and 
Fieser, 1959; Goutarel, 1961; Jeger and Prelog, 1960; Morgan and 
Barltrop, 1958; Schopf, 1961). Some occur unconjugated as the free 
alkamines in nature, but others occur as glycosides or esters. It has 
been customary to base classification of the group on botanical origin, 
but with the number of representatives now known, it is more convenient 
to consider them according to the nature of the skeleton of the alkamine. 
Such a classification in point of fact does not diverge too greatly from 
the botanical classification, but it should serve to give greater emphasis 
to possible structure-action relationships. Chemically, four main groups 
can be recognised.
3-Aza-A-homoandrostane derivatives.
Bases formally derived from the pregnane skeleton.
Bases formally derived from the unrearranged cholestane skeleton.
Bases possessing the “jervi” skeleton.
The first group is small and the only known representatives are the 
four salamander alkaloids samandarine (I), samandarone, samandaridine 
and cycloneosamandione (II) (Schopf, 1961; Habermehl, 1962). Their 
pharmacological properties have been studied in detail by Gessner and his 
co-workers (1948 and earlier papers) who showed that these compounds 
exhibit analeptic activity, producing convulsions in mice and antagonising 
the narcotic effects of barbiturates, ethylurethane and tribromoethanol in 
salamander larvae and small fish.
OH
HN
OHIII
Their action on smooth muscle appears to be variable. Thus they 
produce vasoconstriction of the Lowen-Trendelenburg preparation of 
* Colombo Plan Fellow, 1958-62.tPresent address: Department of Pharmacy, Royal College o f Science and Technology, Glasgow, C .l.
JPart I appeared on pp. 325-349 of June, 1962 issue.
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isolated frog vessels, relax the carotid artery of calves, relax the guinea-pig 
uterus and antagonise the action of adrenaline on certain preparations. 
Intracutaneous injection in man produces pain and hyperaemia.
Bases Formally Derived from Pregnane 
The alkaloids of this group occur in various plants belonging to the 
family Apocynaceae and are characterised by the possession of amino 
functions at C(3) or C(20), or at both positions. Usually the members
TABLE I
M o n o a c i d  b a s e s  d e r i v e d  f r o m  p r e g n a n e
3 - A m i n o p r e g n a n e s
Alkaloid Structure m .p .“G. {«]D in GHGls Source Refs.
Funtumine 3a-Am ino-20-oxo-5a- 126 +  95 Funtumia latifolia 1GatHasNO pregnaneFuntumidine 3 a-Amino-20a-hydroxy- 182 +  1 0 F. latifolia 1G2 1H 3 7 NO 5 «-pregnaneH olam ine 3 a-Am ino-20-oxo -pregn- 135 +  23 Holarrhena floribunda 2C 2 1H 3 3NO 5-eneHolaphyllaraine 3 3-Amino-20-oxo-pregn- 260 as +  33 as HGl H . floribunda 2 ,3CaiHasNO 5-ene HGl salt saltH olaphylline 3 3-M ethylam ino-20-oxo- 128 +  23 H . floribunda 3CzaHasNO pregn-5-eneParavallarine 3 3-M ethylamino-20a- 181 ■ - 5 2 Paravallaris micro- 4CzaHaaNOg hydroxypregn-5-en-18- carboxylic acid lactone phylia
2 0 - A m i n o p r e g n a n e s
Alkaloid Structure m.p. ® G. [«]d in G H G l s Source Refs.
Funtuphyllamine A 20a-Am ino-3 3-hydroxy- 173 +  13 Funtumia africana 5
G a i H a ^ N O 5a-pregnaneFuntuphyllamine B 20a-M ethylamino-3 3- 214 +  24 F. africana and 5 .6
G a g H a g N O hydroxy-5a-pregnane MalouetiabequaertianaFuntuphyllamine G 20a-Dimethylamino-3 3- 172 +  24 F. africana 5
G a a H ^ i N O hydroxy-5a-pregnane F. africanaFuntumafrine B 20a-M ethylam ino-3-oxo- 160 +  43 ■ 5
C g a H a î N O 5 «-pregnaneFuntumafrine G 20«-Dim ethylamino- 174 +  45 F. africana and 5
G a a H a a N O 3-OXO-5 «-pregnane M . bequaertianaGluco-alkaloid 20«-Am ino-3 3-hydroxy- — — Conopharyngia 7
G 37H 45N O 6 pregn-5-ene-3- pachysiphonD-glucoside Holarrhena febrifugaHolafebrine 20«-Am ino-3 3-hy droxy- 177 - 6 1 8 a
C a i H a a N O pregn-5-ene &r)d Kibataliaarborea
A l k a l o i d s  n o t  f u l l y  c h a r a c t e r i s e d
Alkaloid Structure m.p. ° G . [ « ] d  in G H G l s Source Refs.
H oladysam ine — 173 - 7 8 Holarrhena 8
G a s H a 7 N O antidysentericaHoladysine — 1 2 0 - 1 9 9 H . antidysenterica 8
C a 3 H a 7 N OIrehine — 163 - 3 0 Funtumia elastica 8
C a s H a g N OLatifoline — 135 - 4 F. latifolia 8 *
G a a H a 7 N O
1. Janot, Qui Khuong H uu and Goutarel (1959), 2. Janot, Gavé and Goutarel (1960). 3. Janot, Gavé and Goutarel (1959). 4. Le M en (I960). 5. Janot, Qui K huong Huu and Goutarel 1960).
6 . Janot, Lainé and Goutarel (1960). 7. D ickel, Lucas and M acPhlllamy (1959). 8 . Goutarel (1961). 
8 a. Janot and others (1962b)
*Latifoline is now  known to  be the 33-hydroxy compound corresponding to conamine (Table II) 
(Janot, Qui Khuong H uu and Goutarel, 1962).
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of this group occur in nature as the free alkamine but at least one repre­
sentative is found in glycosidic combination (Dickel, Lucas and Mac- 
Phillamy, 1959) and at least two others are found in the form of pyro- 
terebate ester conjugates (Rostock and Seebeck, 1958).
The chemistry of the monoacid bases has recently been reviewed 
(Goutarel, 1961) and the known alkaloids belonging to this group are 
listed in Table I. Examples of the monoacid bases with the nitrogen atom 
in the 3-position are funtumine (III) (Janot, Qui Khuong Huu and 
Goutarel, 1959), and paravallarine (IV) (Le Men, 1960) which possesses 
a saturated lactone ring, and thus bears some structural resemblance 
to the dihydrocardenolides. A typical example of the monoacid bases 
possessing the nitrogen atom in the 20-position is afforded by funtu­
phyllamine A (V) (Janot, Qui Khuong Huu and Goutarel, 1960).
>=o
MeHN
III IV
The alkaloids containing two nitrogen atoms in the molecule can be 
subdivided into three main groups. Where the nitrogen atom on C(20) 
is not incorporated in a ring the alkaloids belong to the holarrhimine 
class, which ^  is exemplified by holarrhimine itself (VI) (Cemy, 
Labler and Sorm, 1957). Where the nitrogen atom on C(20) forms 
a bridge to C(18) the conarrhimine and conkurchine groups result. 
In the conarrhimine group the nitrogen ring is fully saturated whilst in 
the conkurchine group the nitrogen ring possesses a double bond in the 
17-20-position (Tschesche and Roy, 1956). The most extensively investi­
gated alkaloids of the conarrhimine and conkurchine groups are conessine 
and conessidine respectively. The known diacid alkaloids of the pregnane 
group are listed in Table II.
HOZNH: NHCH:
H HjN
V VI
Two main pharmacological actions appear to be characteristic of the 
pregnane group of alkaloids. These are hypotensive activity and local
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anaesthetic activity and both properties do not appear to be dependent 
upon either the number or the position of the nitrogen atoms. Thus 
hypotensive activity has been reported in kurchicine (Chopra, Gupta and 
Chopra, 1933) (later shown to be impure holarrhimine (Bertho, 1939)) 
and conessine (Bakhsh, 1936; Burn, 1915; Paris, 1938) as well as in 
funtumine, funtumidine and related alkaloids (Quévauviller and Blanpin, 
1960, and earlier refs.) and in 20a-amino-3jS-hydroxy-5-pregnene-jSD- 
glucoside (Dickel and others, 1959). The activity of this last compound 
inspired the synthesis of several related glycosides (Lucas and others, 1960) 
and some of these synthetic compounds also exhibited hypotensive activity 
when administered intravenously to dogs, although like the parent 
alkaloid, they were inactive by the oral route. For similar reasons 
the 20-glucoside of funtumidine (glùcofuntumidine) was prepared syn­
thetically for pharmacological studies (Quévauviller and Blanpin, 1960).
More detailed studies have indicated that the hypotensive properties 
stem from direct actions on the heart and blood vessels. Conessine and 
holarrhimine, in the anaesthetised cat (Bakhsh, 1936; Bum, 1915) show 
a preliminary rise in blood pressure before a prolonged depression and 
this has been attributed to an initial stimulation of the smooth muscle 
of the blood vessels, followed by slowing and incoordination of the heart. 
Section of the vagi has no influence on the drop in blood pressure (Bakhsh, 
1936; Chopra and others, 1933) although the magnitude of the fall is 
smaller in decerebrate cats (Chopra and others, 1933), indicating that the 
medullary centres are playing some rôle.
Conessine and holarrhimine have been shown to produce a dilatation 
of the splanchnic vessels but to contract the renal vessels (Bakhsh, 1936; 
Chopra and others, 1933) whilst funtumine and funtumidine have been 
shown to dilate both peripheral and coronary vessels (Quévauviller and 
Blanpin, 1958), and to exhibit a positive inotropic and negative chrono­
tropic action on the isolated rabbit heart. Conessine and holarrhimine 
have been reported to stimulate intestinal and uterine contractions 
(Bakhsh, 1936; Chopra and others, 1933) but later work (Stephenson^ 
1948) has shown that conessine has a quinidine-like action and antagonises 
the action of acetylcholine on skeletal, cardiac and smooth muscle. In 
this connection it is interesting that funtumidine has been reported to 
slightly inhibit peristalsis of the dog intestine in situ (Quévauviller and 
Blanpin, 1958).
The local anaesthetic activity exhibited by the pregnane group of 
alkaloids (Bum, 1915; Chopra and others, 1933; Quév auviller and Blan­
pin, 1958) is in most compounds more pronounced than that of cocaine 
(Quévauviller and Blanpin, 1960; Stephenson, 1948; Stephenson and 
Dutta, 1948; Trevan and Boock, 1927) but as the compounds produce 
necrosis on injection (Stephenson, 1948; Stephenson and Dutta, 1948) 
they are without clinical value.
Other actions which have been shown to be present in the group include 
antipyretic activity (Quévauviller and Blanpin, 1960; Paris, 1938) and 
ability to potentiate barbiturate hypnosis (Quévauviller and Blanpin, 1960). 
Holarrhimine and conessine exert a direct narcotic effect on frogs, but
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this action is absent in mammals (Bakhsh, 1936; Burn, 1915). Although 
funtumidine has been classed as a tranquilliser on the basis of its ability 
to depress motility in rats (La Barre and Desmarez, 1959) it is possible 
that the effect could be produced by a direct paralysis of the peripheral 
motor nerves rather than by a reserpine-like action. Conessine has 
been shown to inhibit certain enzymes (Chopra and others, 1927; 
Kaushiva and Ghatak, 1956) and holamine on intraperitoneal administra­
tion gives rise to Parkinsonian-like tremors (Quévauviller and Blanpin, 
1960).
The structural similarity of the funtumia alkaloids to the steroid 
hormones inspired an investigation of these agents for hormonal activity 
(Blanpin and Quévauviller, 1960). The results showed that all the alka­
loids studied were devoid of positive hormonal properties, but there were 
some indications that the bases exhibited a degree of antagonism towards 
a limited number of specific effects of the natural hormones.
Conessine has been termed a general protoplasmic poison since it 
exhibits marked toxicity towards various micro-organisms, especially 
protozoans (Bertho, 1944b; Chopra and others, 1927; Goyal, 1935; 
Henry and Brown, 1923; Paris, 1938). It appears to have little or no 
activity against the malaria parasite (Stephenson, 1948) or helminths 
(Janot and Cavier, 1949; Mackie and others, 1955) although it has been 
reported to show weak antituberculous properties (Lambin and Bernard, 
1953; Meissner and Hesse, 1930). Its toxicity towards Entamoeba 
dysenteriae has led to a limited clinical use (see for example Acton and 
Chopra, 1933; Lavier, Crosnier and Merle, 1948; Tanguy, Robin and 
Raoult, 1948) particularly on the Indian subcontinent and there have 
been several studies (see for example Durieux, Trenous and Tanguy, 
1948; Kaushiva, 1957 ; Muhlpfordt and Martinez-Silva, 1956; Piette, 
1950) in which its efficacy has been compared to that of emetine. The 
results indicate that it is inferior to emetine as an amoebicide, but not 
such a potent emetic. Studies have also been made on the distribution 
and fixing of conessine in the monkey (Auffret and Tanguy, 1950) and 
on its rate of elimination in man, which is very slow (Pluchon and Pille, 
1950). Several reviews concerning the clinical potentialities of conessine 
in the treatment of amoebiasis have been published (Duviau, 1953; 
Kemy, 1948; Leake, 1932) and the authors all agree that conessine is 
not a suitable drug.
Alkaloids Formally Derived from Cholestane
Members of this group have been isolated as the free alkamines or 
as glycosides of mono-, di-, tri- and tetrasaccharides but it is possible 
that at least some of the alkamines and lower glycosides are produced 
by the hydrolysis of higher glycosides during the isolation procedure. 
The group embraces steroidal alkaloids occurring in various Solanum spp, 
and at least three alkaloids occurring in Veratrum spp,, namely rubijervine 
(12j8-hydroxysolanidine), isorubijervine (18-hydroxysolanidine) and iso- 
rubijervosine, which is the 3-glucoside of isorubijervine. These alkaloids
are all characterised by a hexacyclic skeleton incorporating a piperidine
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ring and they may be divided into two subclasses according to the im­
mediate environment of the piperidino nitrogen atom. These subclasses 
are the solanidane and spirosolane groups and are exemplified by 
the alkamines solanidine (VII) and tomatidine (VIII) respectively. 
The known alkaloids belonging to the solanidane group are listed in 
Table III and those belonging to the spirosolane group are shown in 
Table IV.
HO HO
VII VIII
Me
The literature contains a number of references to the poisonous nature 
of various Solanum spp. and this can be attributed to the presence of 
cholestane-type alkaloids (see for example Griebel, 1923; Lowe, 1929; 
Rühl, 1951 ; Schowalter and Hartmann, 1924; Sirotina and Spirina, 1948). 
Potato sprouts and potatoes which have turned green through exposure 
above the ground develop a detectable amount of solaninc and its aglycone 
solanidine and human consumption of such potatoes or potato shoots 
has led to a number of outbreaks of potato poisoning, several of which 
have been discussed by Willimott (1933). The most extensively investi­
gated alkaloid of the cholestane group from a biological point of view 
is a-solanine (solanine), but it is to be noted that commercial samples 
of solanine have been shown to consist of 6 components (Kuhn, Low and 
Trischmann, 1955b).
The cholestane group of alkaloids show certain similarities in their 
pharmacological properties to the pregnane group. Thus solanocapsine 
has been shown to slow the heart and induce incoordination by a direct 
action on cardiac muscle (Watt, Heimann and Epstein, 1932) and solanine, 
like conessine, has been shown to possess local anaesthetic properties 
(Weill, 1913). Rubijervine and several of its synthetic esters possess 
hypotensive properties (Poethke and Kuntze, 1958). Both solanine and 
solasonine induce haemolysis (de Lavergne and Kissel, 1935; Fischer, 
1929; Macht, 1933) whilst solanine diminishes blood catalase (Levi, 1936), 
and inhibits non-specific cholinesterase (Pokrovskii, 1956). Solanine is 
also active as a mitotic poison (Danneberg and Schmahl, 1953) and has 
been shown to inhibit the oxygen uptake of mouse ascites tumour cells 
(Schmitz, 1951).
The discovery that extracts of tomato leaves exhibited antifungal 
and antibacterial activity led to the isolation of tomatine (Fontaine and
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Others, 1948) and similarly the observation that the leaves of Solanum 
demissum were resistant to the attacks of the larvae of the potato beetle 
Leptinotarsa decemlineata had as a result the isolation of demissine (Kuhn 
and Gauhe, 1947). Later work showed that other cholestane-type 
glycosidic alkaloids possessed the ability to prevent the ravages of the 
potato beetle and as tested on the leaves of solanum tuberosum, the order 
of potency was leptine I, then tomatine, then demissine, then a-solanine, 
and finally a-chaconine (Kuhn and Low, 1961a). Independent work 
showed demissine to be more active than solacauline, which was more 
active than solanine (Shreiber, 1954). The insecticidal activity of various 
preparations of solanum steroidal alkaloids has, however, been shown 
to be but slight (Bergmann, Levinson and Mechoulam, 1958; PoUacci 
and Gallotti, 1940; Sievers and others, 1949).
Several studies have been devoted to the investigation of the anti­
microbial properties of the group. Tomatine and several other alkaloids 
are antifungal (Chanussot, 1957; McKee, 1959; Sackman, Kern and 
Wiesman, 1959) and solanocapsine is claimed to possess in vitro activity 
against Mycobacterium tuberculosis (Boll and others, 1955-56). A number 
of synthetic solanine-type glycosides have been prepared, but they do 
not appear to have been investigated biologically (Schreiber, 1955).
Alkaloids possessing the “/erv/” Skeleton
The completely characterised alkaloids possessing the modified or 
“jervi” steroid skeleton in which ring C is 5-membered and ring D is 
6-membered, are conveniently divided into two subclasses with the fritil- 
laria alkaloids whose chemical constitution is as yet incompletely estab­
lished, forming a third subclass. The first group consists of alkaloids 
whose alkamines possess a secondary nitrogen atom and contain only 
two or three atoms of oxygen. They occur in nature as the free alkamine 
or as D-glucosides and may be termed the “jerveratrum” alkaloids, as 
suggested by Fieser and Fieser (1959). Representative alkamines of 
this class are jervine (IX) and veratramine (X). The second subclass, 
which may be termed the “ceveratrum” group, consists of alkaloids 
whose alkamines are polyhydroxy tertiary bases possessing seven to nine 
atoms of oxygen and incorporating a quinolizidine ring system.
H'
IX
The alkamine germine (XI) and the closely related alkamines, proto- 
verine, veracevine and zygadenine possess a masked a-ketal system and
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undergo rearrangement with base. In veracevine, the rearrangement is 
particularly facile to yield first cevagenine and then ce vine and for a time 
it was beheved that cevine was the actual alkamine of the veracevine 
ester alkaloids. The ceveratrum alkaloids occur in various Veratrum, 
Zygadenus and Schoenocaulon species and are the agents responsible for 
the poisonous nature of these plants (Bealth and others, 1933 ; Reinhardt, 
1909).
OH
OH
OH
‘OHHO
OH
XI
The ceveratrum group have been isolated as the free alkamines or as 
mono-, di-, tri- or tetra- esters of various organic acids. Partial dé­
acylation of the ester alkaloids occurs readily, however, and it is possible 
that some of the lower esters which have been isolated are in fact artefacts. 
It is the ceveratrum ester alkaloids, more particularly the tri- and tetra- 
esters which are the agents responsible for the hypotensive properties 
present in crude extracts of veratrum alkaloids. The known alkaloids 
of the ceveratrum group, together with the known jerveratrum alkaloids, 
are shown in Table V.
The jerveratrum alkaloids (both the alkamines and the glucosides) are 
characterised by an ability to antagonise the cardioaccelerator action of 
sympathetic nerve stimulation or of sympathomimetic amines (Krayer, 
1952). This effect is thought to arise from a highly selective action upon 
the pacemaker of the heart and is not shown by adrenergic blocking agents. 
Accordingly the term “anti-accelerator agent” has been coined to describe
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compounds exhibiting this particular pharmacological action (Krayer,
1950). Since antiaccelerator activity is absent in the tertiary veratrum 
alkaloids, it was concluded that such activity was associated with a 
secondary nitrogen atom incorporated in a piperidine ring (Krayer, 
Uhle and Ourisson, 1951) and attention was devoted to the prepara­
tion of synthetic steroids possessing a piperidine ring in the side chain 
(Krayer and Briggs, 1950; Uhle, 1951), among which were included 
several compounds prepared by cleavage of the ether link in deriva­
tives of spirosolane. These compounds indeed proved active, but 
later work showed antiaccelerator activity to be present both in 
tertiary amino-steroids (Gould, Shapiro and Herschberg, 1954) and in 
secondary amino-steroids in which the nitrogen atom was not part of 
a piperidine ring (Gould and others, 1954; Margolin and others, 1954). 
These observations serve to emphasise the dangers of postulating 
structure-action relationships from a consideration of an inadequate 
number of compounds of insufficient chemical diversity. Quinidine was 
also shown to possess dual anti-accelerator and antifibrillatory activity 
and in this connection it is interesting that certain nitrogenous steroids 
(Gould and others, 1954; Robson and Trounce, 1955; Schallek and 
others, 1957) such as 17a-(2-piperidylmethyl)-3j8,17j8-dihydroxyandrostane 
(XII) and 16a-cyclohexylamino-3j8-hydroxy-20-oxopregn-5-ene show 
quinidine-like properties.
XII
Detailed investigations have shown that veratramine decreases the 
oxygen consumption of atrial tissue without any initial augmentation 
of uptake (Reiter, 1950). In high doses veratramine produces excitation 
of the central nervous system (Krayer, 1949) whilst it is claimed that 
jervine in high doses produces hypotension in dogs (Wood, 1906).
Preparations of the ceveratrum ester alkaloids of varying purity have 
been employed medicinally from the time of the ancient Greek herbalists 
until the present day, the modem interest lying in their hypotensive 
properties, but as their pharmacology is covered in standard texts and 
has been extensively reviewed elsewhere (Krayer and Acheson, 1946; 
Stoll, 1954), a relatively brief summary will suffice in the present article. 
No attempt will be made to cover the literature pertaining to each 
individual ceveratrum ester.
Much of the earlier work was done with a preparation known as 
veratrine, which was first obtained by Pelletier arid Caventou (1820),
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but as this proved to be a complex mixture (Auterhoff, 1955 ; Blount, 
1935), care must be taken in assessing this work owing to the great 
variation in potency exhibited by the alkamines and their esters (Krayer 
and Acheson, 1946; Krayer, Moe and Mendez, 1944). Other mixtures 
of alkaloids which have been employed in biological studies or medicinally, 
are cevadilline (also called sabadilline), cryptenamine (Kupchan and 
Gruenfield, 1959), proto veratrine, sabadine and sabatrine. As a broad 
generalisation it would appear that the alkamines are almost devoid of 
hypotensive activity, the naturally-occurring monoesters are feebly active, 
the diesters more active and the tri- and tetra-esters very active (Winter- 
steiner, 1953). In this connection it is to be noted that the highly active 
ester alkaloid germitetrine, although giving rise to four molecules of 
organic acids per molecule on hydrolysis, is really only a triester, as one 
of the esterifying acids is 2-hydroxy-2-methyl-3-acetoxybutyric acid 
(Kupchan and Ayres, 1959). Similar potency relationships have been 
found amongst synthetic esters of germine, where it was also discovered 
that several synthetic tetraesters were virtually inactive (Weisenborn 
and others, 1954).
More recent structure-action studies of a large number of synthetic 
esters of protoveriie (Kupchan, Hensler and Weaver, 1961) have shown 
that estérification at positions 3 and 15 is necessary for high activity 
and that estérification at position 16 is accompanied by a profound loss 
of activity. Positions 6 and 7 need, not be esterified for high activity. 
Estérification by a branched chain acid is advantageous at position 15, 
of no great import at position 3 and disadvantageous at position 7. 
Moreover, these relations were found to be broadly true for both the 
naturally-occurring and the previously prepared synthetic esters of germine 
(Weisenborn and others, 1954) whose structures were unknown at the 
time of the original experiments.
The pharmacological actions exhibited by the ceveratrum ester alkaloids 
are complex, making it difficult to analyse the exact contribution each 
makes to the total response, but there would now seem to be general 
agreement that in low doses they act by triggering reflex mechanisms.
The most pronounced pharmacological effect of the ceveratrum esters 
at therapeutic doses is the production of a rapid fall in arterial pressure, 
which is mediated by a reflex general vasodilatation, and a fall in heart 
rate. Thus they act in a unique fashion, differing from all other hypo­
tensive agents. They are without any direct action on the blood vessels. 
The drop in blood pressure is also accompanied by respiratory depression. 
These effects have been demonstrated in various species of animals as 
well as in man and the experiments have indicated the existence of 
species differences (Rothlin and Cerletti, 1954), rodents being much more 
resistant to the hypotensive effect than man, the dog, or the cat.
The experimental evidence indicates that the afferent sensory receptors, 
upon which the ceveratrum esters act to produce the reflex fall in blood 
pressure, lie in the lungs and the heart (Heymans and Neil, 1958), with 
their afferent fibres lying in the vagi. Elicitation of the Benzold-Jarisch 
reflex (Aviado and Schmidt, 1955; Jarisch and Richter, 1939; von
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Benzold and Hirt, 1867) as it is now known, however, is not the only 
reflex action produced by the ceveratrum esters, as vagotomised animals 
may still show a fall in blood pressure, indicating that other receptors 
are also involved (Heymans and Yleeschhouwer, 1950; Wang, Ngai 
and Grossman, 1955). The most important of these other receptors 
appear to be the baroreceptors situated in the region of the carotid 
bifurcation (see for example Aviado and others, 1955; Martini and 
Calliauw, 1955). Experiments with dogs would seem to indicate that 
stimulation of receptors within the nodose ganglion are responsible for 
the production of emesis (Borison and Fairbanks, 1952).
In higher concentrations the ceveratrum esters induce vasoconstriction 
and so exert a pressor effect. This action is mediated in part at least 
by the liberation of adrenahne from the adrenal medulla (Krayer, Moe 
and Mendez, 1944; Mendez and Montes, 1943).
At high doses the ceveratrum esters also produce changes in the electro- 
physiological state of nerve and muscle (see for example Shanes, 1958) 
which manifest themselves in the elicitation of a series of repetitive 
responses to a single stimulus—the so-called “veratrinic” response (see 
for example Acheson and Rosenbleuth, 1941; Gregor, 1904). It is 
thought that these electrophysiological changes result from alterations 
in the concentration of calcium ions on the cell membrane (Gordon and 
Welsh, 1948; Straub, 1954) with disruption of the normal ion transport 
mechanisms across the membrane (Shanes, 1952 and earlier papers; 
Straub, 1956) although muscle and nerve do not show the same changes 
in ionic migration when exposed to ceveratrum esters. Thus there is 
an increase of potassium ion efflux from nervous tissue (Shanes, 1952) 
and cardiac muscle (Lister and Lewis, 1959; Vick and Kahn, 1957) but 
no increase from skeletal muscle (Lister and Lewis, 1959). In view of 
the general assumption that ionic exchange occurs by similar mechanisms 
in all tissues (Davson and Danielli, 1952 ; Heilbrunn, 1956 ; Hodgkin, 1951) 
these facts are disturbing. It has also been shown that the ceveratrum 
esters do not promote potassium ion influx into potassium-poor cold- 
stored human erythrocytes (Kahn, Acheson and Cohen, 1955).
Whatever the detailed mechanism, it would appear safe to conclude 
that the ceveratrum esters interfere with the functioning of the cell 
membrane and it is probable that similar changes occur at the sensory 
afferent receptors (Jarisch and Zotterman, 1948) which would appear 
to have a far greater sensitivity than nerve or muscle cells.
Experimentally veratrine has been used to induce auricular arrhythmias 
in order to screen drugs for antifibrillatory activity (Scherf and Chick,
1951).
Other Actions o f  Ceveratrum Esters
Pronounced insecticidal activity is present in the ceveratrum group 
and dusts and extracts prepared from the seeds of Schoenocaulon spp, 
(sabadilla seed) have been tried as insecticides (see for example Anderson, 
1945; Frazier, 1945; Filmer and Smith, 1946; Ikawa and others, 1945; 
Walton, 1946), over eighty publications dealing with their efficacy against
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various insect species appearing in the years 1944-1956. These studies 
have also been extended to include ceveratrum alkaloid preparations 
from Veratrum spp. (see for example Fisher, 1940; Jaretzky and Janecke, 
1940; Krupp, Lendle and Stapenhorst, 1952; Seiferle, Johns and Richard­
son, 1942). A particularly active preparation is produced by treating 
sabadilla seed with lime (Allen and Brunn, 1945; Walton, 1945). As 
is true for hypotensive activity, the alkamines appear virtually inactive 
as insecticides (Allen and others, 1945). In attempts to elucidate the 
exact mechanism by which the ceveratrum esters act upon the insect, 
several studies have been concerned with their effect on various enzyme 
systems (Collias, McShan and Lilly, 1952; Hartley and Brown, 1955).
Other studies have been concerned with their ability to induce mutations 
in Drosophila funebris (Tinyakov, 1947) and their ability to produce 
C-mitotic effects (Burroni, 1955).
TABLE VI 
F r i t i l l a r i a  a l k a l o i d s
Alkaloid m .p. °C [a]o in CHCI3 Refs.
AlginineC2SH39N O 3 271-272
+ 1 0 8  (EtOH) 1 1 2
Amian thine 
C2 7H 4 1N O 2
251-253 - 8 7 113
BaseC 2 7H 4 5 N O 3 256 114BeilupeimineC 2 7 H 4SNO3 155-157 - 5 3  (EtOH) 114Chinpeimine
C 2 7H 4 SNO2
247-248 - 2 1 114
Fritiminine 258-260 — 114ImperolineC2 7 H 4 6N O 3 237-238 - 8 115Imperonine
C2 7H 4 3 N O 3
239 - 6 5 115
Peimidine
C 2 7H 4 5 N O 2
2 2 2 - 7 4  (EtOH) 116
Peimine{syn Peimunine Verticine apo Verticine) ^271145^03
223-224 - 2 6  (EtOH) 117-120
Peiminine(jsyn Peimiphine Peimitidine Verticilline Fritillarine)C 2 7H 4 3N O 3PeimissineC 2 7H 4 3N O 4Sipeimine{syn Imperialine)C 3 7H 4 3N O 3SonpeimineC 2 7H 4 3N O 4
212-213 - 7 8 116, 1 2 0 , 1 2 1
270 - 5 1  (EtOH) 116
267 - 3 6 122-124
256-258 114
112. Yunusov, K onovalova and Orekhov (1939). 113. Neuss (1953). 114. Chu and Loh (1956b).115. Paul and B oit (1958). 116. Chou (1947). 117. Chou and Chu (1941). 118. Chu and Loh (1956a,b, and earlier papers). 119. Ito and others (1961). 120. W u (1944). 121. Chi, K ao and Chang (1940).122. Bauer and others (1958). 123. Boit (1954). 124. Chu and Loh (1955).
The Fritillaria Alkaloids
The fritillaria group on present indications would appear to possess 
the same skeleton as the ceveratrum group, but to possess only two or 
three hydroxyl groups (Chu and Loh, 1956b and earlier papers). The 
group deserves more research, especially on the inter-relations of the
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alkaloids which are claimed to be individual entities. These alkaloids 
are listed in Table VI.
The pharmacology of the group is also in need of re-investigation with 
modern techniques. The Chinese drug pei-mu (Chou, 1954), from which 
many of the alkaloids have been isolated, was used quite irrationally 
for widely diverse conditions (Chi, Kao and Chang, 1936). Claims 
(Liu, Chang and Chang, 1936) that one of the alkaloids, peimine (also 
called peimunine) resembles atropine in its pharmacological properties 
seem surprising, as do claims of veratrine-like activity (Narumi, 1935), 
since these alkaloids do not possess the ester groups now known to 
be essential for this activity. On the other hand, reports (Chen, Chen 
and Chou, 1933; Narumi, 1936) that peimine and peiminine possess 
hypotensive properties and induce incoordination in the heart are more 
in line with the known activity of the pregnane group of alkaloids and 
may further illustrate the lack of dependence of these properties upon 
the position and configuration of the nitrogen atom in nitrogenous 
steroids. Additional evidence on this point would be provided by the 
reports (Zolotukhina, 1945) that alginine, the alkaloid from Fritillaria 
sewerzowii, possesses pronounced local anaesthetic activity, comparable 
to that of cocaine and exhibits vasodilatatory properties—if one assumes 
that the originally proposed molecular formula (Yunusov, Konovalova 
and Orekhov, 1939) is in error and that alginine does indeed have a 
cevane skeleton.
Amianthine, whose admission to the group is by no means certain, 
is obtained from the plant known as staggergrass or fly poison (Amian- 
thium muscaetoxicum) (Neuss, 1953). This alkaloid has been shown to 
depress respiration and lower blood pressure and to be definitely without 
a typical veratrinic action on muscle (Alsberg, 1914).
There are a number of other alkaloids which, in all probability, belong 
to the steroid group, but their purity, identity or chemical constitution, 
are still unknown. Three such alkaloids which would appear to be pure 
entities are geralbine (Stoll and Seebeck, 1952), which is a C22 compound 
and raddeanine (Aslanov and Sadykov, 1956) and veratrobasine (Stoll, 
Stauffacher and Seebeck, 1955), which are C24 compounds. Raddeanine 
has been shown to stimulate the central nervous system of cats, rabbits 
and dogs in small doses, but in larger doses to be a depressant (Zolotukhina,
1944).
C o nclusio ns
Despite the shortcomings of current theories of drug action and the 
lack of a simple correlation of chemical structure and biological activity, 
it is nevertheless clear from the foregoing account that much of the recent 
interest in the biological properties of nitrogenous steroids has a rational 
basis. Two examples may be quoted. The first is the application of 
the conclusions drawn from the receptor theory to the synthesis of the 
anabolic steroidal [3,2-c] pyrazoles and [2,3-d] isoxazoles, and the second 
is the synthesis of new drugs suggested by the supporting moiety theory. 
Both represent significant steps forward. Only within the last ten years
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has interest developed in the synthetic nitrogenous steroids and, in view 
of the encouraging progress in the field, it would seem that even greater 
attention will be devoted to these compounds in the future. This is 
especially true now that aza-steroid hormone analogues have been 
synthesised (Zderic, Carpio and Limon, 1962) and with the interesting 
demonstration that the anabolic steroid 17j8-hydroxy-17a-methylandros- 
tano-[3,2-c]-pyrazole loses its ability to promote nitrogen retention on 
introduction of a double bond into the 4-position whilst it is converted 
into an oestrogenic compound showing no anabolic or androgenic 
properties when the 4,-6-diene system is introduced (Beyler, Potts and 
Arnold, 1961). With the recent discoveries that anabolic properties are 
present in a number of steroidal Schiff’s bases (Irmscher, 1962) and that 
hypotensive properties are present in certain steroidal enamines (Clinton 
and others, 1962), it can be confidently predicted that nitrogenous steroids 
will play a further rôle in studies of drug action.
Moreover, the nitrogenous steroids as a group faithfully reflect the 
biological properties of the steroids in general, affording a broad spectrurii 
of biological action and emphasizing changes in pharmacological 
properties with species, and routes of administration. Certain individual 
members, notably the ceveratrum ester alkaloids, display a variety of 
pharmacological actions which in themselves have led the pharmacologist 
to disentangle basic mechanisms of action, thus contributing to a better 
understanding of biological phenomena. Nitrogenous steroids are not 
unique in this respect, but they do present a happy choice with which 
to illustrate the slow but certain development of the theoretical aspects 
of pharmacology.
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APEEKDIX I 
Addendum
IH H
(i)
After publication of 'Biological Activity in Steroids
Possessing Nitrogen Atoms* several important publications having
bearing on the subject came to our notice* Foremost amongst
these were the proceedings of a symposium on the chemistry and
biochemistry of the solanum alkaloids held in Berlin in 1959
and published in I96I, a copy of the publication being given to
us by Dr* E* Schreiber to whom we are greatly indebted for this
2courtesy* At this symposium it was reported that the alkaloid
solasodamine (Table IV in review) is in fact solasonine mono-
hydrate whilst the alkaloid solauricine is a mixture of solasonine
and solamargine* The alkamine 'solauricidine* was concluded to2be a complex formed solasodine and solasodine galactoside*
Other papers delivered at the symposium included a report
of the action of solanum alkaloids on the chemoreceptors of5Leptinotarsa decemlineata Say, a comprehensive review of the4distribution of the solanum alkaloids and a survey of the
medicinal applications of the extra-European Solanum species,
6mainly amongst primitive peoples.
Further publications which were overlooked in the review
6were those by Schreiber and Ripperger in which the constitution 
of the alkamine solanocapsine (Table IV in review) was shown to be 
3P-amino-22,26-imino-l6{3,25-oxido-5o£,22a,25P j25of-cholestan-23-ol 
(l), thus being a deviation from the usual spiro structure*
(ii)
In the field of synthetic nitrogenous steroids further
7 gthiazolo steroids and some [2,3d] triazolo steroids have been
synthesised as analogues of the anabolic steroidal [3,2c] pyrazoles*
9Several [I7,l6c] pyrazolino steroids have also been prepared
as have several steroids possessing a quinoline ring system fused 
10to ring D. These latter compounds were prepared as potential
antitumour agents in view of the earlier report^^ that another
steroido-quinoline possessed haemolytic properties# Syntheses
of a number of cyano steroid hormone derivatives have been 
12reported and lactam isosteres of the spiro-lactone aldosterone
13antagonists have been prepared# Application of the a-amino-
nitrile synthesis to the preparation of a number of 17-alkyl-17-
dimethylamino steroids gave a new oestrogenic compound, 17P-N,N-
14dime thy lamino-17a-methyl-3*niethoxyoestra-l ,3, 5-triene # Further
work with steroidal nitrogen mustards has resulted in the
synthesis of the 2-[bis(2-chloroethyl)-aminomethyl] derivative 
16of oestrone#
The great interest in new nitrogenous steroids as
potential therapeutic agents may be expected to be maintained for
some time# The successful development of photochemical methods
16for the synthesis of nitrogenous steroids can be expected to 
widen interest still further, as will the demonstration that
17steroids can be amidated by microorganisms#
(iii)
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APPENDIX II
Attempts to secure Acovenoside A 
from the trunk wood of 
Ac00anthera longiflora Stapf
HO
- O
HO
HQ CH
OH
HO OH
IL
(i)
Preparation of 1-oxygenated steroids suitable for
conversion into la-amino steroids is usually a somewhat tedious
procedure^ although microbiological methods of 1-hydroxylation 
2are available and recently a new chemical method for introducing
5an oxygen substituent at the 1-position has been developed. In
order, therefore, to secure a suitable starting material whibh
would permit the inclusion of certain la-amino steroids in the
study of steroidal bisquaternary ammonium salts, it was decided
to ascertain whether the trunk wood of Acocanthera longlflora
Stapf. would prove to be a suitable source of the 1-hydroxy
compound acovenoside A (XV, p.20 ). This cardiac glycoside
4is known to be present in the seeds and bark of Acocanthera 
longiflora, and it was felt that it might also be present in the 
trunk wood since extracts of the wood are used by natives of the 
drier and cooler regions of East Africa as potent arrow poisons. 
Large quantities of the trunk wood were kindly made available by
5Mr. J* J. Lewis. Application of the established conversion 
of acovenosigenin A (the aglycone of acovenoside A) into l?p- 
carbomethoxy-lp-hydroxy-)-oxo-5P-androstane (l) would then give 
a compound capable of conversion (e.g. by application of the 
Hunsdiecker reaction ) into an androstane derivative with oxygen 
functions at C-1 and C-l?.
X(il)
Another possible favourable aglycone for this type of
7approach would be ouabagenin (ll) although the number of hydroxyl
groups in this compound would give additional complications.
The trunk wood of Acocanthera longiflora Stapf. was finely
ground for the following work by British Byewoods Ltd., to whom
the author wishes to express his sincere appreciation.
During preliminary investigations it was found that water
was a suitable solvent for the large scale extraction of the
total bitter glycosidic material from the wood. Subsequent
extraction of the wood with ethanol or chloroform failed to achieve
the isolation of any further cardiac glycosides (as evidenced by
paper chromatography) and so it was concluded that all such
compounds were extractable by the water. Ultraviolet spectro-
photometric determinations indicated the presence of aromatic
components in the ethanol and chloroform extracts. The aqueous
extracts of the Acocanthera wood were very bitter in taste and
showed effects on the isolated rabbit heart muscle preparation
Xtypical of the digitalis-like glycosides. The U.V. spectra of the 
bitter principle in ethanol showed absorption « 2l4mp.
The author wishes to thank Mr. J. J. Lewis for arranging the 
biological testing of various materials during these investigations.
(ill)
gcharacteristic of the carenolide ap-unsaturated lactone system.
4Application of the reported procedure for partitioning the 
glycosidal components present in the seeds and bark of Acocanthera 
longiflora Stapf into * chloroform soluble* and * chloroform/ethanol* 
(2îl) soluble components failed to give acovenoside A which is 
readily isolated from the chloroform soluble fraction by direct 
crystallisation from methanol. It is conceivable that as the 
woody parts of plants in general contain comparatively low amounts 
of lipoid soluble substances, the wood under investigation would 
not yield as a high proportion of chloroform soluble glycosides 
as the seeds.
Extensive investigations led to an entirely satisfactory 
procedure for the fractionation of the glycosidal components of 
the wood of Acocanthera longiflora Stapf. by column chromatography. 
This is outlined below. The yields which are indicated in 
brackets are based on the total dry weight of the wood.
Extraction: The powdered wood of Acocanthera longiflora Stapf.
(8 kg.) was soaked in water (18 1.) for three days at room 
temperature under a layer of xylene to prevent growth of moulds.
The aqueous extract was removed by suction and the insoluble 
residue was successively extracted with water (1 0 1 .) three times 
to yield 40 1. of total aqueous extract. The residual wood at
(iv)
this stage was completely free from any hitter taste. The
combined aqueous extracts were concentrated to a semi-solid
(l 1 .) in a climbing film evaporator by repeated recyclisation»
The concentrated extract (1 1.) was diluted with methanol
(3 1*) and the insoluble cream coloured non-bitter residue was
removed by filtration. The methanolic filtrate was distilled
in vacuo to yield a hygroscopic solid (320 g. 4^). The paper
9partition chromatography described by Miyatake e^ al. for 
cardiac glycosides of Digitalis purpurea L., when applied to the 
crude extract of Acocanthera, showed the presence of four 
components. The paper chromatogram was developed using water- 
saturated methyl ethyl ketone as the moving phase and water- 
saturated chromatographic filter paper (Whatman) as the stationary 
phase. The chromatogram was developed for 8 hr. dried, sprayed 
with a solution of antimony trichloride (20^ in CHSlj), heated 
at 70*0 for 3 min. and the components spotted under an ultraviolet 
lamp.
Separation of The Crude Glycosidic Components by Column 
Chromatography: The methanolic extract (320 g.) was incorporated
in alumina (grade Y, 600 g.) with the aid of methanol and dried 
in vacuo at 40®C. The dried # alumina/extract * mixture was 
poured into a glass chromatographic column containing butanol.
(v)
Elution with butanol (2 1.) gave a cream coloured, slightly 
hygroscopic, strongly bitter crude glycoside (l60 g. 2^) showing 
the presence of four substances on paper chromatography. The Ep 
values corresponded exactly to those of the four components of 
the crude extract.
Chromatographic Purification of The Glycosides: The crude
glycosides obtained above (l60 g.) were chromatographed over 
alumina (grade V 1kg.) using butanol saturated with water as 
solvent. The first fraction (400 ml. of eluant) gave an amber 
coloured viscous material which was freely soluble in chloroform. 
The next fraction (200 ml. of eluant) gave a semi-solid which 
was partially soluble in chloroform (total chloroform soluble 
fraction, 24 g.0^3^). This fraction did not give any spots on 
paper cliromatography, all the material moving with the solvent 
front. The last eluted fractions (1.3 1.) gave a white, non- 
hygroscopic, strongly bitter chloroform insoluble glycosidic 
component (6 4 g. 0.8^) showing four components on paper chroma­
tography - identical with those from the crude glycosides. The 
chloroform soluble fraction did not yield any light petroleum 
soluble material.
Isolation of Cardenolide : The chloroform soluble material
(6 g.) was taken in methanol (20 ml.) and allowed to stand at
(vi)
room temperature for 24 hr. The white needles, which separated, 
were removed hy filtration (ca. 0*9 g#) m.p. 158-160*0. The mother 
liquor on standing at room temperature for 7 days gave 0.1 g. 
more of the same product, m.p# 158-l60*C. (combined yield 1.0 g. 
0.05^)^ Recrystallised from methanol, rods, m.p# 159-160*,
[a]^^ - 6 4*0 * (C = 0#92 in acetone) (Pound: 0,62.16, 62.29$
H,8.02, 8 .6 5$ Methoxyl, 4*70, 4*67* Calculated for Acovenoside A
(^ 30^ 46^ 9)* C,6 5*4 5$ 2 ,8 .5 6$ Methoxyl, 5*45/^) (^30^6Pi 1 
requires: 0 ,6 1#8 4 $ 2,7*96^). 217^  [calculated for
3^ 0^ 46 9i 1 1 8 ,6 0 0].
4 ’10The melting point of acovenoside A is reported as 
225-225*0 (from methanol) and double m.p. 160-163:230-232*0 
(from methanol/ether or from acetone/ether). 2o double m.p# was 
observed for the present product after repeated attempts employing 
various solvent systems for recrystallisation.
The mother liquor when left at room temperature in the 
open air, afforded several small crops of mixed crystalline 
materials over a period of 6 months which appeared to be mixtures 
(indistinct m.p#s).
Acetate of Cardenolide *A*: The glycoside of m.p. 159-160®
(32 mg.) was dissolved in pyridine (O.5 ml.) and treated with 
acetic anhydride (0 .3  ml#) at room temperature. After 40 hr. 
the mixture was diluted with water to yield white needles, m.p#
(y ü )
227-229“C.
Chloroform Insoluble Material: All attempts to obtain crystalline
products from this material proved unsuccessful. A solution of 
the material (500 mg.) in pyridine (5 ml.)was treated with 
acetic anhydride (3 ml.) and allowed to stand at room temperature 
for 48 hr* The reaction mixture on dilution with water gave 
a cream coloured precipitate which was removed by filtration and 
recrystallised from ethanol, needles (4 2 0 mg.) m.p. 289-299*0
4decomp, (reported for acolongifloroside-k-acetate 288-294*0 
decomp#).
Table I shows the proportion of total glycosides and
glycosidic fractions, on a solubility basis, of the trunk wood
compared with those of the root bark, the wood bark and the seeds
4
as described by Reichstein e^ al. The non-glycosidal, light 
petroleum soluble fraction is also included. Table II lists 
the cardiac glycosides isolated from Acocanthera species together 
with their m.p.s and [a]gS.
TAB IE I.
Fractions Trunk Wood Wood Bark Root Bark Seeds
Chloroform soluble 0*3% 1.22^ l.l6ji 2.5%
Chloroform insoluble 0.8^ 0.446^ 0.52^ 2.1^
Total glycosides . 1.1^ 1.67^ 1.66^ 4*6^
Acovenoside A - 0*44^ 0.22^ 1.2^Acolongifloroside k (0.8^) 0.01^ not report- 0.6^
,  eaLight petroleum - 0.47% 0.32% not reportedsoluble
TABLE II
Cardiac Glycosides of Aeooanthera Species
(viii)
Glycoside M.p.*C [«]d Refs.
1 . Acovenoside A 22 2 -2 2 5 — 64*8(Dioxane)
10
2 . Acovenoside B 251-253 -7 1 .4(Dioxane) 10
5. Acovenoside C I88-I9O (Methanol)
11
4. Ac 0longifloras ide E 2 5 7 -2 6 0 —36(Methanol) 4
5. Acolongifloroside G 264-268 y "24(Methanol) 4
6. Ac 0longifloros ide E 25 0 -2 3 5 -6 7(Methanol) 4
7. Acolongifloroside J (158-1 6 0)(260-280) -6 9 .7(Methanol) 4
8. Acolongifloroside K -54*1(Methanol) 4
9. Acofrioside L 24 8-253 -54*1(Methanol)
12
10. Acofrioside M 185-224 -5 4 .5(Methanol) 12
11 Ouabain 183-187 -44*3(Methanol)
12
The paper chromatographic method of separation described
9by Miyatake ^  al. for Digitalis glycosides was not satisfactory 
when applied to the chloroform soluble glycosides of Acocanthera 
longiflora, but it could be useful for the chloroform insoluble 
glycosides, although in the present work, the components shown 
to be present by the paper chromatography did not appear to be 
separable on column chromatography.
(ix)
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This thesis is divided into four sections vdth the addition of two 
appendices. The first section gives a brief summary of the theoretical 
justifications for undertaking the research and includes an account of 
the role of acetylcholine at the neuromuscular synapse and an account 
of the receptor theory of neuromuscular blockade. The classification 
of neuromuscular blocldLng agents is then discussed and a survey given 
of the two point, multi-point and one point attachment theories. These 
considerations are followed by a discussion of rigid bis quaternary 
molecules leading to an outline of the factors influencing the choice 
of the compounds whose syntheses were to be attempted and an account 
of the synthetic routes proposed.
The second section of the thesis is a report of the preparation 
and reduction of a number of methanesulphonates derived from hydroxy 
5p- and 5a-cholanes. These studies were deemed necessary in view of 
the poor yields of £-toluenesulphonates vihich were encountered in certain 
instances and indeed it was found that utilisation of methanesulphonyl 
chloride rather than the more commonly employed p-toluenesulphoi^/l 
chloride afforded superior yields of sulphonate esters. In the course 
of this work it was shown that the material previously reported as 
5a,12a-dihydroxy-6p-cholane was in fact a mixture of this compound with 
12a, 24-dihydroxy-5p-cholane. Selectivity of sulphonation of the 
hydroxyl groups at positions 5,7,12 and 24 of the cholane skeleton is 
discussed. lithium aluminium hydride reduction of the sulphonate esters
was shown to hydrogenolyse the sulphonyloxy group when it is in the 
equatorial configuration and to generate the parent alcohol when the 
sulphonyloxy group has the axial configuration. Gas liquid chromato­
graphic analyses of certain conrolex mixcures of steroidal hydrocarbons 
are reported.
The third section of the thesis reports the results of a study 
of the reductions under a variety of conditions, of 12-oximino-5p-cholane 
and 12-oximino-5a-cholane. In all instances only the 12a-amino compound 
was obtained and the assignments of configuration are rigorously proved. 
All attempts to obtain 12p-amino compounds by nucleophilic displacement 
reactions were unsuccessful.
The fourth section of the thesis records attempts to synthesise 
various steroidal bis quaternary ammonium conpounds.
Appendix I consists of the reprints of a review article entitled, 
"Biological Activity in Steroids Possessing Nitrogen Atoms", published 
in two parts and prepared as a general background with which to place 
the present work in perspective. An addendum indicates progress in the 
field since the review was published and points out several errata in 
the review.
Appendix II describes an attempt to isolate acovenoside A, which 
would have served as a suitable material for the preparation of 1-amino 
steroids, from the trunk wood of Acocanthera longiflora Stapf. However 
although present in the seeds and bark of this tree, acovenoside A was 
not present in the woori. Another hitherto unreported cardenolide 
glycoside was shown to be present but its constitution was not establishe
